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ASDN Aldosterone sensitive distal nephron 
bw Body weight  
Ca2+ Calcium 
CCD Cortical collecting duct  
cd Control diet  
Dexa Dexamethasone  
DOCA Deoxycorticosterone acetate  
ddH2O Double distilled water 
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PDK1 Phosphoinositide dependent kinase 1  
PI-3K Phosphatidylinositide-3-kinase  
PKB Protein kinase B  
PPARγ Peroxisome proliferator activated receptor γ  
PTH Parathyroid hormone 
ROMK Renal outer medullary potassium channel  
rt Room temperature 
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SGK 1 Serum and glucocorticoid inducible kinase 1  
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TNFα Tumor necrosis factor alpha 
TRPV5 Transient receptor potential cation channel-5 
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Summary 
 
The serum- and glucocorticoid-inducible kinase (SGK1) is ubiquitously expressed and 
under genomic control by cell stress (including cell shrinkage) and hormones (including 
gluco- and mineralocorticoids). Two novel isoforms of SGK where identified and  termed 
SGK2 and SGK3, whose catalytic domains share 80% amino acid sequence identity with each 
other and with SGK1 (Kobayashi et al., (1999) Biochem J).  
The present studies examined some aspects of the renal function of mice deficient of 
kinases SGK1 and SGK1-SGK3 (knock-out, ko) compared with their wildtype littermates 
(wildtype, wt).  
SGK1 stimulate the renal epithelial Ca2+ channel TRPV5 in Xenopus oocytes cells. 
Therefore one of these studies was based on in vivo experiments performed to explore the role 
of SGK1 in the regulation of renal Ca2+ handling. 
The effects of mineralocorticoids, leading to development of renal fibrosis, on renal 
tubular Na+ reabsorption and salt appetite involve the SGK1. The kinase is highly expressed 
in fibrosing tissue. The question was raised - what is the involvement of SGK1 in renal 
fibrosis? 
Whereas SGK1 is under genomic control of mineralocorticoids and glucocorticoids, 
SGK3 is constitutively expressed. The SKG1-knockout (sgk1−/−) mouse has an impaired 
ability to retain NaCl when it is fed a salt-deficient diet. In the SGK3-knockout (sgk3−/− 
mouse fed standard and salt-deficient diets, NaCl excretion is normal. The possibility was 
considered that SGK1 and SGK3 could mutually replace each other, thus preventing severe 
NaCl loss in sgk1−/− and sgk3−/− mice. 
For in vivo experiments regarding the regulation of Ca2+ channel the sgk1−/− mice 
under control diet (cd), immunohistochemistry revealed lower abundance of TRPV5 and 
calbindin D-28K protein than in sgk1+/+ mice (colocalized in distal convoluted tubules and 
connecting tubules). Renal Ca2+ excretion under control diet was significantly lower in 
sgk1−/− than in sgk1+/+ mice. No significant differences were observed between genotypes 
under the control diet in the plasma concentrations of intact parathyroid hormone and 
1.25(OH)2D3. Under control diet absolute and fractional urinary excretion of Ca2+ was 
significantly lower in sgk1−/− than in sgk1+/+ mice. 
Under a Ca2+-deficient diet TRPV5 protein abundance markedly increased in both 
genotypes, clearly pointing to SGK1-independent regulation of TRPV5. 
In Western blot analysis, the membrane protein level of TRPV5 and cytosolic 
calbindin D-28K were lower in sgk1−/− than in sgk1+/+ mice. Quantitative real-time PCR 
measurements did not reveal statistically significant differences between the genotypes in the 
levels of mRNA encoding TRPV5 or calbindin D-28K.  
Under control diet in both genotypes renal excretion was less than 2% of the 
calculated dietary Ca2+ intake and fecal Ca2+ excretion. Under a Ca2+- deficient diet, renal 
elimination of Ca2+ decreased significantly in both sgk1−/− and sgk1+/+ mice. The ability of 
the sgk1−/− mice to decrease urinary Ca2+ output again points to SGK1- independent 
regulation of renal tubular Ca2+ reabsorption. However, the decrease of absolute and 
fractional excretion upon exposure to the Ca2+-deficient diet was blunted in the sgk1−/− mice. 
Thus, the Ca2+-deficient diet dissipated the differences of absolute and fractional Ca2+ 
excretions between sgk1−/− and sgk1+/+ mice. Replacement of tap water in the drinking bottle 
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with 1% saline led to the expected increase in urinary Na+ output, paralleled by a moderate 
increase in urinary Ca2+ output, but the urinary excretion of Ca2+ remained slightly lower in 
sgk1−/− than in sgk1+/+ mice. To explore the sensitivity of renal Ca2+ excretion to inhibition of 
Na+ reabsorption, the NKCC2 inhibitor furosemide (20 μg/g bw) was applied with or without 
the carboanhydrase inhibitor acetazolamide (50 μg/g bw). Furosemide alone increased renal 
Ca2+ excretion in sgk1−/− and sgk1+/+ mice and abolished the difference of Ca2+ excretion 
between genotypes. The additional administration of acetazolamide did not further increase 
natriuresis or calciuria.  
In conclusion, despite decrease in TRPV5 abundance in the connecting tubule, SGK1 
knockout mice are anticalciuric presumably due to a decrease in extracellular volume and 
enhancement of Na+ and Ca2+ reabsorption upstream of the aldosterone-sensitive distal 
nephron including the loop of Henle. 
To study the role of SGK1 in renal fibrosis, sgk1−/− and their wild-type littermates 
sgk1+/+ were implanted with desoxycorticosterone acetate (DOCA)-release pellets and offered 
1% saline as drinking water for 12 weeks.   
Treatment with DOCA/high salt led to a marked increase of fluid and Na+ intake in 
both genotypes. Three weeks after the initiation of DOCA/high salt treatment, the fluid intake 
increased by 3.0 ± 0.2-fold in sgk1−/− mice, and by 11.1 ± 1.9-fold in sgk1+/+ mice increasing 
even more during the whole study. After 12 weeks of treatment, body weight increased 
significantly (p<0.05) more in sgk1+/+ mice than in sgk1−/− mice and the urinary volume 
augmented significantly by 24.8 ± 5.0-fold in sgk1+/+ mice and 3.9 ± 0.4-fold in sgk1−/− mice 
with further increase until 12 weeks. DOCA/high salt treatment tended to enhance creatinine 
clearance in sgk1+/+, but decreased it in sgk1−/− mice.  
The DOCA/high salt treatment tended to increase the fractional excretion of K+ (not 
significant) in both genotypes. Within 3 weeks of DOCA/high salt treatment, the fractional 
Na+ excretion reached 42.7 ± 8.8-fold in sgk1+/+ mice and 14.5 ± 3.6-fold (n=9) in sgk1−/− 
mice and the fractional Ca2+ excretion increased 11.5 ± 3.7-fold in sgk1+/+ mice and 6.0 ± 1.3-
fold (n=9) in sgk1−/− mice. After 12 weeks of DOCA/high salt treatment blood pressure was 
significantly higher in sgk1+/+ mice than in sgk1−/− mice.  Urinary albumin excretion was 
markedly increased following treatment of sgk1+/+ mice with DOCA/high salt, the increase 
was almost absent in sgk1−/− mice, even though the increase of systemic blood pressure was 
similar up to 7 weeks of treatment of sgk1+/+ and sgk1−/− mice.  
Histological analysis revealed a marked influence of DOCA/high salt treatment on the 
morphology of kidneys from sgk1+/+ mice. The treatment was followed by marked glomerular 
enlargement with segmental glomerulosclerosis and tubulointerstitial fibrosis in sgk1+/+ mice, 
effects clearly blunted in sgk1−/− mice.  
In conclusion, SGK1 is required for the development of severe albuminuria following 
DOCA/high salt treatment whereas lack of SGK1 protects against DOCA/high-salt-induced 
albuminuria and renal fibrosis. 
To study the possibility that SGK1 and SGK3 could mutually replace each other, thus 
preventing severe NaCl loss in sgk1−/− and sgk3−/− mice, double knock-out mutants (sgk1−/− / 
sgk3−/−) were compared with their wildtype littermates (sgk1+/+/sgk3+/+). The sgk1−/−/sgk3−/− 
mice share the delayed hair growth with sgk3−/− mice and the modestly impaired renal salt 
retention with sgk1−/− mice. Blood pressure was slightly, but significantly (p<0.03), lower in 
sgk1−/−/sgk3−/− than in sgk1+/+/sgk3+/+ mice, a difference that was maintained in mice fed low-
and high-salt diets. Plasma aldosterone concentrations were significantly (p<0.01) higher in 
sgk1−/−/sgk3−/− than in sgk1+/+/sgk3+/+ mice fed control and low-salt diets. During salt 
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depletion, absolute and fractional excretions of Na+ were significantly (p< 0.01) higher in 
sgk1−/−/sgk3−/−   than in sgk1+/+/sgk3+/+ mice. The fractional Na+ excretion was significantly 
decreased by low salt diet in both sgk1+/+/sgk3+/+ mice (p<0.0001) and sgk1−/−/sgk3−/− mice 
(p<0.0001). 
 After birth, the sgk1−/−/sgk3−/− mice gained body weight slightly slower than 
sgk1+/+/sgk3+/+, mice at 12 weeks being almost identical in body weight. Exposure to low salt 
diet did not significantly alter body weight. Food intake per body weight was slightly but 
significantly larger in sgk1−/−/sgk3−/− than in sgk1+/+/sgk3+/+ mice both at control diet 
(p<0.0084) and at low salt diet (p<0.0013). Fluid intake in sgk1−/−/sgk3−/− mice similarly 
tended to increase following salt deficient diet and tended to be larger in sgk1−/−/sgk3−/− than 
in sgk1+/+/sgk3+/+ mice. Fecal dry weight was significantly higher in sgk1−/−/sgk3−/−mice on 
control diet, whereas this difference disappeared under low salt diet. Fecal Na+ excretion 
significantly decreased under low salt diet in both sgk1+/+/sgk3+/+ (p<0.0002) and 
sgk1−/−/sgk3−/− (p<0.0001) mice but no significant differences were observed between 
sgk1+/+/sgk3+/+ and sgk1−/−/sgk3−/− mice on either diet. Fecal K+ excretion, plasma 
concentrations of Na+ and K+ and the hematocrit were similar in sgk1+/+/sgk3+/+  and 
sgk1−/−/sgk3−/− mice on either diet as well as at control and low salt diet in both genotypes. 
Plasma K+ concentration tended to augment upon treatment with low salt diet and tended to be 
higher in sgk1+/+/sgk3+/+ than in sgk1−/−/sgk3−/− mice. No significant differences were 
observed in creatinine clearance and in urinary flow rate between sgk1+/+/sgk3+/+ and 
sgk1−/−/sgk3−/− mice on either diet or between control diet and low salt diet in either 
genotype. Under low salt diet urinary sodium excretion decreased significantly in both 
sgk1+/+/sgk3+/+ mice (p<0.0002) and sgk1−/−/sgk3−/− mice (p<0.0001). The absolute and 
fractional urinary K+ excretion tended to be higher in sgk1−/−/sgk3−/− than in sgk1+/+/sgk3+/+ 
mice, a difference reaching statistical significance under low salt diet (p<0.03). The low salt 
diet did not significantly influence the absolute or fractional K+ excretion in the sgk1+/+/sgk3+/+ 
mice whereas it tended to increase K+ excretion in the sgk1−/−/sgk3−/− mice. Under control diet 
blood pressure was significantly (p<0.05) lower in sgk1−/−/sgk3−/− than in sgk1+/+/sgk3+/+ 
mice. Under both low (p<0.05) and high (p<0.05) salt diet blood pressure remained 
significantly lower in sgk1−/−/sgk3−/− than in sgk1+/+/sgk3+/+ mice. 
 
 
 Renal function of kinase deficient mice 
 
 - 8 - 
 
 Renal function of kinase deficient mice 
 
 - 9 - 
 
Zusammenfassung  
 
Die Serum- und Glucocorticoid-induzierbare Kinase (SGK1) wird ubiquitär 
exprimiert, wobei die Expression durch zellulären Stress (einschließlich Zellschrumpfung) 
sowie Hormone (einschließlich Gluco- und Mineralocorticoide) reguliert wird. Zwei weitere 
Isoformen der SGK wurden identifiziert und mit SGK2 und SGK3 bezeichnet. Die 
Aminosäuresequenzen der katalytischen Domänen von SGK2 und SGK3 stimmen zu 80% 
miteinander und mit SGK1 überein (Kobayashi et al., (1999) Biochem J).  
Die vorliegenden Studien untersuchen einige Aspekte der Nierenfunktion von 
Mäusen, die keine SGK1 bzw. keine SGK1 und SGK3 exprimieren (knock-out, KO), 
verglichen mit der Wildtyp-Maus (wildtype, WT). 
SGK1 stimuliert den renalen epithelialen Ca2+- Kanal TRPV5 in den Zellen. Aus 
diesem Grund basiert eine der vorliegenden Studien auf in vivo- Experimenten zur 
Unteruschung der Funktion von SGK1 in der Regulation des renalen Ca2+-Transports. 
SGK1 ist an verschiedenen Effekten von Mineralocorticoiden beteiligt, welche zur 
Entwicklung renaler Fibrose führen sowie die tubuläre Na+- Rückresorption und das 
Verlangen nach Salz beeinflussen. Gewebe, die von Fibrose betroffen sind, zeigen eine hohe 
Expression der Kinase. Dies führte zu der Frage, welche Rolle SGK1 bei renaler Fibrose 
spielt.  
Während SGK1 auf Expressionsebene durch Gluco- und Mineralocorticoide reguliert 
ist, wird SGK3 grundsätzlich exprimiert. Die Fähigkeit der SGK1-defizienten Maus (sgk1−/−), 
unter salzarmer Ernährung NaCl zurück zu halten, ist vermindert. Dagegen ist die NaCl-
Exkretion der SGK3-defizienten Maus (sgk3−/−) sowohl bei einer Standard-Diät als auch bei 
salzarmer Ernährung unverändert. Daraufhin wurde in Erwägung gezogen, dass SGK1 und 
SGK3 sich gegenseitig in ihrer Funktion ersetzen und so einen schweren NaCl-Verlust in der 
sgk1−/−- und sgk3−/−-KO Maus verhindern können.  
Immunohistochemische Untersuchungen der in vivo-Experimente bezüglich der 
Regulation des Ca2+-Kanals zeigten unter Kontrolldiät (KD) eine geringere Häufigkeit von 
TRPV5 und des Calbindin D-28K Proteins in sgk1−/−-Mäusen verglichen mit den sgk1+/+-
Mäusen (beide Proteine kommen im distalen und verbindenden Tubulus nebeneinander vor). 
Die renale Ca2+-Exkretion unter KD war bei den sgk1−/−-Mäusen im Vergleich zur sgk1−/−-
Maus signifikant verringert. Bezüglich der Plasmakonzentrationen an intaktem 
Parathyroidhormon 1.25(OH)2D3 bestand zwischen beiden Genotypen kein signifikanter 
Unterschied. Sowohl die absolute als auch die fraktionelle Exkretion von Ca2+ mit dem Urin 
unter KD war bei den sgk1−/− KO-Mäusen signifikant geringer als bei den sgk1+/+- Mäusen. 
Unter Ca2+-armer Ernährung nahm die Häufigkeit des TRPV5-Proteins in beiden 
Genotypen deutlich zu, was auf eine SGK1-unabhängige Regulation von TPRV5 hinweist.  
Western blot-Analysen zeigten ein geringeres Vorkommen von TRPV5 und des 
cytosolischen Calbindin D-28K Proteins in sgk1−/−-KO Mäusen verglichen mit der sgk1+/+-
WT Maus. Jedoch zeigte die quantitative real-time PCR keine statistisch signifikanten 
Unterschiede zwischen beiden Genotypen in Hinblick auf die mRNA-Spiegel von TRPV5 
oder Calbindin D-28K. 
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Unter KD betrug die renale Exkretion bei beiden Genotypen weniger als 2% der 
kalkulierten Ca2+-Aufnahme aus dem Gehalt in der Diät und der fäkalen Ca2+-Ausscheidung. 
Unter Ca2+-armer Ernährung nahm die renale Eliminierung von Ca2+ sowohl bei der sgk1−/−-
KO Maus als auch bei der sgk1+/+-Maus signifikant ab. Die Fähigkeit der sgk1−/−- Maus, den 
renalen Ca2+-Verlust noch weiter zu reduzieren, deutet erneut auf eine SGK1-unabhängige 
Regulation der tubulären Ca2+-Rückresorption in der Niere hin. Allerdings war die 
beobachtete Abnahme sowohl der absoluten als auch der fraktionellen Ausscheidung unter 
Ca2+-armer Diät bei der sgk1−/−-KO Maus abgeschwächt. Folglich verringerte die Ca2+-arme 
Diät die Unterschiede zwischen WT und KO bezüglich der absoluten und fraktionellen Ca2+-
Exktretion. Wurde das Wasser in der Trinkflasche durch 1% Kochsalzlösung ersetzt, nahm 
die renale Na+-Ausscheidung wie erwartet zu. Dieser Effekt wurde von einem moderaten 
Anstieg der renalen Ca2+- Ausscheidung begleitet. Dabei war die Ca2+- Ausscheidung bei den 
sgk1−/−- Mäusen etwas geringer im Vergleich zu den sgk1+/+-Mäusen. Zur Untersuchung der 
Abhängigkeit der renalen Ca2+-Ausscheidung von einer Hemmung der Na+-Rückresorption 
wurde der NKCC2 - Inhibitor Furosemid (20 μg/g KG) allein bzw. in Kombination mit dem 
Carboanhydrase-Inhibitor Acetazoamid (50 μg/g KG) appliziert. Furosemid allein führte 
sowohl bei den sgk1−/−- Mäusen als auch bei den sgk1+/+-Mäusen zu einem Anstieg der 
renalen Ca2+- Ausscheidung und zur Aufhebung der Unterschiede in der Ca2+-Exkretion 
zwischen beiden Genotypen. Die zusätzliche Gabe von Acetazoamid hatte keinen weiteren 
Anstieg der Natriurese oder Calciurie zufolge.  
Zusammenfassend kann gesagt werden, dass SGK1-KO Mäuse trotz einer geringeren 
Häufigkeit von TRPV5 im verbindenden Tubulus keine Calciurie aufweisen. Dies beruht auf 
einem verringerten extrazellulären Volumen sowie einer verstärkten Rückresorption von Na+ 
und Ca2+ stromaufwärts des Aldosteron-sensitiven distalen Nephrons einschließlich der 
Henle-Schleife.  
Zur Untersuchung der Rolle von SGK1 in der renalen Fibrose wurden sgk1−/−-Mäuse 
und deren sgk1+/+- Wurfgeschwister 12 Wochen lang mit die Desoxycorticosteronacetat 
(DOCA)-Freisetzung anregenden Pellets gefüttert und das Trinkwasser mit 1% Kochsalz 
versetzt.  
Die DOCA/Hochsalz-Diät führte bei beiden Genotypen zu einem deutlichen Anstieg 
der Flüssigkeits- und Na+-Aufnahme 3 Wochen nach Beginn der beschriebenen Diät konnte 
ein Anstieg der Flüssigkeitsaufnahme um das 3.0 ± 0.2-fache bei den KO-Mäusen bzw. um 
das 11.1 ± 1.9-fache bei den WT-Mäusen beobachtet werden, wobei es im restlichen Verlauf 
der Studie zu einer weiteren Steigerung in der Flüssigkeitsaufnahme kam.   
Nach 12 Wochen Diätgabe wiesen die sgk1+/+ - Mäuse eine signifikant (p<0.05) 
höhere Zunahme an Körpergewicht auf als ihre sgk1−/−-Wurfgeschwister. Weiterhin nahm das 
Urinvolumen bis zum Ende der 12 Versuchswoche signifikant um das 24.8 ± 5.0-fache bei 
den sgk1+/+- WT Mäusen bzw. um das 3.9 ± 0.4-fache bei den sgk1−/−-KO Mäusen zu. Die 
DOCA/Hochsalz-Diät führte tendenziell zu einer Steigerung der Kreatinin-Clearance bei den 
WT-Mäusen, bei den KO-Mäusen dagegen jedoch zu einem Rückgang der Kreatinin-
Clearance.  
Die Gabe der DOCA/Hochsalz - Diät hatte tendenziell eine Zunahme der fraktionellen 
K+-Ausscheidung (nicht signifikant) bei beiden Genotypen zufolge. Bereits nach 3 Wochen 
der DOCA/Hochsalz - Diät wies die Na+-Exkretion einen 42.7 ± 8.8-fachen Anstieg bei den 
sgk1+/+- Mäusen bzw. einen Anstieg um das 14.5 ± 3.6-fache (n=9) bei den sgk1−/−- Mäusen 
auf. Die fraktionelle Ca2+-Ausscheidung stieg um das 11.5 ± 3.7-fache bei den sgk1+/+- 
Mäusen und um das 6.0 ± 1.3-fache (n=9) bei den sgk1−/−- Mäusen an. Nach 12 Wochen der 
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DOCA/Hochsalz - Diät wiesen die sgk1+/+-Mäuse einen signifikant höheren Blutdruck auf als 
ihre sgk1−/− - Wurfgeschwister. Die Albuminausscheidung über den Urin war  bei den 
sgk1+/+- Mäusen nach Gabe der DOCA/Hochsalz - Diät deutlich gesteigert. Dieser Effekt 
blieb bei den sgk1−/− - Mäusen dagegen nahezu aus, obwohl der systemische Blutdruck bei 
beiden Genotypen während der ersten 7 Wochen des Experimentes gleich war.   
Histologische Untersuchungen zeigten einen deutlichen Einfluss der DOCA/Hochsalz-
Diät auf die Morphologie der Niere der sgk1+/+- Mäuse. Die Diät führte zu einer merklichen 
Vergrößerung der Glomerula mit segmentaler Glomerulosklerose und tubulointerstitieller 
Fibrose bei den sgk1+/+ - WT Mäusen, während diese Effekte bei den sgk1−/−- KO Mäusen 
nur in abgeschwächter Form auftraten.  
Zusammengefasst zeigt sich, dass SGK1 an der Entwicklung einer schweren 
Albuminurie als Folge einer DOCA/Hochsalz-Diät beteiligt ist, während das Fehlen von 
SGK1 vor einer DOCA/Hochsalz-Diät induzierten Albuminurie und renaler Fibrose schützt.  
Zur Untersuchung der Hypothese, dass SGK1 und SGK3 sich gegenseitig ersetzen 
können, um so einem schweren NaCl-Verlust bei sgk1−/−- und sgk3−/− -KO Mäusen entgegen 
zu wirken, wurden Doppel-KO-Mutanten (sgk1−/− / sgk3−/−) mit ihren WT-Wurfgeschwistern 
(sgk1+/+/sgk3+/+) verglichen. Die sgk1−/−/sgk3−/−- Mäuse wiesen den gleichen verminderten 
Haarwuchs wie die sgk3−/−- Mäuse sowie die mäßig beeinträchtigte renale Salzretention wie 
die sgk1−/−- Mäuse auf. Der Blutdruck der Doppel-KO Mutanten war leicht, aber signifikant 
(p<0.03) verringert gegenüber der sgk1+/+/sgk3+/+- WT Maus. Dieser Unterschied konnte 
sowohl bei salzarmer als auch bei salzreicher Diät beobachtet werden. Die Plasma-
Aldosteronkonzentrationen waren unter Gabe von KD und salzarmer Diät bei den 
sgk1−/−/sgk3−/−- Mäusen signifikant (p<0.01) höher als bei den sgk1+/+/sgk3+/+  - Mäusen. 
Unter Salzdepletion waren die absolute und fraktionelle Na+-Exkretion bei den 
sgk1−/−/sgk3−/−- Mäusen signifikant (p< 0.01) höher als bei den sgk1+/+/sgk3+/+-Mäusen. Die 
fraktionelle Na+-Ausscheidung war unter salzarmer Ernährung sowohl bei den 
sgk1−/−/sgk3−/−-Mäusen als auch bei den sgk1+/+/sgk3+/+-Mäusen signifikant verringert 
(p<0.0001). 
Nach der Geburt nahmen die sgk1−/−/sgk3−/−- Mäuse etwas langsamer an Gewicht zu 
als die sgk1+/+/sgk3+/+-Mäuse, nach 12 Wochen wiesen beide Genotypen jedoch das selbe 
Körpergewicht auf. Die Fütterung der salzarmen Diät hatte keinen signifikanten Einfluss auf 
das Körpergewicht der Tiere. Die Nahrungsaufnahme pro Körpergewicht war bei den 
sgk1−/−/sgk3−/−-Mäusen nur wenig, aber signifikant höher als bei den sgk1+/+/sgk3+/+ -Mäusen 
sowohl unter Kontrolldiät (p<0.0084) als auch unter salzarmer Ernährung (p<0.0013). Die 
Flüssigkeitsaufnahme der sgk1−/−/sgk3−/−-Mäuse schien infolge salzarmer Ernährung 
zuzunehmen und war tendentiell höher als bei den sgk1+/+/sgk3+/+-Mäusen. Das 
Trockengewicht der Fäzes war bei den  sgk1−/−/sgk3−/−-Mäusen unter Kontrolldiät signifikant 
höher. Dieser Unterschied konnte unter salzarmer Ernährung nicht festgestellt werden. Die 
fäkale Na+-Exkretion nahm bei salzarmer Diät signifikant sowohl bei den sgk1+/+/sgk3+/+-
Mäusen (p<0.0002) als auch bei den sgk1−/−/sgk3−/−-Mäusen (p<0.0001) ab, während unter 
KD keine signifikanten Unterschiede bezüglich der fäkalen Na+-Ausscheidung zwischen 
beiden Genotypen festgestellt werden konnten. Die fäkale K+-Ausscheidung, die 
Plasmakonzentrationen von Na+ und K+ sowie der Hämatokrit waren bei den sgk1+/+/sgk3+/+- 
und sgk1−/−/sgk3−/−-Mäusen sowohl unter KD als auch bei salzarmer Ernährung gleich. Die 
Plasmakonzentration an K+ schien unter salzarmer Diät zuzunehmen und war tendentiell 
höher bei den sgk1+/+/sgk3+/+-Mäusen im Vergleich zu den Doppel-KO Mäusen. Bezüglich 
der Kreatinin-Clearance und des Urinvolumens bestanden keine signifikanten Unterschiede 
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zwischen beiden Genotypen bei beiden Diäten sowie zwischen den beiden Ernährungsformen 
bei dem jeweiligen Genotyp. Unter salzarmen Ernährungsbedingungen nahm die Na+-
Ausscheidung sowohl bei den sgk1+/+/sgk3+/+-Mäusen (p<0.0002) als auch bei den 
sgk1−/−/sgk3−/−- Mäusen (p<0.0001) signifikant ab. Die absolute und fraktionelle K+-
Ausscheidung schien bei den sgk1−/−/sgk3−/−-Mäusen höher zu sein als bei den 
sgk1+/+/sgk3+/+-Mäusen. Dieser Unterschied erreichte unter salzarmer Diät statistische 
Signifikanz (p<0.03). Die salzarme Ernährung hatte bei den sgk1+/+/sgk3+/+-Mäusen keinen 
signifikanten Einfluss auf die absolute oder fraktionelle K+-Exkretion, wogegen es bei den 
sgk1−/−/sgk3−/−- Mäusen zu einer tendenziell gesteigerten K+-Ausscheidung kam. Unter 
Kontrolldiät war der Blutdruck der sgk1−/−/sgk3−/−-Mäuse signifikant niedriger (p<0.05) im 
Vergleich zu ihren sgk1+/+/sgk3+/+-Wurfgeschwistern. Sowohl unter salzarmer Ernährung 
(p<0.05) als auch bei salzreicher Diät (p<0.05) war der Blutdruck der sgk1−/−/sgk3−/−- Mäuse 
signifikant niedriger als bei den sgk1+/+/sgk3+/+- Mäusen. 
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1. Introduction 
 
1.1. Kidney anatomy 
 
The kidneys are organs that filter wastes (such as urea) from the blood and excrete 
them, along with water, as urine. The medical field that studies the kidneys and diseases of 
the kidney is called nephrology (nephro- meaning kidney is from the Ancient Greek word 
nephros; the adjective renal meaning related to the kidney is from Latin rēnēs, meaning 
kidneys). In humans, the kidneys are located in the posterior part of the abdomen. There is 
one on each side of the spine; the right kidney sits just below the liver, the left below the 
diaphragm and adjacent to the spleen. Above each kidney is an adrenal gland (also called the 
suprarenal gland). The asymmetry within the abdominal cavity caused by the liver results in 
the right kidney being slightly lower than the left one while the left kidney is located slightly 
more medial. The kidneys are retroperitoneal, which means they lie behind the peritoneum, 
the lining of the abdominal cavity. They are approximately at the vertebral level T12 to L3. 
The upper parts of the kidneys are partially protected by the eleventh and twelfth ribs, and 
each whole kidney is surrounded by two layers of fat (the perirenal and pararenal fat) which 
help to cushion it. Congenital absence of one or both kidneys, known as unilateral or bilateral 
renal agenesis can occur. In a normal human adult, each kidney is about 10 cm long, 5.5 cm in 
width and about 3 cm thick, weighing 150 grams. Together, kidneys weigh about 0.5% of a 
person's total body weight. The kidneys are "bean-shaped" organs, and have a concave side 
facing inwards (medially). On this medial aspect of each kidney is an opening, called the 
hilum, which admits the renal artery, the renal vein, nerves, and the ureter. The outer portion 
of the kidney is called the renal cortex, which sits directly beneath the kidney's loose 
connective tissue/fibrous capsule. Deep to the cortex lies the renal medulla, which is divided 
into 10-20 renal pyramids in humans. Each pyramid together with the associated overlying 
cortex forms a renal lobe. The tip of each pyramid (called a papilla) empties into a calyx, and 
the calices empty into the renal pelvis. The pelvis transmits urine to the urinary bladder via 
the ureter. 
 
Blood supply 
Each kidney receives its blood supply from the renal artery, two of which branch from 
the abdominal aorta. Upon entering the hilum of the kidney, the renal artery divides into 
smaller interlobar arteries situated between the renal papillae. At the outer medulla, the 
interlobar arteries branch into arcuate arteries, which course along the border between the 
renal medulla and cortex, giving off still smaller branches, the cortical radial arteries 
(sometimes called interlobular arteries). Branching off these cortical arteries are the afferent 
arterioles supplying the glomerular capillaries, which drain into efferent arterioles. Efferent 
arterioles divide into peritubular capillaries that provide an extensive blood supply to the 
cortex. Blood from these capillaries collects in renal venules and leaves the kidney via the 
renal vein. Efferent arterioles of glomeruli closest to the medulla (those that belong to 
juxtamedullary nephrons) send branches into the medulla, forming the vasa recta. Blood 
supply is intimately linked to blood pressure. 
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Figure nr. 1 - Kidney structure. 
Parts of the kidney: 1. Renal pyramid; 2. Efferent vessel; 3. Renal artery; 4. Renal vein; 5. Renal hilum; 6. Renal 
pelvis; 7. Ureter; 8. Minor calyx; 9. Renal capsule; 10. Inferior renal capsule; 11. Superior renal capsule; 12. 
Afferent vessel; 13. Nephron; 14. Minor calyx; 15. Major calyx; 16. Renal papilla; 17. Renal column. 
 
 
The basic functional unit of the kidney is the nephron, of which there are more than a 
million within the cortex and medulla of each normal adult human kidney. Nephrons regulate 
water and solute within the cortex and medulla of each normal adult human kidney. Nephrons 
regulate water and soluble matter (especially electrolytes) in the body by first filtering the 
blood under pressure, and then reabsorbing some necessary fluid and molecules back into the 
blood while secreting other, unneeded molecules. Reabsorption and secretion are 
accomplished with both cotransport and countertransport mechanisms established in the 
nephrons and associated collecting ducts. 
 
Collecting duct system 
The fluid flows from the nephron into the collecting duct system. This segment of the 
nephron is crucial to the process of water conservation by the organism. In the presence of 
antidiuretic hormone (ADH; also called vasopressin), these ducts become permeable to water 
and facilitate its reabsorption, thus concentrating the urine and reducing its volume.  
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Figure nr. 2 - Nephron structure. 
 
Conversely, when the organism must eliminate excess water, such as after excess fluid 
drinking, the production of ADH is decreased and the collecting tubule becomes less 
permeable to water, rendering urine dilute and abundant. Failure of the organism to decrease 
ADH production appropriately, a condition known as syndrome of inappropriate ADH 
(SIADH), may lead to water retention and dangerous dilution of body fluids, which in turn 
may cause severe neurological damage. Failure to produce ADH (or inability of the collecting 
ducts to respond to it) may cause excessive urination, called diabetes insipidus (DI). A second 
major function of the collecting duct system is the maintenance of acid-base homeostasis. 
After being processed along the collecting tubules and ducts, the fluid, now called urine, is 
drained into the bladder via the ureter, to be finally excluded from the organism. 
 
Functions 
The kidneys have four major responsibilities: 
• Balancing body fluids 
Healthy kidneys know how much fluid to get rid of and how much to save for the 
body to function properly. 
• Balancing body chemicals 
Healthy kidneys are responsible for maintaining a proper balance of various chemicals 
your body needs to function. One of the most important of these is potassium, which is 
needed for nerve and muscle control. Too much or too little potassium can cause weak 
muscles and heart problems. Healthy kidneys are also active in balancing the levels of 
calcium, phosphorus and magnesium in your blood. 
• Removal of waste products 
A waste product called urea is formed from the breakdown of protein from the foods 
you eat. Another waste product called creatinine is formed by normal muscle activity.  
• Release of essential hormones 
Normal, healthy kidneys release several vital hormones into the bloodstream, 
including:  
1. renin, which helps regulate blood pressure,  
2. erythropoietin (EPO), which helps bone marrow make red blood cells, 
3. a activated form of vitamin D, which regulates calcium absorption from 
food and helps maintain healthy bones, 
4. urodilatin. 
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Every 24 hours, the kidneys filter and clean about 200 quarts of fluid from the blood. 
Of this, about 198 quarts are absorbed back and retained in the body, and about two quarts are 
sent to the bladder in the form of urine. 
 
Excretion of waste products 
The kidneys excrete a variety of waste products produced by metabolism, including 
the nitrogenous wastes: urea (from protein catabolism) and uric acid (from nucleic acid 
metabolism) and water. 
 
Homeostasis 
The kidney is one of the major organs involved in whole-body homeostasis. Among 
its homeostatic functions are acid-base balance, regulation of electrolyte concentrations, 
control of blood volume, and regulation of blood pressure. The kidneys accomplish these 
homeostatic functions independently and through coordination with other organs, particularly 
those of the endocrine system. The kidney communicates with these organs through hormones 
secreted into the bloodstream. 
 
Acid-base balance 
The kidneys regulate the pH, by eliminating H ions concentration called augmentation 
mineral ion concentration, and water composition of the blood. By exchanging hydronium 
ions and hydroxyl ions, the blood plasma is maintained by the kidney at a slightly alkaline pH 
of 7.4. Urine, on the other hand, is acidic at pH 5 or alkaline at pH 8. The pH is maintained 
through four main protein transporters: NHE3 (a sodium-hydrogen exchanger), V-type H-
ATPase (an isoform of the hydrogen ATPase), NBC1 (a sodium-bicarbonate cotransporter) 
and AE1 (an anion exchanger which exchanges chloride for bicarbonate). Due to the polar 
alignment of cells in the renal epithelia NHE3 and the H-ATPase are exposed to the lumen 
(which is essentially outside the body), on the apical side of the cells, and are responsible for 
excreting hydrogen ions (or protons). Conversely, NBC1 and AE1 are on the basolateral side 
of the cells, and allow bicarbonate ions to move back into the extracellular fluid and thus are 
returned to the blood plasma.  
 
Blood pressure 
Sodium ions are controlled in a homeostatic process involving aldosterone which 
increases sodium ion reabsorption in the distal convoluted tubules.When blood pressure 
becomes low, a proteolytic enzyme called Renin is secreted by cells of the juxtaglomerular 
apparatus (part of the distal convoluted tubule) which are sensitive to pressure. Renin acts on 
a blood protein, angiotensinogen, converting it to angiotensin I (10 amino acids). Angiotensin 
I is then converted by the Angiotensin-converting enzyme (ACE) in the lung capillaries to 
Angiotensin II (8 amino acids), which stimulates the secretion of Aldosterone by the adrenal 
cortex, which then affects the kidney tubules. 
Aldosterone stimulates an increase in the reabsorption of sodium ions from the kidney 
tubules which causes an increase in the volume of water that is reabsorbed from the tubule. 
This increase in water reabsorption increases the volume of blood which ultimately raises the 
blood pressure. 
 
Plasma volume 
Any significant rise or drop in plasma osmolality is detected by the hypothalamus, 
which communicates directly with the posterior pituitary gland. A rise in osmolality causes 
the gland to secrete antidiuretic hormone, resulting in water reabsorption by the kidney and an 
increase in urine concentration. The two factors work together to return the plasma osmolality 
to its normal levels. 
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1.2. Protein kinase  
 
A protein kinase is a kinase enzyme that modifies other proteins by chemically adding 
phosphate groups to them (phosphorylation). This usually results in a functional change of the 
target protein (substrate) by changing enzyme activity, cellular location, or association with 
other proteins. Up to 30% of all proteins may be modified by kinase activity, and kinases are 
known to regulate the majority of cellular pathways, especially those involved in signal 
transduction, the transmission of signals within the cell. The human genome contains about 
500 protein kinase genes; they constitute about 2% of all eukaryotic genes. The chemical 
activity of a kinase involves removing a phosphate group from ATP and covalently attaching 
it to one of three amino acids that have a free hydroxyl group. Because protein kinases have 
profound effects on a cell, their activity is highly regulated. Kinases are turned on or off by 
phosphorylation (sometimes by the kinase itself - cis-phosphorylation/autophosphorylation), 
by binding of activator proteins or inhibitor proteins, or small molecules, or by controlling 
their location in the cell relative to their substrates.  
Disregulated kinase activity is a frequent cause of disease, particularly cancer, where 
kinases regulate many aspects that control cell growth, movement and death. Approximately 
fifty of the hundred or so known genes that have been directly linked to induction of cancer 
(i.e. oncogenes) encode protein kinases. The remainder of the oncogenes specify proteins that 
either activate kinases or are phosphorylated by kinases. Although the findings are less direct, 
aberrant cell signalling through protein kinases has also been associated with cardiovascular 
disease, diabetes, inflammation, arthritis and other immune disorders, and neurological 
disorders such as Alzheimer's disease. Over 400 human diseases have been connected to 
protein kinases. Drugs which inhibit specific kinases are being developed to treat several 
diseases, and some are currently in clinical use. 
With the sequencing of the complete human genome, it is now possible to identify all 
the related genes within distinct families. It is most efficient if a company can develop 
expertise around a single family of highly similar proteins. Lessons learned from one family 
member are most rapidly transferable to related proteins. Protein kinases are the largest family 
of related genes identified so far that encode enzymes with measurable catalytic activities that 
are suitable to screen for inhibitory drugs. 
Protein kinases are amongst the most meticulously investigated enzymes by 
researchers. There is a wealth of data about these enzymes that already serves as a solid 
foundation from which to build. The primary structures of over 500 human protein kinases are 
already known and the three-dimensional structures of many different protein kinases have 
been elucidated. Extensive artificial mutagenesis of several protein kinases has been 
performed to establish detailed structure-function relationships. After the proteases, protein 
kinases represent the most attractive candidates for molecular modelling studies to design new 
drugs. 
It is estimated that over 25% of the drug discovery efforts in pharmaceutical and 
biotech companies are focused on protein kinase inhibitors. These drugs have demonstrated 
applications for treatment of a wide range of diseases including cancer, inflammation, 
diabetes, congestive heart failure, and neurological damage. Over 60 protein kinase inhibitors 
are currently in advanced clinical trials, and three are now available in the market place 
(Herceptin, Gleevec, and Ireesa). The pharmaceutical industry has clearly come to fully 
recognize the therapeutic potential of protein kinase inhibitors. 
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In the genome of the yeast Saccharomyces cerevisiae, protein kinases represent the 
largest family of related genes (121 out of 6144 yeast genes encode protein kinases). Many of 
these kinase genes have mammalian counterparts that will substitute for them in genetically 
re-engineered yeast. In the fly Drosophila melanogaster, 319 of its 13338 genes encode 
protein kinases. In the worm C. elegans, 437 of its 18266 genes specify protein kinases. For 
all of these organisms, this translates to approximately 2% of the total genes corresponding to 
protein kinases. Recently, the complete genome of the mustard plant Arabidopsis thaliana 
was reported and it features 1049 putative protein kinases out of 25706 genes. This 
represented about 4% of that plant's genome. The human genome appears to encode 500 
protein kinases in addition to many pseudo-protein kinase genes, and these have been sub 
classified into over 57 families. There may well be additional protein kinases that remain to 
be identified. Protein kinases are readily recognized, because they feature characteristic amino 
acid sequences that distinguish these enzymes from other proteins.  
There are 5 types of protein kinase (according to the type of action): 
 
• Serine/threonine-specific protein kinases 
• Tyrosine-specific protein kinases 
• Histidine-specific protein kinases 
• Aspartic acid/glutamic acid-specific protein kinases 
• Mixed kinases 
 
1) Serine/threonine-specific protein kinases 
 
Serine/threonine protein kinases phosphorylate the -OH group of serine or threonine 
(which has similar sidechains). Activity of these protein kinases can be regulated by specific 
events (e.g. DNA damage), as well as numerous chemical signals, including cAMP/cGMP, 
diacylglycerol, and Ca2+/calmodulin. These kinases are not specific to a similar consensus 
sequence - that is there is no common "target sequence" to be phosphorylated. Since the 
substrate to be phosphorylated aligns with the kinase by several key amino acids (usually 
through hydrophopic forces and ionic bonds), a kinase is usually specific, not to a single 
substrate, but to a whole "substrate family" having common properties. The kinases are 
usually inactivated by a pseudosubstrate that binds to the kinase like a real substrate but lacks 
the amino acid to be phosphorylated. Its removal activates the kinase. The catalytic domain of 
these kinases is highly conserved.  
 
 - Phosphorylase kinase: phosphorylase kinase was the first Ser/Thr protein kinase to 
be discovered (Krebs EG et al., (1959) J Biol Chem). 
  
 - Protein kinase A: protein kinase A consists of two domains, a small domain with 
several β sheet structures and a larger domain containing several α helices. The binding sites 
for substrate and ATP are located in the catalytic cleft between the domains (or lobes). When 
ATP and substrate bind, the two lobes rotate so that the terminal phosphate group of the ATP 
and the target amino acid of the substrate move into the correct positions for the catalytic 
reaction to take place.  
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Regulation 
Protein kinase A has several functions in the cell, including regulation of glycogen, 
sugar, and lipid metabolism. It is controlled by cAMP: in the absence of cAMP, the kinase is 
a tetramer of two regulatory and two catalytic subunits (R2C2), with the regulatory subunits 
blocking the catalytic center of the catalytic subunits. Binding of cAMP to the regulatory 
subunit leads to dissociation of active RC dimers. Also, the catalytic subunit itself can be 
regulated by phosphorylation.  Downregulation of protein kinase A occurs by a feedback 
mechanism: one of the substrates that are activated by the kinase is a phosphodiesterase, 
which converts cAMP to AMP, thus reducing the amount of cAMP that can activate protein 
kinase A.  
 
 - Protein kinase C: protein kinase C is actually a family of protein kinases that require 
Ca2+, diacylglycerol, and a phospholipid such as phosphatidylcholine for activation. Thus, 
protein kinase C is activated through the same signal transduction pathway as phospholipase 
C. At least twelve members of the protein kinase C family have been identified in mammals, 
due to their high sequence homology. The protein kinase C usually means the protein kinase 
Cα enzyme.  
 
Structure and regulation 
Protein kinase C enzymes consist of an N-terminal regulatory domain and a C-
terminal catalytic domain. The kinases are inactive in the absence of activating agents, due to 
autoinhibition of the regulatory domain. They can be activated tumor promoters such as 
tetradecanoyl-phorbol-acetate (TPA) or by the cofactors Ca2+, diacylglycerol and a 
phospholipid. The common linear structure of protein kinase C enzymes is: N-
pseudosubstrate - TPA-binding - (Ca2+-binding) - ATP-binding - substrate-binding- C. 
Upon activation, protein kinase C enzymes are translocated to the plasma membrane 
by RACK proteins (membrane-bound receptor for activated protein kinase C proteins). The 
protein kinase C enzymes are known for their long-term activation: they remain activated 
after the original activation signal or the Ca2+-wave is gone. This is presumably achieved by 
the production of diacylglycerol from phosphatidylcholine by a phospholipase; fatty acids 
may also play a role in long-term activation.  
 
Function 
The consensus sequence of protein kinase C enzymes is similar to that of protein 
kinase A, since it contains basic amino acids close to the Ser/Thr to be phosphorylated. Their 
substrates are MARCKS proteins, MAP kinase, transcription factor inhibitor IκB, the vitamin 
D3 receptor VDR, Raf kinase, calpain, and the EGF receptor.  
 
Ca2+/calmodulin-dependent protein kinases: 
Also called CaM kinases, these kinases are primarily regulated by the Ca2+/calmodulin 
complex. These kinases show a memory effect on activation. Two types of CaM kinases are:  
• Specialized CaM kinases. An example is the myosin light chain kinase 
(MLCK) that phosphorylates myosin, causing muscles to contract.  
• Multifunctional CaM kinases. Also collectively called CaM kinase II, which 
play a role in many processes, such as neurotransmitter secretion, transcription factor 
regulation, and glycogen metabolism.  
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Structure and autoregulation 
The CaM kinases consist of an N-terminal catalytic domain, a regulatory domain and 
an associative domain. In the absence of Ca2+/calmodulin, the catalytic domain is auto 
inhibited by the regulatory domain, which contains a pseudo substrate sequence. Several CaM 
kinases aggregate into a homo-oligomer or hetero-oligomer. Upon activation by 
Ca2+/calmodulin, the activated CaM kinases autophosphorylate each other, in an 
intermolecular reaction.  
This has two effects:  
• An increase in affinity for the calmodulin complex, prolonging the time the 
kinase is active.  
• Continued activation of the phosphorylated kinase complex even after the 
calmodulin complex has dissociated from the kinase complex, which prolongs the 
active state even more.  
 
 
 2) Tyrosine-specific protein kinases 
 
Tyrosine-specific protein kinases phosphorylate tyrosine amino acid residues, and are, 
like serine/threonine-specific kinases, used in signal transduction. They act primarily as 
growth factor receptors and in downstream signaling from growth factors; some examples: 
• Platelet-derived growth factor (PDGF) receptor; 
• Epidermal growth factor (EGF) receptor; 
• Insulin receptor and insulin-like growth factor (IGF1) receptor; 
• Stem cell factor (scf) receptor (also called c-kit). 
 
- Receptor tyrosine kinases: 
These kinases consist of a transmembrane receptor with a tyrosine kinase domain 
protruding into the cytoplasm. They play an important role in regulating cell division, cellular 
differentiation, and morphogenesis. More than 50 receptor tyrosine kinases are known in 
mammals. 
  
Structure 
The extracellular domain serves as the ligand-binding part of the molecule. It can be a 
separate unit that is attached to the rest of the receptor by a disulfide bond. The same 
mechanism can be used to bind two receptors together to form a homo- or heterodimer. The 
transmembrane element is a single α helix. The intracellular or cytoplasmic domain is 
responsible for the (highly conserved) kinase activity, as well as several regulatory functions. 
 
Regulation 
Ligand binding causes two reactions: 
• dimerization of two monomeric receptor kinases or  
• stabilization of a loose dimer. 
 Many ligands of receptor tyrosine kinases are multivalent. Some tyrosine receptor 
kinases (e.g., the platelet-derived growth factor receptor) can form heterodimers with other 
similar but not identical kinases of the same subfamily, allowing a highly varied response to 
the extracellular signal. 
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Trans-autophosphorylation (phosphorylation by the other kinase in the dimer) of the 
kinase. 
The autophosphorylation causes the two subdomains of the intrinsic kinase to shift, 
opening the kinase domain for ATP binding. In the inactive form, the kinase subdomains are 
aligned so that ATP cannot reach the catalytic center of the kinase. When several amino acids 
suitable for phosphorylation are present in the kinase domain (e.g., the insulin-like growth 
factor receptor), the activity of the kinase can increase with the number of phosphorylated 
amino acids; in this case, the first phosphorylation is said to be a cis-autophosphorylation, 
switching the kinase from "off" to "standby". 
 
Signal transduction 
The active tyrosine kinase phosphorylates specific target proteins, which are often 
enzymes themselves. An important target is the ras protein signal-transduction chain. 
 
-  Receptor-associated tyrosine kinases: 
Tyrosine kinases recruited to a receptor following hormone binding are receptor-
associated tyrosine kinases and are involved in a number of signaling cascades, principally 
those involved in cytokine signaling (but also others, including growth hormone). One such 
receptor-associated tyrosine kinase is Janus kinase (JAK), many of whose effects are 
mediated by STAT proteins.  
 
3) Histidine-specific protein kinases 
 
Histidine kinases are structurally distinct from most other protein kinases and are 
found mostly in prokaryotes as part of two-component signal transduction mechanisms. A 
phosphate group from ATP is first added to a histidine residue within the kinase, and later 
transferred to an aspartate residue on a 'receiver domain' on a different protein, or sometimes 
on the kinase itself. The aspartyl phosphate residue is then active in signaling. 
Histidine kinases are found widely in prokaryotes, as well as in plants and fungi. The 
pyruvate dehydrogenase family of kinases in animals is structurally related to histidine 
kinases, but instead phosphorylate serine residues, and probably do not use a phospho-
histidine intermediate. 
 
4) Aspartic acid/glutamic acid-specific protein kinases 
 
5) Mixed kinases 
 
Some kinases have mixed kinase activities. For example, MEK (MAPKK), which is 
involved in the MAP kinase cascade, is a mixed serine/threonine and tyrosine kinase. 
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1.3. The SGK kinases 
 
The serum- and glucocorticoid-regulated kinase (SGK) was originally cloned from rat 
mammary tumor cells as a glucocorticoid responsive gene. The human isoform was 
subsequently cloned as a cell volume–sensitive gene upregulated by both hypertonic and 
isotonic cell shrinkage (Waldegger S. et al., (1997) Proc Natl Acad Sci; Waldegger S. et al., 
(2000) Cell Physiol Biochem). 
Because of the discovery of the 2 isoforms SGK2 and SGK3 (Kobayashi T. et al., 
(1999) Biochem J) the originally cloned kinase is labeled SGK1. SGK1 is expressed in renal 
tubular epithelial cells (Naray-Fejes-Toth A. et al., (1999) J Biol Chem; Loffing J. et al., 
(2001) Am J Physiol Renal Physiol) and its transcription is strongly stimulated by 
mineralocorticoids (Chen SY. et al., (1999) Proc Natl Acad Sci USA) suggesting a role in 
renal Na+ regulation. Indeed, coexpression of SGK1 with the renal epithelial Na+ channel 
(ENaC), in Xenopus oocytes markedly upregulates Na+ channel activity by enhancing channel 
protein abundance in the cell membrane.  
SGK kinases are expressed in a wide variety of species including shark and 
Caenorhabditis elegans. Yeast expresses two orthologs, Ypk1 and Ypk2, which are involved 
in endocytosis and required for survival. Yeast lacking Ypk1 and Ypk2 can be rescued by 
mammalian SGK1. SGKs participate in the regulation of transport, hormone release, 
neuroexcitability, cell proliferation, and apoptosis. 
Little is known about genomic regulation of SGK2 and SGK3, which appear to be less 
sensitive to hormonal regulation than SGK1.The serum- and glucocorticoid-inducible kinase-
1, SGK1, is a known downstream effector of the PI3K cascade. SGK1 belongs to the “AGC” 
family of serine-threonine kinases and shares approximately 45% to 55% homology with Akt 
in its catalytic domain. 
In contrast to Akt, SGK1 is also regulated at the transcriptional level in response to 
various hormones, growth factors, and extracellular stresses in a cell type – dependent 
manner, allowing sgk1 to be available for its targets only when needed. SGK1 was originally 
cloned from murine mammary tumor cells as a glucocorticoid-responsive gene. Human SGK1 
was subsequently cloned as a cell volume-sensitive gene upregulated by hypertonic cell 
shrinkage. Increasing evidence suggests that expression, enzymatic activity, and cellular 
localization of SGK1 are regulated in response to various stimuli controlling not only cell 
volume and epithelial transport, but also cardiac action potential and cell proliferation, 
survival, and apoptosis. Excessive transcription of SGK1 has been shown to parallel diabetic 
nephropathy, glomerulonephritis, hepatic cirrhosis, pulmonary fibrosis, and polymorphisms of 
the SGK1 gene correlated with hypertension. Despite the wide tissue distribution of sgk1 and 
its sensitivity to various stimuli, the role of SGK-1 in the cardiovascular and pulmonary 
system remained ill defined. Because heparin, an inhibitor of thrombin formation, has been 
shown to decrease SGK1 mRNA in aortic smooth muscle cells, we hypothesized that SGK1 
may play a role in thrombin signaling in human pulmonary artery smooth muscle cells 
(PASMC). We found that SGK1 is activated and induced by thrombin, that it regulates TF 
expression and activity in PASMC, and that it is present in remodeled pulmonary vessels with 
media hypertrophy associated with ph (Rachida S. et al., (2006) Circ Res). 
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1.3.1. The SGK1 
 
SGK1 was originally cloned as an immediate early gene transcriptionally stimulated 
by serum and glucocorticoids in rat mammary tumor cells (Firestone G. et al., (2003) Cell 
Physiol Biochem). The human isoform has been discovered as a cell volume-regulated gene 
upregulated by cell shrinkage. 
Transcription of SGK1 is upregulated by both serum and glucocorticoids. Several 
other hormones and mediators stimulate SGK1 transcription, including mineralocorticoids, 
gonadotropins (Lang F. et al., (2006) Physiol Rev), 1.25-dihydroxyvitamin D3 (1.25(OH)2D3), 
transforming growth factor-α (TGF-α) (Kumar JM. et al., (1999) J Am Soc Nephrol; Lang F. 
et al., (2000) Proc Natl Acad Sci USA), interleukin-6 (Mc Ewen BS. et al., (1995) Vitam 
Horm), fibroblast and platelet-derived growth factor (Mizuno H. et al., (2001) Genes Cell), 
thrombin (Belaiba R. et al., (2006) Circ Res), endothelin (Wolf Sc. et al., (2006) Biochem 
Pharmacol), as well as other cytokines (Verenivov A. et al., (2001) Physiol Biochem). 
Moreover, activation of peroxisome proliferator-activated receptor γ (PPAR γ) stimulates 
SGK1 gene transcription (Hong G. et al., (2003) Faseb J). The human isoform has been 
identified as a cell volume-regulated gene that is transcriptionally upregulated by cell 
shrinkage. 
 In renal epithelial (A6) cells, SGK1 expression is stimulated by cell swelling rather 
than cell shrinkage (Rozansky DJ. et al., (2002) Am J Physiol Renal Physiol). SGK1 
transcription is further stimulated by excessive glucose concentrations (Lang F. et al., (2000) 
Proc Natl Acad Sci USA; Saad S. et al., (2005) Kidney Int), heat shock, ultraviolet (UV) 
radiation, and oxidative stress. SGK1 transcription is inhibited by heparin (Delmolino LM. et 
al., (1997) J Cell Physiol) and by mutations in the gene MECP2, which underlies Rett 
syndrome (RTT), a disorder with severe mental retardation (Nuber UA. et al., (2005) Hum 
Mol Genet). 
Intestinal SGK1 transcription is further regulated by dietary iron (Marzullo L. et al., 
(2004) Gene). Signaling molecules involved in the transcriptional regulation of SGK1 include 
protein kinase C (Lang F. et al., (2000) Proc Natl Acad Sci USA; Mizuno H and Nishida E., 
(2001) Genes Cells), the protein kinase Raf (Mizuno H and Nishida E., (2001) Genes Cells), 
mammalian mitogen-activated protein kinase (BMK1) (Hayashi M. et al., (2001) J Biol 
Chem), mitogen-activated protein kinase (MKK1) (Davies SP. et al., (2000)  Biochem J; 
Mizuno H and Nishida E., (2001) Genes Cells), stress-activated protein kinase-2 (SAPK2, 
p38 kinase) (Bell LM. et al., (2000) J Biol Chem; Chen S. et al., (2004) Hypertension; 
Waldegger S. et al., (2000) Cell Physiol Biochem) and phosphatidylinositol (PI) 3-kinase.  
Follicle-stimulating hormone (FSH) stimulates phosphorylation and activation of 
protein kinase B (PKB/Akt) and serum and glucocorticoid-induced kinase (SGK): evidence 
for a kinase-independent signaling by FSH in granulosa cells, cAMP (Gonzalez-Robayna IJ. 
et al., (2000) Mol Endocrinol; Klingel K. et al., (2000) Am J Physiol Gastrointest Liver 
Physiol) and p53 (Maiyar AC. et al., (1996) J Biol Chem; Maiyar AC. et al., (1997) Mol 
Endocrinol).  
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Moreover, SGK1 transcription is stimulated by an increased cytosolic Ca2+ 
concentration (Klingel K. et al., (2000) Am J Physiol Gastrointest Liver Physiol) and by nitric 
oxide (Turpaev K. et al., (2005) Free Radic Biol Med). SGK1 transcript levels are increased 
by ischemia of brain (Nishida Y. et al., (2004) Brain Res) and kidney (Feng Y. et al., (2006) 
Kidney Blood Pressure Res). SGK1 expression is decreased during rejection of transplanted 
kidneys (Velic A. et al., (2005) Am J Transplant).  
Similar to its isoforms SGK2 and SGK3, SGK1 is activated by insulin and growth 
factors via phosphatidylinositol 3-kinase and the 3-phosphoinositide-dependent kinase PDK1. 
SGKs activate ion channels (e.g.: ENaC, TRPV5, ROMK, Kv1.3, KCNE1/KCNQ1, GluR1, 
GluR6), carriers (e.g., NHE3, GLUT1, SGLT1, EAAT1–5), and the Na+-K+-ATPase. They 
regulate the activity of enzymes (e.g., glycogen synthase kinase-3, ubiquitin ligase Nedd4–2, 
phosphomannose mutase-2) and transcription factors (e.g., forkhead transcription factor 
FKHRL1, α-catenin, nuclear factor kB).  
Leukocyte SGK1 transcript levels are enhanced by treatment with dialysis (Friedrich 
B. et al., (2005) Nephrol Dial Transplant). A striking increase of SGK1 expression is 
observed during wound healing (Iyer V. et al., (1999) Science) and in fibrosing tissue, such as 
diabetic nephropathy (Kumar J. M et al., (1999) J Am Soc Nephrol), glomerulonephritis 
(Friedrich B. et al., (2002) Kidney Blood Press Res), liver cirrhosis (Fillon S. et al., (2002) 
Cell Physiol Biochem), fibrosing pancreatitis (Klingel K. et al., (2000) Am J Physiol 
Gastrointest Liver Physiol), Crohn’s disease (Waldegger S. et al., (1999) Gastroenterology), 
lung fibrosis and cardiac fibrosis (Vallon V. et al., (2006) J Mol Med). SGK1 gene 
transcription is stimulated by DNA damage through p53 and activation of extracellular signal-
regulated kinase (ERK1/2) (Mizuno H. et al., (2001) Genes Cells; You H. et al., (2004) Proc 
Natl Acad Sci USA), and is also upregulated after neuronal injury (Imaizumi K. et al., (1994) 
Brain Res), neuronal excitotoxicity (Hollister R. et al., (1997) Neuroscience), and neuronal 
challenge by exposure to microgravity (David S. et al., (2005) J Neurosci).  
The promoter of the rat SGK1 gene carries several putative and confirmed 
transcription factor binding sites including those for the glucocorticoid receptor (GR), the 
mineralocorticoid receptor (MR), the progesterone receptor (PR), the vitamin D receptor 
(VDR), the retinoid X receptor (RXR), the farnesoid X receptor (FXR), the sterol regulatory 
element binding protein (SREBP), PPARγ, the cAMP response element binding protein 
(CREB), the p53 tumor suppressor protein, the Sp1 transcription factor, the activating protein 
1 (AP1), the activating transcription factor 6 (ATF6), the heat shock factor (HSF), 
reticuloendotheliosis viral oncogene homolog (c-Rel) and nuclear factor κB (NFκB), signal 
transducers and activators of transcription (STAT), the TGF-α-dependent transcription factors 
SMAD3 and SMAD4, and forkhead activin signal transducer (FAST) (Firestone G. et al., 
(2003) Cell Physiol Biochem). The regulation of SGK1 transcript levels is fast; appearance 
and disappearance of SGK1 mRNA require circa 20 min (Waldegger S. et al., (1997) Proc 
Natl Acad Sci USA).  
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Figure nr. 3 - Dual role of SGK1 in the maintenance of salt homeostasis and 
blood pressure. 
SGK1 plays a dual role in the regulation of salt balance, i.e., in the stimulation of both renal Na+ reabsorption and 
salt appetite. SGK1 contributes to aldosterone- and insulin-induced stimulation of renal Na+ reabsorption. The 
increased extracellular fluid volume (ECV) enhances the cardiac output (C.O.), thus increasing mean arterial blood 
pressure (MAP). The enhanced blood pressure leads to pressure natriuresis and thus secondarily increases renal salt 
excretion, eventually counteracting renal salt retention. A II, angiotensin II; R, total peripheral vascular resistance. 
 
 
 
SGK1 participate in the regulation of transport, hormone release, neuroexcitability, 
cell proliferation, and apoptosis. SGK1 contributes to Na+ retention and K+ elimination of the 
kidney, mineralocorticoid stimulation of salt appetite, glucocorticoid stimulation of intestinal 
Na+/H+ exchanger and nutrient transport, insulin-dependent salt sensitivity of blood pressure 
and salt sensitivity of peripheral glucose uptake, memory consolidation, and cardiac 
repolarization. 
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Figure nr. 4 - Middle: putative role of SGK1 in the regulation of K+ and Ca2+ 
channels required for stimulation of cell proliferation. 
Mitogenic factors stimulate the Ca2+ release-activated Ca2+ channel ICRAC. Ca2+ entry through this channel is highly 
sensitive to cell membrane potential, which is maintained by K+ channels. The stimulation of the voltage-sensitive K+ 
channel Kv1.3 by SGK1 may serve to maintain the cell membrane polarization and thus sustain oscillating Ca2+ entry 
through ICRAC. Left: current generated by depolarization of HEK cells overexpressing constitutively active S422DSGK1 
(sgk-SD) or the inactive K127NSGK1 mutant (sgk-KN). Right: peak Ca2+ concentration after Ca2+ entry in Ca2+-depleted 
fibroblasts from wild-type mice (sgk1+/+, open bars) or SGK1 knockout mice (sgk1-/-, solid bars) fibroblasts. Ca2+ entry 
in sgk1-/- fibroblasts is not sensitive to serum deprivation or to dexamethasone plus IGF-I (Shumilina E. et al, (2005) J 
Cell Physiol). 
 
A common SGK1 gene variant is associated with increased blood pressure and body 
weight. SGK1 may thus contribute to metabolic syndrome. SGK1 may further participate in 
tumor growth, neurodegeneration, fibrosing disease, and the sequelae of ischemia. SGK3 is 
required for adequate hair growth and maintenance of intestinal nutrient transport and 
influences locomotive behavior. In conclusion, SGK1 cover a wide variety of physiological 
functions and may play an active role in a multitude of pathophysiological conditions. There 
is little doubt that further targets will be identified that is modulated by the SGK and that 
further SGK-dependent in vivo physiological functions and pathophysiological conditions will 
be defined. 
 
 
1.3.2. The SGK1 Isoforms SGK2 and SGK3  
 
There are two paralogs of SGK1, SGK2 and SGK3/CISK, which share 80% amino 
acid identity with SGK1 and with each other in their catalytic domains (Kobayashi T. et al., 
(1999) Biochem J; Liu D. et al., (2000) Curr Biol; Dai F. et al., (1999) Genomics). 
SGK3 is expressed in all tissues tested thus far and is particularly high in the embryo, 
adult heart and spleen. Expression of SGK2 is most abundant in epithelial tissues including 
kidney, liver, pancreas, and presumably choroid plexus of the brain. The subcellular 
distribution may be nuclear and cytoplasmic, as SGK2 and SGK3 contain a similar nuclear 
localization signal sequence as SGK1. 
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  The gene encoding human SGK1 has been localized to chromosome 6q23, whereas 
the gene encoding SGK2 is localized to chromosome 20q12. SGK3 is identical to the 
cytokine-independent survival kinase CISK (Liu D. et al., (2000) Curr Biol). 
  The three enzymes differ in the region N-terminal of the C-terminal catalytic domain: 
SGK2 contains a relatively short N terminus (98 amino acids), with no discernable domain, 
whereas SGK3 has a longer N terminus (162 amino acids) comprising a phox homology (PX) 
domain (Xu J. et al., (2001) Cell Biol).  
PX domains were originally found as conserved domains in the p40phox and p47phox 
subunits of the neutrophil NADPH oxidase (phox) superoxide-generating complex (Ponting 
CP., (1996) Protein Sci). These domains are part of many proteins involved in intracellular 
protein trafficking, such as the sorting nexins. PX domains are phosphoinositide-binding 
domains that appear to be important for localization of these proteins to membranes 
(especially endosomes) enriched in phosphoinositides. In this respect, these domains resemble 
other domains such as the pleckstrin homology (PH), FYFE, FERM and ENTH domains. 
PKB/Akt contains a PH domain in its N terminus, which is important for PKB/Akt activation 
by phosphoinositide-3 kinases (PI-3Ks). This domain enables the colocalization with the 3-
phosphoinositide-dependent protein kinase-1 (PDK1), which is known to phosphorylate and 
activate PKB/Akt. Similarly, SGK3’s PX domain is involved in SGK3 localization and 
activity: It is necessary for phosphoinositide binding, endosomal localization, and proper 
kinase activity. Moreover, structural studies indicate that it may play a role in dimerization of 
the kinase. With respect to their physiological role(s), it has been shown in vitro that both the 
SGK2 and SGK3 enzymes have the same phosphorylation consensus as SGK1 (and 
PKB/Akt), namely R-X-R-X-X-(S/T). It is likely, however, that other factors, such as 
surrounding amino acids, subcellular localization, or cofactors are important for the 
specificity of and functional differences between the enzymes. For example, in Xenopus A6 
cells, only SGK1 and not the coexpressed PKB modulates the activity of the epithelial Na+
 
channel (ENaC) (Arteaga MF. et al., (2005)  Am J Physiol Renal Physiol).  
The role of SGK2 has mainly been studied in heterologous expression systems such as 
Xenopus laevis oocytes or HEK293 cells and with respect to numerous transport and channel 
proteins. These studies revealed that SGK2 can stimulate the activity of K+
 
channels such as 
the voltage- gated K+
 
channel Kv1.3 (Gamper et al., (2002) Pflügers Arc,; Henke et al., (2004) 
J Cell Physiol), Na+-K+-ATPase (Henke G. et al., (2002) Kidney Blood Press Res), KCNE1 
(Embark et al., (2003) Pflügers Arch), ENaC (Friedrich et al., (2003) Pflügers Arch), the 
glutamate transporter EEAT4 (Böhmer et al., (2004) Biochem Biophys Res Commun), and the 
glutamate receptors GluR6 (Strutz-Seebohm et al., (2005) J Physiol) and GluR1 (Strutz-
Seebohm et al., (2005a) J Physiol). All of these transport proteins are also stimulated in the 
same cellular systems by SGK1, SGK3, and/or PKB; hence, the physiological relevance of 
these findings has to be considered with caution. To define more precisely the role of SGK2, 
it will be necessary to carry out additional studies, using more relevant cell or animal systems 
and knocking down SGK2 by either RNA interference protocols or by gene inactivation. 
SGK3/CISK, which is better characterized than SGK2, was identified in a screen for 
antiapoptotic genes (Liu et al., (2000) Curr Biol) and found to act downstream of the PI-3K 
pathway and in parallel with PKB/Akt. Moreover, it was demonstrated to phosphorylate and 
inhibit Bad (a proapoptotic protein) and FKHRL1, a proapoptotic transcription factor. 
Knockout (ko) mice have been generated; these mice are viable and fertile and have normal 
Na+ handling and glucose tolerance, as opposed to the KO mice of SGK1 or PKB/Akt2 
(McCormick et al., (2004) Mol Biol Cell; Garofalo et al., (2003) J Clin Invest; Wulff et al., 
(2002) J Clin Invest). However, they display after birth a defect in hair follicle development, a 
defect preceded by disturbances in the β-catenin/Lef1 gene regulation (McCormick et al., 
(2004) Mol Biol Cell). Like SGK2, SGK3 has been implicated in the regulation of numerous 
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transporters and channels, including K+ channels (Gamper et al., (2002) Pflügers Arch; Henke 
et al., (2004) J cell Physiol); Embark et al., (2003) Pflügers Arch), Na+-K+-ATPase (Henke G. 
et al., (2002) Kidney Blood Press Res), the glutamate transporter EEAT1 (Boehmer et al., 
(2003) Cardiovasc Res), the cardiac voltage-gated Na+ channel SCN5A (Boehmer et al., 
(2003) J Neurochem), ENaC (Friedrich et al., (2003) Pflügers Arch), Na+-dicarboxylate 
cotransporter 1 (Böhmer et al., (2004) Biochem Biophys Res Commun), the chloride channel 
ClCa/barttin (Embark et al., (2004) Pflügers Arch), the epithelial Ca2+ channel TRPV5 
(Embark et al., (2004) Pflügers Arch), the Na+-phosphate cotransporter NaPi2b (Palmada M. 
et al., (2004) Cell Physiol Biochem), the amino acid transporter ASCT2 (Palmada M. et al., 
(2005) Cell Physiol Biochem), GluR1, and GluR6 (Strutz-Seebohm et al., (2005); Strutz-
Seebohm et al., (2005a) J Physiol). For the same reasons mentioned above for SGK2, 
additional studies on SGK3 will be necessary to evaluate the physiological relevance of these 
findings.  
 
1.4. Tissue distribution of SGK isoforms  
 
SGK isoforms are expressed in numerous tissues and cell lines. Among the three 
kinases, SGK1 (Waldegger et al., (1997) Proc Natl Acad Sci USA; Kobayashi et al., (1999) 
Biochem J) and SGK3 show the broadest distribution, with expression in many tissues 
including the brain, placenta, lung, liver, pancreas, kidney, heart and skeletal muscle. In situ 
hybridization studies localized SGK1 mRNA in several epithelial and/or nonepithelial cells 
within the brain (Wärntges et al., (2002) Cell Physiol Biochem; Nishida et al., (2004) Brain 
Res; Tsai et al., (2002) Proc Natl Acad Sci USA; Stichel et al., (2005) Eur J Neurosci; 
Gonzalez-Nicolini A. and McGinty F., (2002) Brain Res Gene ExpPatterns), eye (Rauz et al., 
(2003) Exp Eye Res; Rauz et al., (2003a) Invest Ophtalmol Vis Sci), lung (Wärntges et al., 
(2002) Cell Physiol Biochem) liver (Fillon et al., (2002) Comp Biochem Physiol A Mol Integr 
Physiol), ovary (Alliston et al., (2000) Endocrinology), pancreas (Klingel et al., (2000) Am J 
Physiol Gastrointest Liver Physiol), intestine (Waldegger et al., (1999) Gastroentherology) 
and kidney (Chen et al., (1999) Proc Natl Acad Sci USA; Friedrich et al., (2002) Kidney Blood 
Press res; Huber et al., (2001) Pflügers Archive).  
SGK1 mRNA expression is established very early in embryonic development, as 
indicated by in situ hybridizations on whole-mount preparations of mouse embryo (Lee et al., 
(2001) Mech Dev). By embryonic day (E) 8.5, SGK1 is already highly expressed in the 
decidua and yolk sac. By days E9.5– E12.5 it is found in the developing heart, eye, and lung, 
and it becomes highly expressed by days E13.5–E16.5 in the brain choroid plexus, kidney 
distal tubules, bronchi/bronchiole, adrenal glands, liver, thymus, and intestine (Lee et al., 
(2001) Mech Dev). In contrast to SGK1 and SGK3, SGK2 reveals a more restricted 
distribution and is highly abundant only in the liver, kidney, and pancreas, where it is found in 
two different SGK2 species, referred to as SGK2α and SGK2β (Kobayashi et al., (1999) 
Biochem J). SGK isoform expression varies also between cell lines cultured in vitro. Similar 
to its expression pattern in vivo, SGK1 is broadly expressed in cultured cells and is readily 
detectable in, for example, hepatoma cells, fibroblasts and mammary tumor cells (Webster et 
al., (1993) J Biol Chem; Kobayashi et al., (1999) Biochem J). By contrast, SGK2 mRNA is 
expressed in hepatoma cells but not in fibroblasts, whereas SGK3 is found in fibroblasts but 
not in hepatoma cells. Remarkably, all three SGK isoforms are expressed in cells derived 
from the renal cortical collecting duct (Naray-Fejes-Toth et al., (2004) Proc Natl Acad Sci 
USA).  
In mammals, SGK1 is expressed in virtually all tissues tested (Waldegger S. et al., 
(1997) Proc Natl Acad Sci USA). However, transcript levels vary profoundly among different 
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cell types of any given tissue, such as brain, eye, lung, kidney, liver, intestine, pancreas, and 
ovary. Moreover, typical expression patterns are found during embryonic development.  
 
1.5. Stimuli of SGK   
 
SGK1 is under transcriptional control of numerous stimuli. SGK1 is activated by 
insulin and growth factors via phosphatidylinositol 3-kinase and the 3-phosphoinositide-
dependent kinase PDK1. Like SGK1, the mRNA encoding SGK3 is expressed in all tissues 
examined, but SGK2 mRNA is only present at significant levels in liver, kidney and pancreas 
and, at lower levels, in the brain. The levels of SGK2 mRNA and SGK3 mRNA are not 
increased by stimulation with serum or dexamethasone. SGK2 and SGK3 are activated in 
vitro by PDK1, albeit more slowly than SGK1, and their activation is accompanied by the 
phosphorylation of Thr193 and Thr253 respectively. Like SGK1, SGK2 and SGK3 are activated 
5-fold by H2O2, to a smaller extent by insulin-like growth factor-1 (2- fold) than SGK1 (5-
fold). 
 
1.6. Regulation of SGK kinase activity 
 
To become functional, the SGK protein kinases require activation by phosphorylation, 
which is accomplished through a signaling cascade involving PI 3-kinase, the 3-
phosphoinositide (PIP3)-dependent kinase PDK1, and a yet unidentified but also PIP3-
dependent kinase that has been referred to as PDK2 or “hydrophobic motif” (H-motif) kinase 
(Collins BJ. et al., (2003) EMBO J; Frodin M. et al., (2002) EMBO J; Kobayashi T. et al., 
(1999) Biochem J; Mora A. et al., (2004) Semin Cell Dev Biol; Nilsen T. et al., (2004) J Biol 
Chem; Park J. et al., (1999) EMBO J). PIP3 is degraded by the phosphatase and tensin 
homolog PTEN (Lian Z. et al., (2005) Oncogene; Oudit GY. et al., (2004) J Mol Cell Cardiol; 
Sulis ML. et al., (2003) Trends Cell Biol), which thus disrupts PI 3-kinasedependent 
activation of the SGKs. Maximal stimulation of SGK1 activity requires the PDK1-dependent 
phosphorylation at 256Thr within the activation loop (T-loop) and phosphorylation at 422Ser in 
the hydrophobic motif at its COOH terminus by PDK2/H-motif kinase (Kobayashi T. et al., 
(1999) Biochem J; Park J. et al., (1999) EMBO J). The PDK1-mediated SGK1 
phosphorylation is facilitated when 422Ser is already phosphorylated. 
Phosphorylation of SGK1 at 422Ser promotes SGK1 binding to the PDK1 interacting 
fragment (PIF)-binding pocket and phosphorylation at 256Thr by PDK1 (Biondi RM. et al., 
(2001) EMBO J). An alternate mechanism of SGK1 activation by PDK1 involves the scaffold 
protein Na+-H+ exchanger regulating factor 2 (NHERF2). NHERF2 mediates the assembly of 
SGK1 and PDK1 via its PDZ domains and PIF consensus sequence (Chun J. et al., (2003) J 
Biochem Tokyo). NHERF2 interacts with the PDZ binding motif of SGK1 through its first 
PDZ domain and with PIF-binding pocket of PDK1 through its PIF tail. The formation of the 
ternary complex facilitates the phosphorylation of SGK1 on 256Thr in its T-loop by PDK1 
(Chun J. et al., (2003) J Biochem Tokyo).  
Most recent evidence suggests that the activation of SGK1 by PDK1 may indirectly 
involve the serine/threonine kinase WNK1 (with no lysine kinase 1) (Xu BE. et al., (2005) 
Proc Natl Acad Sci Usa). It is well established that insulin-like growth factor I (IGF-I) 
enhances SGK1 activity in a PI3-kinase-dependent manner via PDK1. Recent evidence 
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suggested a role of WNK1 in the activation of SGK1 by IGF-I (Xu BE. et al., (2005) J Biol 
Chem). According to this evidence, IGF-I induces SGK1 activity by stimulating WNK1 
phosphorylation at 58Thr, a site that is phosphorylated by protein kinase B (PKB/Akt). The 
PI3-kinase-dependent step in the activation of SGK1 by IGF-I was thus suggested to be the 
PDK1-dependent activation of PKB/Akt and the subsequent phosphorylation of WNK1 at 
58Thr (Xu BE. et al., (2005) J Biol Chem). Neither the catalytic activity nor the kinase domain 
but the NH2-terminal 220 residues of WNK1 are required for activation of SGK1 (Xu BE. et 
al., (2005) J Biol Chem). WNK1 binds SGK1 directly but does not phosphorylate it, 
suggesting that WNK1 serves as a scaffold protein to assemble other molecules required for 
maximal SGK1 activation. Its phosphorylation at 58Thr by PKB-Akt may induce binding of 
accessory proteins or a conformational change in SGK1 that stimulates the kinase. However, 
further experimental evidence is needed to elucidate how WNK1 phosphorylation promotes 
SGK1 activation. SGK2 and SGK3 may similarly be activated by PDK1 and PDK2/H-motif 
kinase. The equivalent phosphorylation sites for SGK2 and SGK3 are predicted to be at 
193Thr-356Ser and 253Thr-419Ser, respectively, but this requires further investigation. The 
kinases are also regulated by WNK1, although to a lesser extent than SGK1 (Xu BE. et al., 
(2005) J Biol Chem). 
  Replacement of the serine at position 422 by aspartate, in the human SGK, leads to the 
constitutively active S422DSGK1 (Kobayashi T. et al., (1999) Biochem J), whereas 
replacement of lysine at position 127, within the ATP-binding region required for enzymatic 
activity, with asparagine leads to the inactive K127NSGK1 (Kobayashi T. et al., (1999) 
Biochem J). Analogous mutations in the human SGK2 and SGK3 lead to the constitutively 
active S356DSGK2 and S419DSGK3 and the constitutively inactive K64NSGK2 and 
K191NSGK3. In part through the PI3-kinase pathway, SGK1 is activated by insulin 
(Kobayashi T. et al., (1999) Biochem J), IGF-I (Hayashi M. et al., (2001) J Biol Chem; 
Kobayashi T. et al., (1999) Biochem J), hepatic growth factor (HGF) (Shelly C. et al., (2002) 
J Cell Sci) and follicle stimulating hormone (FSH) (Richards JS. et al., (2002) Mol 
Endocrinol). SGK1 can be activated by bone marrow kinase/extracellular signal-regulated 
kinase 5 (BK/ERK5) or by p38α. The kinases do not phosphorylate SGK1 at 256Thr but at 
78Ser, which is outside the catalytic domain (Hayashi M. et al., (2001) J Biol Chem; Meng F. 
et al., (2005) Am J Physiol Cell Physiol). How this phosphorylation activates SGK1 is not 
known. SGK1 can also be activated by an increase of cytosolic Ca2+ activity, an effect 
presumably mediated by calmodulin - dependent protein kinase kinase (CaMKK) (Imai S. et 
al., (2003) Life Sci). Moreover, the small G protein Rac1 activates SGK1 via a PI3-kinase-
independent pathway (Shelly C. et al., (2002) J Cell Sci). Additional activators of SGK1 
include neuronal depolarization (Kumari S. et al., (2001) Brain Res), cAMP (Kumari S. et al., 
(2001) Brain Res; Perrotti N. et al., (2001) J Biol Chem; Thomas CP. et al., (2004) Am J 
Physiol Lung Cell Mol Physiol), lithium (Kumari S. et al., (2001) Brain Res), oxidation 
(Kobayashi T and Cohen P., (1999) Biochem J; Prasad N. et al., (2000) Biochemistry) and 
adhesion to fibronectin (Shelly C. et al., (2002) J Cell Sci). Similar to SGK1, SGK2 and 
SGK3 are activated by oxidation, insulin, and IGF-I through a signaling cascade. 
 Renal function of kinase deficient mice 
 
 - 31 - 
 
1.7. Degradation of SGKs 
 
SGK1 is rapidly degraded, with a half-life of 30 min (Brickley DR. et al., (2002) J 
Biol Chem). Ubiquitination of SGK1 labels the kinase for degradation by the proteasome 
(Brickley DR. et al., (2002) J Biol Chem). SGK1 degradation may be mediated by the 
ubiquitin ligase Nedd4–2 (neuronal precursor cells expressed developmentally 
downregulated) (Zhou R.et al., (2005) J Biol Chem). Nedd4–2 contains a series of tryptophan-
rich sequences (WW motifs) that interact with a proline-tyrosine PY motif present in its target 
proteins. SGK1 bears such a PY motif. Overexpression of Nedd4–2 decreases steady state 
levels of SGK1 in a dose-dependent manner by increasing SGK1 ubiquitination (presumably 
within the first 60 NH2-terminal amino acids) and subsequent degradation in the 26S 
proteasome. Conversely, silencing of Nedd4–2 by RNA interference, or loss of the NH2-
terminal amino acids, abrogates the ubiquitination and thus increases the half-life of SGK1. 
The effect of Nedd4–2 apparently requires phosphorylation of the ubiquitin ligase by SGK1, 
as SGK1 degradation is reduced by a phosphorylation site-deficient Nedd4–2 mutant (Nedd4–
2S/T-A) or by SGK1 inhibition. Accordingly, active SGK1 favors its own degradation, thus 
contributing to the limitation of its action (Zhou R. et al., (2005) J Biol Chem). 
 
1.8. Influence of SGK on renal function 
 
SGKs activate ion channels (e.g. ENaC, TRPV5, ROMK, Kv1.3, KCNE1/KCNQ1, 
GluR1, GluR6), carriers (e.g. NHE3, GLUT1, SGLT1, EAAT1–5), and the Na+-K+-ATPase. 
They regulate the activity of enzymes (e.g. glycogen synthase kinase-3, ubiquitin ligase 
Nedd4–2, phosphomannose mutase-2) and transcription factors (e.g. forkhead transcription 
factor FKHRL1). The functional significance of SGK1, SGK2, and SGK3 is still far from 
understood. Notably, all three kinases are potent regulators of ion channel activity, transport, 
and transcription (Bhargava A. and Pearce D., (2004) Trends Endocrinol Metab; Fillon S. et 
al., (2001) Comp Biochemi Physiol Mol Integr Physiol). Functional analysis of gene-targeted 
mice lacking SGK1 (Wulff P. et al., (2002) J Clin Invest) and SGK3 (McCormick JA. et al., 
(2004) Moll Biol Cell) provided insight into the functional significance of SGK1- and SGK3-
dependent regulation of physiological functions. Interestingly, neither knockout of SGK1 or 
SGK3, nor knockout of both SGK1 and SGK3 leads to a severe phenotype, suggesting that 
neither SGK1 nor SGK3 is required for survival. Closer inspection of the renal physiology of 
those mice discloses, however, multiple physiological deficits pointing to the broad functional 
role of these kinases.  
The role of SGK1 in renal Na+, K+ and Ca 2+ reabsorbtion will be discussed. 
 
a) Role of SGK1 in aldosterone dependent Na
+ 
reabsorption  
  
Although SGK isoforms are expressed in various tissues and cell types, the role of 
SGK1 in aldosterone-dependent regulation of Na+ homeostasis is the best-studied function of 
these kinases with respect to epithelial ion transport. The kidneys play a pivotal role in the 
maintenance of Na+ homeostasis. Urinary Na+ excretion must be tightly regulated to maintain 
a constant extracellular volume during varying dietary Na+ intake and extrarenal Na+ losses. 
The final control of renal Na+ excretion is achieved by the ASDN i.e. the late distal 
convoluted tubule, the connecting tubule and the cortical as well as the medullary collecting 
ducts (CCD and MCD respectively) (Loffing J. et al., (2001) Am J Physiol Renal Physiol). 
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Figure nr. 5 - Schematic picture of an ENaC (the second α-subunit is omitted for 
clarity). 
 
 
 Transepithelial Na+ transport in these segments is accomplished by Na+ entry into the 
epithelial cells via the epithelial Na+ channel (ENaC) in the luminal membrane and by exit of 
Na+ through the Na+, K+-ATPase in the basolateral plasma membrane. ENaC represents the 
rate limiting step in this process and is highly regulated (Kellenberger S. and Schild L., (2002) 
J Physiol). It is composed of three subunits (α, β and γ) (Canessa CM. et al., (1994) Nature; 
Lingueglia et al., (1993) FEBS Lett; Lingueglia et al., (1994) J Biol Chem) with a 
stoichiometry of 2α1β1γ (Firsov et al., (1998) EMBO J), although other stoichiometries have 
also been proposed (octa- or nonamers) (Eskandari et al., (1999) J Biol Chem; Snyder et al., 
(1998) J Biol Chem). Its subunits have a similar topology, with two transmembrane domains, 
one extracellular loop, and two cytoplasmic ends (Renard et al., (1994) J Biol Chem; Canessa 
CM. et al., (1994) Nature; Snyder et al., (1994) PMID). Each subunit also contains, at its C-
terminal end, a PY-motif (P-P-X-Y, where P is a proline, Y a tyrosine, and X any amino 
acid), which is known as protein: protein interaction motifs that can interact with tryptophan 
(W)-rich WW domains (Chen HI. and Sudol M., (1995) Proc Natl Acad Sci USA; Staub O. 
and Rotin D., (1996) Am Physiol Soc).  
The importance of these PY-motifs for ENaC regulation has been recognized by the 
findings that most cases of Liddle’s syndrome, K+-ATPase (Zecevic M. et al., (2004) Pflügers 
Arch; Setiawan I. et al., (2002) Pflügers Arch) with SGK1 profoundly increases the activity of 
both Na+- transporting proteins. Likewise, SGK2 and SGK3 stimulate ENaC (Friedrich B. et 
al., (2003) Pflügers Arch) and Na+- K+-ATPase (Henke G. et al., (2002) Kidney Blood Press 
Res). 
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Figure nr. 6 - Left: model for the Serum- and Glucocorticoid-inducible Kinase-1 
(SGK1)-dependent regulation of Na+ reabsorption and K+ secretion in the aldosterone-
sensitive distal nephron. 
Aldosterone binds to mineralocorticoid receptors (MR) and stimulates the expression of SGK1, α-epithelial Na+ channel 
(αENaC), renal outer medullary K+ channel (ROMK), and the Na+-K+-ATPase. αENaC associates with constitutive β- and γ-
subunits to form fully active ENaC. SGK1 can be phosphorylated on 422Ser by insulin or insulin-like growth factor I (IGF-I) 
through a signaling cascade involving phosphatidylinositol 3-kinase (PI3K) and an unknown kinase (PDK2?/hydrophobic 
motif kinase). Phosphorylated 422Ser allows binding of PDK1 and/or NHERF2 with subsequent phosphorylation of SGK1 at 
256Thr. PDK1 might activate SGK1 indirectly through phosphorylation of WNK1 kinase. The mechanism of SGK1 activation 
by WNK1 is yet unknown but does not require SGK1 phosphorylation. Activated SGK1 increases Na+ reabsorption in part 
by phosphorylation of the ubiquitin ligase Nedd4–2, allowing binding of the chaperone 14–3-3 to phosphorylated 444Ser. This 
interaction prevents Nedd4–2-mediated ubiquitination of the ENaC-PY motif and thus internalization and degradation of 
ENaC. SGK1 further stimulates ENaC by upregulation of transcription, by direct phosphorylation of the channel protein and 
by inhibition of the inducible nitric oxide synthase (iNOS). In addition to its effect on ENaC, SGK1 stimulates the Na+-K+-
ATPase and K+ channels including ROMK. Right: arithmetic means ± SE of ENaC-induced currents in Xenopus oocytes 
coexpression experiments showing that coexpression of wild-type SGK1 but not of the inactive mutant K127NSGK1 leads to 
stimulation of an ENaC mutant lacking the SGK1 phosphorylation consensus sequence (S622AENaC). 
  
 The stimulatory effect of SGK1 on ENaC is related both to an increased number of 
channels in the plasma membrane (Lang F. et al., (2000) Proc Natl Acad Sci USA; Loffing J. 
et al., (2001) Am J Physiol Renal Physiol; Alvarez de la Rosa D. et al., (1999) J Biol Chem) 
and an activation of channels already present in the membrane (Diakov A. and Korbmacher 
C., (2004) J Biol Chem). The first effect likely involves the action of Nedd4-2, as there are 
several consensus phosphorylation motifs (2–3 depending on the splice variant) on Nedd4-2 
and a PY-motif on SGK1 that may serve as a binding site for Nedd4-2.  
In Xenopus oocytes, SGK1 induces Nedd4-2 phosphorylation on two of these 
phosphorylation sites (primarily Ser444, but also Ser338) (Embark HM. et al., (2004) Cell 
Physiol Biochem; Palmada M. et al., (2004) Am J Physiol Gastrointest Liver Physiol; 
Debonneville C. et al., (2001) EMBO J), which decreases the interaction of Nedd4-2 with 
ENaC and finally leads to an enhanced expression and activity of ENaC at the cell surface 
(Debonneville C. et al., (2001) EMBO J).  
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Figure nr. 7 - Schematic view of Nedd4-2 and Sgk1. 
(A) Scheme of Xenopus Nedd4-2 with the consensus phosphorylation sites and Xenopus Sgk1 with the indication 
of the catalytic domain, the catalytically essential Lys130 and the PY motif. (B) Conserved consensus 
phosphorylation sites in mouse, human and Xenopus Nedd4-2. 
 
 
This inhibitory effect of SGK1 on Nedd4-2 likely involves 14-3-3 proteins as 
phosphorylation of Ser444 in Nedd4-2 creates a possible binding site for such proteins, an 
inherited form of salt-sensitive hypertension are caused by mutations in the genes encoding β- 
and γ -ENaC (Hansson JH. et al., (1995) Proc Natl Acad Sci USA; Shimkets RA. et al., (1994) 
Cell). These mutations invariably cause either the deletion or the mutation of the PY-motifs 
on these subunits. When such Liddle channels are expressed in heterologous systems, 
increases in both the density at the cell surface and the open probability of ENaC are observed 
(Firsov et al., (1996) Proc Natl Acad Sci USA; Snyder PM. et al., (1994) Cell; Schild et al., 
(1995) Proc Natl Acad Sci USA; Schild et al., (1996) EMBO J). Loffing and his coworkers, 
has demonstrated that these PY-motifs are the binding sites for ubiquitin-protein ligases of the 
Nedd4/Nedd4-like family (Kamynina E. et al., (2001) EMBO J) and particularly of Nedd4-2 
(Kamynina E. et al., (2001) EMBO J; Snyder PM. et al., (2004) J Biol Chem).  
It is thought that Nedd4-2 binds via its WW domains with the PY-motifs of ENaC and 
ubiquitylates ENaC on its own α and γ subunits, consequently leading to the internalization 
and degradation of ENaC in the endosomal/lysosomal system (Snyder PM. et al., (2004) J 
Biol Chem). In Liddle’s syndrome, this mechanism is impaired owing to the inactivation of a 
PY-motif, causing the accumulation of ENaC at the plasma membrane (Kamynina E. and 
Staub O., (2002) Am J Physiol Renal Physiol). The activity of ENaC and the Na+, K+-ATPase 
is tightly regulated by aldosterone and by SGK1 (Vallon V. et al., (2005) Am J Physiol Regul 
Integr Comp Physiol; Bhargava A. et al., (2004) Trends Endocrinol Metab). 
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Experiments in heterologous expression systems (i.e., X. laevis oocytes) revealed that 
coexpression of either ENaC or Na+ (consensus: R-S-X-pS-X-P) increases SGK stimulation. 
Indeed, in X. laevis oocytes, SGK1 increases the binding of 14-3-3 to Nedd4-2 in a 
phosphorylation-dependent manner, a dominant-negative 14-3-3 mutant profoundly attenuates 
SGK1-dependent stimulation of ENaC, and overexpression of the 14-3-3 protein impairs 
Nedd4-2-dependent ubiquitylation of ENaC (Ichimura T. et al., (2005) J Biol Chem).  
In addition to this indirect action of SGK1 on ENaC cell surface abundance, it was 
proposed that SGK1 can directly interact with ENaC (Wang J. et al., (2001) Am J Physiol 
Renal Physiol) and increase ENaC channel activity by phosphorylating the α-ENaC subunits 
(Diakov A. and Korbmacher C.,  (2004) J Biol Chem). Diakov and Korbmacher used outside-
out membrane patches of X. laevis oocytes expressing rat ENaC to demonstrate that addition 
of recombinant, constitutively active SGK1 directly stimulates ENaC currents two- to 
threefold. An alanine mutation of the serine residue in the SGK1 consensus R-X-R-X-X-S 
phosphorylation motif abolishes the stimulatory effect on ENaC in this experimental setting. 
Experiments in native Xenopus A6 cells expressing endogenous SGK1 and ENaC 
further confirmed that the action of SGK1 on ENaC is complex and likely involves (a) 
increases in the subunit abundance in the plasma membrane and (b) activation of channels 
already in the plasma membrane combined with an increase in ENaC open probability 
(Alvarez de la Rosa D. et al., (2004) J Physiol). However, in this model the stimulatory effect 
on ENaC channel activity cannot be explained by a direct SGK1-dependent phosphorylation 
of α-ENaC because Xenopus α-ENaC does not contain the SGK1 consensus phosphorylation 
motif. That direct phosphorylation of ENaC at the SGK1 consensus site is not essential for 
ENaC activation is also supported by data from Lang and coworkers (Lang F. et al., (2000) 
Proc Natl Acad Sci USA; Friedrich B. et al., (2002) Kidney Blood Press Res) that showed that 
channels with a serine-to-alanine mutation within the consensus site of α-ENaC are still 
rigorously upregulated by coexpression of SGK1 in Xenopus oocytes.  
NDRG-2, which is an aldosterone-induced protein in the ASDN, is another target of 
SGK1 (Boulkroum S. et al., (2002) J Biol Chem; Murray JT. et al., (2004) Biochem J). 
Although the functional role of NDRG-2 in the ASDN is not known, this protein may also 
have some function in the SGK1-dependent signaling cascade related to Na+
 
transport. As an 
aldosterone-induced protein, SGK1 is thought to mediate at least some of the physiological 
effects of aldosterone on ENaC and Na+, K+-ATPase. The stimulatory effect of aldosterone 
(or of dexamethasone) on SGK1 expression has now been firmly documented in several 
studies on various in vitro and in vivo systems, including Xenopus A6 cells (Bhargava A. et 
al., (2004) Trends Endocrinol Metab), primary rabbit CCD cells (Narey-Fejes-Toth et al., 
(1999) J BiolChem), mouse inner MCD cells (Gumz et al., (2003) Am J Physiol Renal 
Physiol), mouse mpkCCDcl4 (Flores SY.  et al., (2005) J Am Soc Nephrol), mouse M1 cells 
(Helms MN. et al., (2003) Am J Physiol Renal Phyisol) and mouse and rat kidneys (Chen et 
al., (1999) Proc Natl Acad Sci USA; Loffing et al.,(2001) Am J Physiol Renal Physiol; 
Bhargava A. et al., (2001) Endocrinology). Corticosteroids rapidly (within 30 minutes) induce 
SGK1 at the mRNA and/or protein levels. This induction precedes or at least coincides with 
enhanced phosphorylation of Nedd4-2 (Flores SY.  et al., (2005) J Am Soc Nephrol), the 
activation of transepithelial Na+
 
transport in cultured renal epithelia (Naray-Fejes-Toth A. et 
al., (1999) J Biol Chem; Bhargava A. et al., (2004) Trends Endocrinol Metab; Flores SY.  et 
al., (2005) J Am Soc Nephrol), and reduced renal Na+ secretion in intact animals (Bhargava A. 
et al., (2001) Endocrinology).  
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At least part of the stimulatory effect of aldosterone on SGK1 appears to be mediated 
by activation of the MR, as indicated by findings in primary rabbit collecting duct cells in 
vitro (Narey-Fejes-Toth et al., (1999) J Biol Chem) and kidneys in vivo (Bhargava A. et al., 
(2001) Endocrinology). Consistently, physiologically relevant concentrations of aldosterone 
are sufficient to significantly induce SGK1 mRNA in the renal cortex and outer medulla 
(Muller OG. et al., (2003) J Am Soc Nephrol). The physiological importance of aldosterone in 
SGK induction is also supported by the fact that dietary Na+
 
restriction, which physiologically 
increases plasma aldosterone, induces SGK1 mRNA in the renal cortex (Farjah M. et al., 
(2003) Hypertension). The aldosterone-dependent induction of SGK1 occurs specifically in 
the ENaC-positive cells of the ASDN, whereas SGK1 expression in other nephron portions 
such as the thick ascending limb or the proximal tubule is not increased by aldosterone. 
Likewise, the high level of expression of SGK1 in the renal papilla is not further stimulated 
by aldosterone, suggesting that SGK1 expression at this site is controlled by factors other than 
aldosterone. The renal papilla plays an important role for the urinary concentration 
mechanism, and the cells in the renal papilla can be exposed to a large variation in 
extracellular osmolarity depending on the requirements for diuresis to antidiuresis. SGK1 
expression is strongly modulated by osmotic cell shrinkage and swelling (Waldegger S. et al., 
(1997) Proc Natl Acad Sci USA; Rozansky DJ. et al., (2002) Am J Renal Physiol), and it is 
therefore conceivable that SGK1 participates in the functional adaptation of the renal papilla 
cells to fluctuation of extracellular osmolarity.  
Consistent with this notion, recent data suggest that SGK1 mediates the osmotic 
induction of the type A natriuretic peptide receptor (NPR-A) in rat inner MCD cells (Chen S. 
et al., (2004) Hypertension). Aldosterone also controls SGK1 expression in the distal colon 
(Coric CM. et al., (2004) Am J Physiol Gastrointest Liver Physiol; Bhargava A. et al., (2001) 
Endocrinology). Aldosterone-dependent Na+
 
reabsorption at this site may help to limit 
extrarenal Na+
 
losses during conditions of dietary Na+ restriction. Transepithelial Na+
 
transport 
is achieved mainly by epithelial cells that are situated at the tips of colonic crypts and that 
express high levels of ENaC (Coric CM. et al., (2004) Am J Physiol Gastrointest Liver 
Physiol) and SGK1 (Waldegger S. et al., (1999) Gastroenterology; Coric CM. et al., (2004) 
Am J Physiol Gastrointest Liver Physiol). In spite of these data pointing to aldosterone-
dependent regulation of ENaC via SGK1, recent Western blot and immunohistochemical 
studies on rat kidney and colon, which reported no or rather modest aldosterone-dependent 
induction of SGK1 at the protein level, were interpreted to question the significance of 
aldosterone-dependent induction of SGK1 for ENaC-mediated Na+ transport regulation (Coric 
CM. et al., (2004) Am J Physiol Gastrointest Liver Physiol). Support for a functional 
significance of SGK1 in regulation of transepithelial Na+ transport comes from experiments in 
X. laevis A6 cells and in mouse M1 CCD cells. 
 Transfection of A6 or M1 cells with SGK1 leads to an increase in transepithelial Na+ 
transport, whereas transfection of a dominant-negative “kinase-dead” SGK1 mutant or an 
antisense SGK1 transcript abolishes dexamethasone- and/or insulin-dependent regulation of 
transepithelial Na+ transport (Alvarez de Rosa D. et al., (2003) J Physiol; Faletti CJ. et al., 
(2002) Am J Physiol Cell Physiol). Likewise, the use of interfering RNA to knockdown SGK1 
expression in A6 cells results in a significant reduction in SGK1 protein levels and a ~50% 
reduction in dexamethasone-induced short-circuit currents (Bhargava A. et al., (2001) 
Endocrinology). Consistent with these in vitro findings, experiments in SGK1 KO (sgk1−/−) 
mice supported the importance of SGK1 for aldosterone-dependent regulation of renal Na+ 
transport (Wulff et al., (2002) J Clin Invest). Under a standard diet, the KO mice have 
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unaltered Na+ excretion as compared to their wildtype littermates. However, plasma 
aldosterone levels are significantly increased in sgk1−/− mice, suggesting extracellular volume 
contraction.  
Under dietary Na+ restriction, activated compensatory mechanisms are no longer 
sufficient to keep the mice in Na+
 
balance, and mice disclosed significant loss in renal NaCl 
and in body weight. Experiments on collecting ducts perfused ex vivo revealed significantly 
lower transepithelial amiloride-sensitive potential differences, consistent with a reduced Na+
 
transport activity in the CCD. Although apical localization of ENaC was seen in both Na+- 
restricted sgk1+/+ and sgk1−/− mice, the apical localization of ENaC is inappropriately low in 
the sgk1−/− mice given the several fold higher plasma aldosterone levels in the KO mice.  
Nevertheless, these data, together with the rather mild phenotype of sgk1−/− mice, as 
compared to the much more severe and life-threatening phenotypes of MR or ENaC ko mice, 
suggest that (a) aldosterone-dependent control of ENaC function does not solely rely on the 
induction and activation of SGK1 and (b) some redundancy exists in the signal transduction 
pathway that controls ENaC activity. Consistent with these ideas, Loffing and his coworkers 
found significant phosphorylation of the SGK1 target Nedd4-2 in mouse mpkCCDcl4 cells in 
vitro and in rat collecting ducts in vivo in the absence of any aldosterone and detectable SGK1 
protein expression (Flores SY. et al., (2005) J Am Soc Nephrol). In addition to aldosterone-
dependent regulation of renal Nareabsorption, SGK1 appears to be involved also in the 
regulation of aldosterone-induced salt appetite. Sgk1+/+ and sgk1−/− mice show a similar salt 
intake under standard conditions. Treatment with the synthetic aldosterone analogue 
deoxycorticosterone-acetate (DOCA) increases Na+ intake much more in sgk1+/+ mice than in 
sgk1−/− mice. The underlying mechanism for the reduced mineralocorticoid-induced salt 
intake is unclear (Vallon V. et al., (2005) Am J Physiol Regul Integr Comp Physiol).   
 
b) Role of SGK1 in renal K
+ 
secretion  
 
Aside from its stimulatory effect on renal Na+
 
reabsorption, aldosterone has strong 
kaliuretic action. Renal K+
 
secretion also takes place in the ASDN and is likely mediated by 
the renal outer medullary K+
 
channel ROMK. ROMK is coexpressed with ENaC in the ASDN 
cells, and Na+
 
reabsorption via ENaC provides the necessary driving force for K+ secretion. 
Consistently, pharmacological inhibition (i.e., by amiloride) or genetic loss of function (i.e., 
pseudohypoaldosteronism (PHA) type 1) of ENaC lower renal K+
 
secretion and predispose 
one to hyperkalemia.  
It remains unresolved whether the kaliuretic effect of aldosterone is entirely secondary 
to the activation of ENaC-mediated Na+
 
reabsorption or whether aldosterone directly regulates 
ROMK function. 
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Figure nr. 8 - Schematic drawing of cell signalling mechanisms of luminal (V1 
receptors) and basolateral (V2 receptors) action of arginine vasopressin (AVP). 
The role of V1 receptors and their signalling are derived from the present studies. The role of V2 receptors in 
ROMK channel stimulation is based on the studies of Cassola, Giebisch and Wang. 
 
 
 Patch-clamp studies on rat CCDs found no measurable effect of acute aldosterone 
administration on K+
 
channel number, open probability, or conductance (Palmer LG. et al., 
(1994) Am J Physiol). However, some data suggested that aldosterone induces renal K+
 
secretion already at aldosterone concentrations that do not exhibit any measurable effect on 
urinary Na+
 
excretion (Bhargava et al., (2001) Endocrinology). Moreover, high K+
 
intake 
increases ROMK activity more efficiently in intact rats than in adrenalectomized animals, 
suggesting that aldosterone may have at least a permissive effect on ROMK activation 
(Palmer LG. et al., (1994) Am J Physiol).  
Consistent with a possible role of aldosterone in ROMK regulation, recent studies in 
heterologous expression systems advocated a regulatory action of aldosterone-induced SGK1 
on ROMK cell surface activity and abundance (Palmada M. et al., (2003) Biochem Biophys 
Res Commun). The regulatory role of SGK1 with regard to ROMK may be indirect via 
increased interaction with the Na+, H+
 
exchanger–regulating factor 2 (NHERF2) (Palmada M. 
et al., (2003) Biochem Biophys Res Commun) or direct via increased phosphorylation of 
ROMK at a serine residue within the canonical SGK1 consensus phosphorylation motif (Yoo 
D. et al., (2003) J Biol Chem). 
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Figure nr. 9 - Homology model of Kir1.1 (ROMK) 
 
The in vivo significance of SGK1 in regulation of renal K+
 
transport was recently 
analyzed in SGK1 KO mice. These mice indeed show a disturbed adaptation to an acute and 
chronic K+
 
load, but, as indicated by electrophysiological and immunohistochemical data 
obtained from these mice after a chronic potassium load, this maladaptation likely is related to 
altered ENaC (or Na+, K+-ATPase) activity in the ASDN cells rather than to inhibition of 
ROMK cell surface targeting or activity (Huang DY. et al., (2004) J Am Soc Neprhol).  
 
c) Role of SGK1 in renal Ca2+
 
secretion  
Almost all physiologic processes depend, in one way or another, on calcium. From 
muscle contraction, nervous system function to intracellular signalling, calcium is essential. It 
is critical to maintain blood calcium concentrations within a tight normal range. Deviations 
above or below the normal range frequently lead to serious diseases. There are three major 
pools of calcium in the body: 
• Intracellular calcium: a large majority of calcium within cells is sequestered in 
mitochondria and endoplasmic reticulum. Intracellular free calcium concentrations 
fluctuate greatly, from roughly 100 nM to greater than 1 µM, due to release from 
cellular stores or influx from extracellular fluid. These fluctuations are integral to 
calcium's role in intracellular signaling, enzyme activation and muscle contractions. 
• Calcium in blood and extracellular fluid: roughly half of the calcium in blood is 
bound to proteins. The concentration of ionized calcium in this compartment is 
normally almost invariant at approximately 1 mM or 10000 times the basal 
concentration of free calcium within cells. Also, the concentration of phosphorus in 
blood is essentially identical to that of calcium. 
• Bone calcium: a vast majority of body calcium is in bone. Within bone, 99% of the 
calcium is tied up in the mineral phase, but the remaining 1% is in a pool that can 
rapidly exchange with extracellular calcium. 
 Renal function of kinase deficient mice 
 
 - 40 - 
Three organs participate in supplying calcium to blood and removing it from blood 
when necessary:  
• The small intestine is the site where dietary calcium is absorbed. Importantly, 
efficient absorption of calcium in the small intestine is dependent on expression of a 
calcium-binding protein in epithelial cells. 
• Bone serves as a vast reservoir of calcium. Stimulating net resorption of bone mineral 
releases calcium and phosphate into blood, and suppressing this effect allows calcium 
to be deposited in bone. 
• The kidney is critically important in calcium homeostasis. Under normal blood 
calcium concentrations, almost all of the calcium that enters glomerular filtrate is 
reabsorbed from the tubular system back into blood, which preserves blood calcium 
levels. If tubular reabsorption of calcium decreases, calcium is lost by excretion into 
urine. 
The following table summarizes body responses to changes in calcium: 
 Calcium Deprivation Calcium Loading 
Parathyroid 
hormone Secretion stimulated Secretion inhibited 
Vitamin D Production stimulated by increased parathyroid hormone secretion 
Synthesis suppressed due to 
low parathyroid hormone 
secretion 
Calcitonin Very low level secretion Secretion stimulated by high blood calcium 
Intestinal 
absorption of 
calcium 
Enhanced due to activity of vitamin D on 
intestinal epithelial cells Low basal uptake 
Release of 
calcium and 
phosphate from 
bone 
Stimulated by increased parathyroid 
hormone and vitamin D 
Decreased due to low 
parathyroid hormone and 
vitamin D 
Renal excretion 
of calcium 
Decreased due to enhanced tubular 
reabsorption stimulated by elevated 
parathyroid hormone and vitamin D; 
hypocalcaemia also activates calcium 
sensors in loop of Henle to directly 
facilitate calcium reabsorption 
Elevated due to decreased 
parathyroid hormone-
stimulated reabsorption. 
Renal excretion 
of phosphate 
Strongly stimulated by parathyroid 
hormone; this phosphaturic activity 
prevents adverse effects of elevated 
phosphate from bone resorption 
Decreased due to 
hypoparathyroidism 
General 
Response 
Typically see near normal serum 
concentrations of calcium and phosphate 
due to compensatory mechanisms. Long 
term deprivation leads to bone thinning 
(osteopenia). 
Low intestinal absorption 
and enhanced renal excretion 
guard against development 
of hypocalcaemia. 
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 Control of calcium uptake in the kidney: 
 
PTH also enhances Ca2+ reabsorption in the kidney at the ascending loop of Henle and 
the distal convoluted tubule by increasing the active uptake of calcium by Ca2+-ATPase and a 
Na+-Ca2+ antiporter. Calcium excretion rate is reduced. PTH has little effect on modulating 
calcium fluxes in the proximal tubule where 65% of the filtered calcium is reabsorbed, by 
being coupled to the transport of solutes such as sodium and water. Active Ca2+ reabsorption 
takes place in the distal convoluted tubule (DCT) and connecting tubule (CNT) of the kidney. 
PTH receptors have been detected throughout the kidney, as well as in the actively Ca2+ 
transporting tubules DCT and CNT. About 20% of filtered calcium is reabsorbed in the 
cortical thick ascending limb of the loop of Henle (CTAL) and 15% in the distal convoluted 
tubule (DCT). Here PTH also binds to the PTHR and again by a cyclic AMP-mediated 
mechanism, enhances calcium reabsorption. In the CTAL, this appears to occur by increasing 
the activity of the Na+-K+-2Cl- cotransporter that drives NaCl reabsorption and also stimulates 
paracellular calcium and magnesium reabsorption.  
The extracellular calcium sensor is also resident in the CTAL and can respond to 
increased ECF calcium by activating phospholipase A2, reducing the activity of the Na+-K+-
2Cl- cotransporter and of an apical K+ channel, and diminishing paracellular calcium and 
magnesium reabsorption. Consequently raised ECF calcium antagonizes the effect of PTH in 
this region of the kidney and ECF calcium can regulate its own homeostasis.  
In the DCT, PTH can also influence transcellular calcium transport. This is a multistep 
process involving transfer of luminal Ca2+ into the renal tubule cell via the transient receptor 
potential channel (TRPV5) or ECaC (epithelial calcium channel), translocation of Ca2+ across 
the cell from apical to basolateral surface a process involving proteins such as calbindin-
D28K and finally active extrusion of Ca2+ from the cell into the blood via a Na+-Ca2+ 
exchanger, designated NCX1 and the Ca2+ -ATPase pump. PTH markedly stimulates Ca2+ 
reabsorption in the DCT primarily by augmenting NCX1 activity via a cyclic AMP-mediated 
mechanism.  
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Transient receptor potential channels (TRPs) 
 
The mammalian TRP channels encode a family of about 30 ion channel proteins. This 
superfamily consists of seven diverse groups structurally similar to the originally found 
Drosophila TRP and they differ in ion selectivities, modes of activation and physiological 
functions.  
 
 
 
 
Figure nr. 10 - TRP family with its subgroups. 
The vanilloids, the classical, the melastatin, the mucolipins (TRPML) and the polycystins (TRPP) (members of 
TRPN, TRPA not shown).  
 
TRP proteins are expressed predominantly in the nervous system and are of particular 
importance in sensory physiology. (Montell C. et al., (2005) Sci STKE).   
In each subfamily are three to eight members. (Hönderop JG. et al., (2005) Physiol 
Rev). The reason to identify mammalian TRPs is to characterize those channels that might 
account for highly Ca2+ selective Ca2+ entry mechanism in nonexcitable cells, referred to as 
store-operated Ca2+ entry (SOCE). SOCE is interesting, due to association of these modes of 
Ca2+ entry with processes ranging from T cell activation to apoptosis, cell proliferation, fluid 
secretion and cell migration.(Montell C. et al., (2005) Sci STKE.). The TRP superfamily can 
be divided into two structurally different groups (Clapham DE. et al., (2003) Pharmacol Rev):  
• Group 1: TRPC, TRPV, TRPM, TRPN, TRPA. They share substantial 
sequence identity in the transmembrane domains.  
• Group 2: TRPP and TRPML. They have low sequence similarity and a large 
extracellular loop between the first and the second transmembrane domains. 
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Figure nr. 11 - The seven TRP subfamilies. 
Representatives of the different subfamilies are indicated at the top and bottom, respectively. Several domains are 
indicated: ankyrin repeats (A), coiled coil domain (cc), protein kinase domain (TRPM6/7 only), transmembrane 
segments, and the TRP domain. 
 
TRP proteins are supposed to form 6 membrane-spanning segments whereas the pore 
region is formed by a hydrophilic region between S5 and S6 forms. The N- and C-termini are 
located intracellular. The N-terminus often contains ankyrin repeats as well as a coiled-coil 
domain, which are suspected to bind with other proteins or the cytoskeleton. Especially they 
are thought to be needed for TRP protein interaction because a functional channel contains 4 
TRP subunits, either similar or different ones, to form homo- or heteromers. 
 
 
 
Figure nr. 12 - The quaternary structure of TRP channels allows homo- or 
heteromeric configurations. 
Left: TRP channel subunit, right: structure of functional TRP channel.  
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TRPV (vanilloid) family has six mammalian members grouped into three subfamilies. 
These proteins contain three to five ankyrin repeats and share ~25% amino acid identity to 
TRPC proteins (Montell C. et al, (2005) Sci STKE). TRPV1-TRPV4 form poor selective 
cation channels and are sensitive to heat (Hellwig N. et al., (2005) J Cell Sci). TRPV5 and 
TRPV6 are phylogenetically closely related Ca2+ selective channels (PCa: PNa > 100) 
expressed in epithelia of kidney and intestine and exhibit a constitutive activity (Clapham DE. 
et al., (2003) Pharmacol Rev). Both proteins become permeable to monovalent cations in the 
absence of divalent cations. It was proposed that TRPV6 may be the highly Ca2+-selective, 
store-operated channels, referred to CRAC but several biophysical properties of TRPV6 are 
distinct from those of ICRAC (Kahr H. et al., (2004) J Physiol). Nevertheless there remains 
still the option that TRPV5/ TRPV6 may be subunits of CRAC channels.  
TRPM (long TRPC, melastatin) family is composed of eight members. They share 
~20% identity, have a TRP domain and contain ankyrin repeats at the N-terminus which is 
longer than that of TRPCs and TRPVs (Fleig A. et al., (2004) Novartis Found Symp). 
Transient receptor potential (TRP) cation channel subfamily V, members 5 and 6 
(TRPV5 and TRPV6) have recently been postulated to be the molecular gatekeepers 
facilitating Ca2+ influx in these tissues and are members of the TRP family, which mediates 
diverse biological effects ranging from pain perception to male aggression. Genetic ablation 
of TRPV5 in the mouse allowed us to investigate the function of this novel Ca2+ channel in 
maintaining the Ca2+ balance. Here, we demonstrate that mice lacking TRPV5 display 
diminished active Ca2+ reabsorption despite enhanced vitamin D levels, causing severe 
hypercalciuria. In vivo micropuncture experiments demonstrated that Ca2+ reabsorption was 
malfunctioning within the early part of the distal convolution, exactly where TRPV5 is 
localized. In addition, compensatory hyperabsorption of dietary Ca2+ was measured in TRPV5 
knockout mice. Furthermore, the knockout mice exhibited significant disturbances in bone 
structure, including reduced trabecular and cortical bone thickness. These data demonstrate 
the key function of TRPV5 in active Ca2+ reabsorption and its essential role in the Ca2+ 
homeostasis.  
In humans, the daily dietary Ca2+ intake is less than 1000 mg, of which only 30% is 
absorbed in the intestinal tract. This percentage is significantly enhanced during growth, 
pregnancy, and lactation by increased levels of circulating 1.25-(OH)2D3. Although there is 
continuous turnover of bone mass, there is no net gain or loss of Ca2+ from bone in a young 
and healthy individual. This indicates that healthy adults excrete a maximum of 300 mg Ca2+ 
in the urine to balance the intestinal Ca2+ uptake and that the remaining 98% of the Ca2+ 
filtered in the glomeruli is reabsorbed along the nephron. The molecular mechanism 
responsible for Ca2+ absorption in the small intestine and the kidney was elusive for a long 
time.  
The cloning of transient receptor potential (TRP) cation channel subfamily V, member 
5 (TRPV5; originally called ECaC1) from vitamin D–responsive rabbit renal epithelial cells 
and TRP cation channel subfamily V, member 6 (TRPV6; originally called CaT1) from rat 
duodenum has ignited research into transcellular Ca2+ (re)absorption at the molecular level. 
Mammals harbor at least 21 genes of the so-called TRP channels, whose functions remain 
mostly unknown. TRPV5 has been implicated as the Ca2+ influx channel in the process of 
vitamin D–responsive active Ca2+ reabsorption in the kidney. In comparison, the TRPV5 
homolog TRPV6, which displays an amino acid sequence identity of about 75% to TRPV5, 
has been postulated to be the Ca2+ influx channel facilitating Ca2+ absorption in enterocytes. 
TRPV6 is ubiquitously expressed and has been implicated as part of the capacitative Ca2+ 
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entry mechanism and, therefore, intracellular Ca2+ signaling. TRPV5 and TRPV6 are Ca2+-
selective channels that belong, together with the temperature-activated vanilloid receptors, to 
the TRPV subfamily. Genomic cloning has demonstrated that TRPV5 and TRPV6 form a 
unique pair of novel Ca2+ channels that are transcribed from distinct genes juxtaposed on 
human chromosome 7q35. 
As shown in Xenopus oocytes, SGK1 and SGK3 activate the renal epithelial Ca2+ 
channel TRPV5 by enhancing channel abundance in the plasma membrane, an effect again 
requiring cooperation with NHERF2 (Embark HM. et al., (2004) Cell Physiol Biochem; 
Palmada M. et al., (2005) Cell Physiol Biochem). The TRPV5 C-tail interacts in a Ca2+-
independent manner with NHERF2. Deletion of the second, but not the first, PDZ domain in 
NHERF2 abrogates the stimulating effect of SGK1 on TRPV5 protein abundance (Palmada 
M. et al., (2005) Cell Physiol Biochem). 
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2. The aim of these studies 
 
 
The aim of these studies was to establish the influence of SGK kinases on renal 
function of Na+, K+ and Ca2+ channels at mice, a comparison between the normal mice 
wildtype and genetically modified mice knock-outs. 
Ca2+ homeostasis is a function of intestinal Ca2+ absorption and renal Ca2+ excretion 
(Hönderop et al., (2000) Curr Opin Nephrol Hypertens; Hönderop JG. et al., (2002) Annu Rev 
Physiol). Filtered Ca2+ is reabsorbed in the proximal tubule, loop of Henle, distal convoluted 
tubule, and connecting tubule. In the proximal tubule and loop of Henle, Ca2+ transport is 
accomplished by both transcellular and paracellular transport (Friedman PA. et al., (1995) 
Physiol Rev). In both segments, Ca2+ reabsorption is largely a function of Na+ reabsorption. 
Fine-tuning of renal Ca2+ excretion is achieved in the distal convoluted and connecting tubule, 
which reabsorbs Ca2+ exclusively through the transcellular pathway (Hönderop JG. et al., 
(2000) Curr Opin Nephrol Hypertens; Hönderop JG. et al., (2002) Annu Rev Physiol). The 
rate-limiting step of Ca2+ transport in those nephron segments is the Ca2+ entry across the 
apical cell membrane via the epithelial Ca2+ channel TRPV5/ECaC1 (Hönderop JG et al., 
(2000) J Biol Chem; Hönderop JG. et al., (2002) Biochem Biophys Res Commun). 
 Ca2+ is extruded across the basolateral plasma membrane by a Ca2+ATPase and a 
Na+/Ca2+ exchanger (Hönderop JG. et al., (2000) Am J Physiol Renal Physiol). In vitro 
experiments disclosed the ability of the serum and glucocorticoid-inducible kinase 1 (SGK1) 
to regulate TRPV5 (Embark HM. et al., (2004) Cell Physiol Biochem; Palmada M. et al., 
(2005) Cell Physiol Biochem). It does so, at least partially, by enhancing the channel protein 
abundance within the cell membrane. For this effect, SGK1 requires the cooperation of the 
Na+/H+ exchanger regulating factor 2 (NHERF2) (Embark HM. et al., (2004) Cell Physiol 
Biochem; Palmada M. et al., (2005) Cell Physiol Biochem). NHERF1 and NHERF2 are 
known to modulate the targeting and trafficking of several proteins including TRPV5 into the 
plasma membrane (Baccarini M. et al., (2005), FEBS Lett; Bell LM. et al., (2000), J Biol 
Chem; Bhargava A and Pearce D., (2004) Trends Endocrinol Metab). Transcription of SGK1 
is upregulated by several hormones and mediators including glucocorticoids (Alliston TN. et 
al., (2000), Endocrinology; Bhalla V. et al., (2005) Mol Endocrinol; Bhargava A. et al. (2001) 
Endocrinology), mineralocorticoids (Akutsu N. et al. (2001) MolEndocrinol; Bahr V. et al. 
(2002) Exp Clin Endocrinol Diabetes; Berger S. et al., (1999) Proc Natl Acad Sci USA) and 
1.25-dihydroxycholecalciferol (1.25(OH)2D3) (Abbasi S. et al., (2005) J Biol Chem). 
 The kinase is activated by insulin-like growth factor 1 (IGF1) and insulin through the 
phosphatidylinositol - 3(PI3) kinase and phosphoinositide-dependent kinase 1 (PDK1) (Abriel 
H. et al., (2000) FEBS Lett; Abriel H. et al., (1999) J Clin Invest; Alessi DR. et al., (1997) 
Curr Biol; Alonso L. et al., (2005) J Cell Biol; Asher C. et al., (2003) Biochem Biophys Acta; 
Auld GC. et al., (2005) Biochem J; Bednarski E. et al., (1998) Exp Neurol).  
To explore the functional role of SGK1 in the regulation of renal Ca2+ transport, 
clearance experiments were performed in SGK1 knockout mice (sgk1−/−) and their wild-type 
littermates (sgk1+/+ ). 
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To explore the role of SGK1 in DOCA-induced renal fibrosis, we implanted 
continuous-release DOCA pellets (2.4 mg/day) into gene-targeted mice lacking SGK1 
(sgk1−/−) and their wild-type littermates (sgk1+/+). The mice were exposed to 1% saline in 
drinking water and analyzed by blood pressure measurements, metabolic cages, and renal 
histology. 
SGK1 was originally discovered as a gene genomically upregulated by glucocorticoids 
(Firestone GL et al., (2003) Cell Physiol Biochem) and was later found to be a 
mineralocorticoid-inducible gene (Ali S. et al., (2003) Cell Physiol Biochem; Alvarez de la 
Rosa D. et al., (2005) Am J Physiol Cell Physiol; Aronzon A. et al., (2005) Otol Neurotol; 
Baltaev R. et al., (2005) Pflügers Arch; Böhmer C. et al., (2003) J Neurochem; Böhmer C. et 
al., (2003) Cardiovasc Res; Boulkroun S. et al., (2002). J Biol Chem; Brennan FE and Fuller 
PJ., (2000) Mol Cell Endocrinol; Brooks DE. et al., (1997) Am J Vet Res). SGK1 is expressed 
in the aldosterone-sensitive distal nephron (Akutsu N. et al., (2002) MolEndocrinol;L Böhmer 
C. et al., (2003) J Neurochem) and coexpression of SGK1 markedly enhances activity of the 
epithelial Na+ channel (ENaC) heterologously expressed in Xenopus oocytes  (Abriel H. et al., 
(1999) J Clin Invest, Alvarez de la Rosa D. et al., (1999) J Biol Chem; Aronzon A. et al., 
(2003) Otol Neurotol; Böhmer C. et al., (2006) J Neurochem; Böhmer C. et al., (2003) 
Cardiovasc Res; Brunet A. et al., (2001) Mol Cell Biol) and A6 cells (Faletti CJ et al., (2002)  
Am J Physiol Cell Physiol), an effect at least partially due to phosphorylation of the ubiquitin 
ligase Nedd4-2 (Asher C. et al., (2003) Biochem Biophys Acta; Brickley DR. et al., (2002) J 
Biol Chem), which reduces the affinity of the enzyme to the target protein (Abriel H. et al., 
(1999) J Clin Invest; Böhmer C. et al., (2006) J Neurochem; Brunet A. et al., (2001) Mol Cell 
Biol). 
  As a result, SGK1 inhibits ubiquitination of the ENaC and, thus, leads to enhanced 
ENaC protein abundance in the cell membrane. Also, SGK1 has been suggested to stimulate 
ENaC activity by direct phosphorylation of the carrier protein (Auld GC. et al., (2005) 
Biochem J). SGK1 also enhances the activity of other renal transport systems, including the 
apical renal outer medullary K+ (ROMK) channel (Böhmer C. et al., (2004) Biochem Biophys 
Res Commun; Busjahn A. and Luft FC., (2003) Cell Physiol Biochem), the Na+-K+-ATPase 
(Bhargava A. et al., (2001) Endocrinology; Bramham CR. and Messaoudi E., (2005) Prog 
Neurobiol; Busjahn A. et al., (2004) Cell Physiol Biochem) , the Na+-K+-2Cl- cotransporter 
NKCC2  (Böhmer C. et al., (2006) J Neurochem), the epithelial Ca2+ channel TRPV5, the 
Na+-H+ exchanger NHE3 and the K+ channel KCNE1 (Bednarski E. et al., (1998) Exp 
Neurol). 
  The stimulatory effect of SGK1 on the ENaC (Berridge MJ. et al., (2000) Nat Rev Mol 
Cell Biol), the Na+-K+-ATPase (Bhargava A. et al., (2001) Endocrinology; Bramham CR. et 
al., (2005) Prog Neurobiol; Busjahn A. et al., (2004) Cell Physiol Biochem) and the epithelial 
Ca2+channel TRPV5 (Böhmer C. et al., (2000) Cell Physiol Biochem) in Xenopus oocytes is 
shared by its isoforms SGK3, which has been discovered by homology screening (Blazer-
Yost BL. et al., (1998) Am J Physiol Cell Physiol) and as “cytokine-independent survival 
kinase” (Böhmer C. et al., (2004) Biochem Biophys Res Commun). In contrast to SGK1, 
SGK3 appears not to be a transcriptional target of glucocorticoids or serum (Blom IE et al., 
(2002) Matrix Biol). 
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All three kinases are, however, activated by insulin-like growth factor I and insulin 
through phosphatidylinositol 3-kinase and phosphoinositide dependent kinase 1 (Abbasi S. et 
al., (2005) J Biol Chem; Abriel H. et al., (2000)b FEBS Lett; Bahr V. et al., (2005) Exp Clin 
Endocrinol Diabetes; Bhalla V. et al., (2005) Mol Endocrinol; Bistrup C. et al., (2005) Acta 
Physiol Scand; Blazer-Yost BL. et al., (1999) Am J Physiol Cell Physiol; Boini KM. et al., 
(2006) Diabetes). Accordingly, SGK1 is considered to participate in the regulation of renal 
Na+ excretion by aldosterone, insulin, and insulin-like growth factor I (Alliston TN. et al., 
(2000) Endocrinology; Almeida RD. et al., (2005) Cell Death Differ; Alonso L. et al., (2005) 
J Cell Biol; Bureau I. et al., (1999) J Neurosci). 
The role of SGK1 in renal Na+ reabsorption is illustrated by the phenotype of the 
SGK1-knockout (sgk1−/−) mouse, which shows normal Na+ excretion and blood pressure 
when fed a normal-salt diet but does not show a sufficient decrease in renal Na+ excretion 
when fed a salt-deficient diet (Wulff P. et al., (2002) J Clin Invest). However, the mild 
impairment of renal Na+ retention in the sgk1−/− mouse differs from the severe salt wasting of 
mineralocorticoid receptor- knockout mice (Berger S. et al., (1998) Proc Natl Acad Sci USA) 
and the lethality of ENaC-knockout mice (Hummler E. et al., (1996) Nat Genet). Moreover, 
there was no evidence for renal salt wasting in the SGK3-knockout (sgk3−/−) mouse 
(McCormick JA. et al., (2004) Mol Biol Cell). Thus the following question arises: Does SGK1 
could fully replace SGK3 in sgk3−/− mice, and does SGK3 partially replace SGK1 in sgk1−/− 
mice? The present study was performed to explore whether animals lacking both SGK1 and 
SGK3 would be viable or would suffer from severe salt wasting. 
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3. Material  
 
3.1. Equipment 
 
Accucheck Sensor Comfort (Roche Diagnostics, Manheim, Germany) 
Balance (Sartorius, Göttingen, Germany) 
BioPhotometer Eppendorf (Eppendorf, Wesseling-Berzdorf, Germany) 
Blood pressure computerized data acquisition system (PowerLab 400 and Chart 4, 
AdInstruments, Colorado Springs, USA) 
Blood gas analyzer (Eschweiler System 2000, Kiel, Germany) 
Centrifuge 5417 R (Eppendorf, Hamburg, Germany) 
Electrometric titration (Chloridometer 6610, Eppendorf, Germany)  
Electrophoresis chamber (BioRad, München, Germany)                      
Flame photometry (AFM 5051, Eppendorf, Hamburg, Germany) 
Gamma Counter (Perkin Elmer, Massachusetts, USA) 
Kodak film (Sigma-Aldrich, Hannover, Germany) 
LightCycler System (Roche Diagnostics, Manheim, Germany) 
MagNa Lyser (Roche Diagnostics, Mannheim, Germany) 
Magnetstirrer KMO2 basic IKAMAG (IKA, Staufen, Germany)  
Metabolic cages (Techniplast, Hohenpeissenberg, Germany) 
Multireactiontubes (Eppendorf, Hamburg, Germany) 
MultiChanelPipet (Eppendorf, Hamburg, Germany) 
Multilevel counter (Victor 1420, PerkinElmer, Boston, USA) 
Petri dishes (Greiner Bio-one, Frickenhausen, Germany) 
Pipettes (Eppendorf, Hamburg, Germany) 
Pipette tips (Carl Roth, Karlsruhe, Germany) 
Spectronic GENESYS 6 UV-Vis Spectrophotometer (Thermo Fisher Scientific Inc. 
Massachusets, USA) 
SpeedVac SVC 100 (Savant Life Sciences, Bath, UK) 
Sterile PS-tube 4.5 ml 12.4/75 MM (Greiner bio-one, Frickenhausen, Germany) 
Sterile filters (Millipore, Cork, Ireland) 
Syringes, Omnifix-H, 1ml (Braun, Melsungen, Germany) 
Ultracentrifuge (Beckman Coulter, Krefeld, Germany) 
UV-cuvettes 8.5mm (Plastiband, Antwerp, Belgium) 
Vortex (Labnet Abimed, Langenfeld, Germany) 
Waterbath (Labortechnik, Seelbach, Germany) 
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3.2. Material 
 
Sgk1+/+ and sgk1−/− mice (n=30 each, 5-7 moths old) 
Sgk1+/+ and sgk1−/− mice (n=12 each, 6-9 moths old) 
Sgk1 +/+/sgk3+/+ and sgk1−/−/sgk3−/− mice (n=9 each, 12-16 months old) 
3.3. Kits 
 
Albumin determination kit (microfluoral, Progen, Heidelberg, Germany) 
Aldosterone kit-IMMUNOTECH, Abeckman Coulter Company (Demeditec, Kiel, Germany)  
cDNA kit (Promega, Mannheim, Germany) 
Creatinine determination kit - creatinine PAP (Lehmann, Berlin, Germany) 
Gamma-B 1.25-Dihydroxy vitamin D (IDS, Boldon, UK) 
Glucose kit: gluco-quant® (Roche Diagnostics, Mannheim, Germany) 
Inorganic Phosphate (Roche Diagnostics, Mannheim, Germany) 
Intact parathormone ELISA kit (Immunotopics, San Clemente, CA, USA) 
Magnesium determination kit (Roche Diagnostics, Mannheim, Germany) 
Master SybrGreen I mix (Roche Molecular Biochemicals, Mannheim, Germany) 
Mouse intact PTH Elisa kit (Immunotopics, California, USA) 
Plasma leptin ELISA kit (Linco, St. Charles, USA) 
RNA kit (RNeasy Mini Kit, Qiagen, Hilden, Germany) 
RNA kit PAXgene System (Qiagen, Hilden, Germany) 
Vasopressin kit ADH (IBL, Hamburg, Germany). 
3.4. Chemicals 
 
Acetic acid 4% (Sigma-Aldrich, Hannover, Germany) 
Acrylamide/Bysacrylamide (Carl Roth, Karlsruhe, Germany) 
Agarose-Gel-Elektrophorese-Chamber (Biorad, München, Germany) 
Aqua ad injectabili (Ampuwa, Niefern, Germany) 
Ammoniumpersulphate (Carl Roth, Karlsruhe, Germany) 
Azotic acid (Sigma-Aldrich; Hannover, Germany)  
Beta-Mercaptoethanol (Sigma-Aldrich; Hannover, Germany) 
BenchMark prestained protein ladder (Invitrogen, California, USA) 
Biorad protein assay solution (BioRad, München, Germany) 
Chlorhidric acid (Carl Roth, Karlsruhe, Germany) 
Complete Protease Inhibitor (Roche Diagnostics, Mannheim, Germany) 
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Diethylether (Carl Roth, Karlsruhe, Germany) 
DOCA pellets (50 mg, Innovative Research of America, Sarasota, Florida, USA) 
EDTA (Sigma-Aldrich, Hannover, Germany)  
EGTA (Sigma-Aldrich, Hannover, Germany)  
Ethanol absolute (99%) (Carl Roth, Karlsruhe, Germany) 
Ethidiumbromid (Sigma-Aldrich, Hannover, Germany) 
Glycin (Merck, Darmstadt, Germany) 
Glycerol (Sigma-Aldrich, Hannover, Germany) 
Glucose (Merck, Darmstadt, Germany) 
Inactin (Sigma-Aldrich, Hannover, Germany) 
Ketamine (Sigma-Aldrich, Hannover, Germany) 
Magnesiumchloride (Sigma-Aldrich; Hannover, Germany) 
Methanol absolute (99%) (Carl Roth, Karlsruhe, Germany) 
Milk powder (Carl Roth, Karlsruhe, Germany) 
Mouse albumin standard (Sigma, Taufkirchen, Germany) 
Natriumacetat (Sigma-Aldrich, Hannover, Germany) 
Natriumchloride (Sigma-Aldrich, Hannover, Germany) 
Nitrocellulose membrane (Schnell&Schlechker, Wiesbaden, Germany) 
Nitrogen liquide (Linde, Wiesbaden, Germany) 
Proteinase K (Boehringer Ingelheim, Manheim, Germany) 
Sterilium (Carl Roth, Karlsruhe, Germany) 
SDS (Sigma-Aldrich, Hannover, Germany)  
TEMED (Carl Roth, Karlsruhe, Germany) 
Trisbuffer (pH 8.5) (Sigma-Aldrich, Hannover, Germany) 
Triton X-100 (Roche Diagnostics, Mannheim, Germany) 
Tris-base (Sigma-Aldrich, Hannover, Germany) 
Tween 20 (Böhringer Ingelheim, Manheim, Germany) 
3.5. Diets (Altromin, Heidenau, Germany) 
 
Standard diet C1310/1314 [0.24% Na+, 0.71% K+, 0.95% Ca2+  (wt/wt)]   
Control diet C1000 [0.24% Na+, 0.71% K+, 0.95% Ca2+ (wt/wt)]  
Low-salt diet C1036 [0.015% Na+, 0.71% K+, 0.95% Ca2+ (wt/wt)]  
Low-Ca2+ diet C1031 [0.24% Na+, 0.71% K+, 0.08% Ca2+ (wt/wt)]  
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3.6. Anti mouse monoclonal antibodies 
 
Alexa Fluor 488 (Invitrogen, Karlsruhe, Germany) 
Antirabbit Alexa 546 antibodies (Invitrogen, Karlsruhe, Germany) 
Anti - TRPV5  (Alpha Diagnostics, San Antonio, Texas, USA) 
Blocking peptide for TRPV5 (Alpha Diagnostics, San Antonio, Texas, USA). 
Calbindin D-28K (Swant, Bellizona, Switerzland) 
HRP-conjugated antimouse secondary antibody (Santa Cruz Biotechnology, Heidelberg, 
Germany) 
GAPDH antibody (Santa Cruz Biotechnology, Heidelberg, Germany) 
GAPDH antibody (Search-LC, Heidelberg, Germany) 
3.7. Software  
 
Blood pressure computerized data acquisition software (PowerLab 400 and Chart 4, Colorado 
Springs, Colorado Springs, USA) 
Data link version 1.0.0 (Herbert &Scheneider Software &CAM, Siglingen, Germany) 
GraphPad Instat version 3.05 (GraphPad Software Inc., San Diego, USA) 
Magellan version 3.11 (Tecan GmbH, Crailsheim, Germany) 
Microsoft Windows 95 (Microsoft GmbH., Remscheid, Germany) 
Office (Excel, Word, PowerPoint) (Germany) 
Quantity One version 4.3.0 (BioRad, München, Germany) 
Sigma plot version 7.0 (Systat Software Inc., Erkrath, Germany) 
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4. Methods 
 
4.1. Generation of sgk1–/– mice  
 
 
Mice deficient in SGK1 (sgk1–/–) were generated and bred as previously described 
(Huang et al., (2004) J Am Soc Nephol; Wulff et al., (2002) J Clin Invest; Huang et al., (2004) 
J Am Soc Nephol). In brief, a conditional targeting vector was generated from a 7-kb fragment 
encompassing the entire transcribed region on 12 exons. The neomycin resistance cassette 
was flanked by two loxP sites and inserted into intron 11. Exons 4–11, which code for the 
sgk1 kinase domain, were “floxed” by inserting a third loxP site into intron 3. A clone with a 
recombination between the first and third loxP site (type I recombination) was injected into 
C57BL/6 blastocytes. Male chimeras were bred to C57BL/6 and 129/SvJ females. 
Heterozygous SGK1-deficient mice were backcrossed to 129/SvJ wild-type mice (Charles 
River, Sulzfeld, Germany) for ten generations and then intercrossed to generate homozygous 
SGK1 knockout mice (sgk1−/−) and their wild type littermates (sgk1+/+). Male and female 
sgk1−/− mice were used in the studies and compared with littermate sgk1+/+ mice of the 
respective gender. Mice were genotyped by PCR (Huang  Y. et al., (2004) J Am Soc Nephol; 
Wulff  P. et al., (2002) J Clin Invest). 
All animal experiments were conducted according to the guidelines of the American 
Physiological Society as well as the German law for the welfare of animals and were 
approved by local authorities.  
For evaluation of renal Ca2+ handling experiments were made on 5- to 7-month-old 
homozygous sgk1 knockout mice and their age- and sex-matched wild-type littermates. Mice 
were maintained on control diet (C1314, Altromin, Heidenau, Germany) prior to the 
experiment. To induce mineralocorticoid excess, wild-type (sgk1+/+) and sgk1 knockout 
(sgk1−/−) mice (6–9 months old, n=12 each) were treated with DOCA (2.4 mg/day) + 1% 
NaCl in drinking water over 12 weeks. Throughout the entire study, mice had free access to a 
standard mouse diet (C1310 - Altromin, Heidenau, Germany). The study was completed in 9 
animals from each group. 
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Figure nr. 13 - Generation of sgk1–/– mice. 
(a) Targeting strategy. The neomycin resistance cassette (gray box) was flanked by two loxP sites (ovals) and 
inserted into intron 11. Exons 4–11, which code for the Sgk1 kinase domain (open boxes), were “floxed” by 
inserting a third loxP site into intron 3. N indicates NheI restriction sites, and the small black bar indicates the 
external 5′ probe used for Southern blot analysis. Expected fragment sizes of the wild-type and targeted sgk1 locus 
are also indicated. One homologously recombined ES cell clone was transiently transfected with Cre recombinase, 
and a clone that had undergone recombination between the first and the third loxP site (type I recombination) was 
chosen for injection. Arrows below the gene indicate PCR primers used for genotyping. Numbers between the 
arrows indicate the size of the amplified fragments. Crossed bars below (a) indicate homologous recombination. 
(b) Southern blot of NheI-digested genomic DNA from ES cell clones after gene targeting hybridized with a 5′ 
external probe (black bar in a). Lane 5 shows a targeted ES cell line. (c) Genotyping by PCR of genomic tail DNA 
of homozygous (–/–) and heterozygous (-/+) sgk1-deficient mice and wild-type mice (+/+) using a mix of three 
specific primers (arrows in a). (d) Autoradiograph of Northern blot analysis of Sgk1-specific transcripts in +/+ and –
/– mice. The deletion of the kinase domain from the genome results in a size reduction of 0.9 kb at the mRNA level 
in sgk1–/– mice. 
 
 
Gene-targeted mice deficient in SGK1 (sgk1−/−) and SGK3 (sgk3−/−) (McCormick A. 
et al., (2004) Mol Biol Cell) were crossed, and the offspring were genotyped by PCR on tail 
DNA using neomycin resistance specific primers as previously described. Mice were 
reproduced by heterozygous crossing. The genetic background of the animals was a mix of 
Sv/J129 and C57BL/6.  
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4.2. Metabolic cages 
 
For evaluation of renal excretion, both sgk1−/− and sgk1+/+ mice were placed 
individually in metabolic cages (Techniplast, Hohenpeissenberg, Germany) for 24-h urine 
collection (Vallon V. et al., (2003) Neprhon Physiology) and had free access to drinking water 
or saline and the respective diet. The inner wall of the metabolic cages was siliconized and 
urine was collected under water-saturated oil.  
Experiments were made on 5- to 7-month-old homozygous SGK1 knockout mice and 
their age- and sex-matched wild-type littermates. The mice were exposed to either a control 
diet (C1310: 0.2% Na+, 1% K+, 0.9% Ca2+, Altromin, Heidenau, Germany), high-salt 
treatment (C1310 plus 1% NaCl in drinking water), or a low-calcium diet (C1031: 0.24% Na+, 
0.7% K+, 0.08% Ca2+, Altromin) with or without supplement of 1% NaCl in drinking water. 
Mice were maintained on control diet prior to the experiment. Before and throughout the 
experiments, mice were allowed free access to tap water or saline as indicated. To assess the 
effects of diuretics on renal clearance, mice were placed individually in metabolic cages 
without access to food or water. Urine was collected for 3 h after the intraperitoneal injection 
of furosemide (Lasix, 20 μg/gbw) with or without additional acetazolamide (Diamox, 50 
μg/gbw). 
To induce mineralocorticoid excess, wild-type (sgk1+/+) and SGK1 knockout (sgk1−/−) 
mice (6–9 months old, n=12 each) were treated with DOCA (2.4 mg/day) plus 1% NaCl in 
drinking water over 12 weeks. Drug delivery was achieved by repeated subcutaneous 
implantation of 21-day-release DOCA pellets in the neck area (Vallon V. et al., (2005) Am J 
Physiol Regul Integr Comp Physiol) during superficial general anesthesia (intraperitoneal 
midazolam 5 mg/kg plus ketamin 50 mg/kg), which was partially antagonized by flumazenil 
(0.5 mg/kg i.p.) afterwards. Prior to the pellet implantation, (control period), the mice had free 
access to plain tap water. After the implantation, the tap water was replaced by 1% NaCl 
(high salt). Throughout the entire study, mice had free access to a standard mouse diet (C1310 
- Altromin, Heidenau, Germany). The study was completed in nine animals from each group. 
For the evaluation of renal function of mice lacking both sgk1 and sgk3, experiments 
were carried out on 12 to 16 months-old homozygous double (SGK1/SGK3)-knockout 
animals (sgk1−/−/ sgk3−/−, 4 females and 5 males) and their wild-type littermates 
(sgk1+/+/sgk3+/+, 4 females and 5 males) and, for comparison, age-matched SGK1- knockout 
animals (sgk1−/−) and their wild-type littermates (sgk1+/+). 
The mice were maintained on a standard diet and tap water before the experiment. For 
evaluation of renal excretion, sgk1+/+/sgk3+/+ and sgk1−/−/ sgk3−/− mice were placed 
individually in metabolic cages over five consecutive days (Techniplast, Hohenpeissenberg, 
Germany) for 24-h urine collection. They had free access to tap water and a control diet 
(C1000, 0.24% Na+ (wt/wt); Altromin, Heidenau, Germany) for 2 days followed by a low-salt 
diet (C1036, 0.015% Na+ (wt/wt); Altromin) for another 3 days. The inner wall of the 
metabolic cages was siliconized, and urine was collected under water-saturated oil. 
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Metabolic cages protocol 
 
A. Assembly 
 
1. Clean all parts very carefully, especially the grid, food and bottle holder and the 
separation conus. 
2. Siliconize the metall grid from both sides, the inner surfaces of the pyramidal 
conus and the ring which is attached to the separation conus. Before siliconizing 
the separation conus, put two paper towels into the lower narrow part and only 
siliconize the upper broad part. Remove any silicone from the lower part with 
70% ethanol.  
3. Put all parts together, make sure that all parts are functioning properly and that 
nothing is broken. 
 
 
B. Maintenance 
 
1. Put all twelve fresh urine collecting tubes in the red rack and fill 150µl water 
saturated oil into them then add the grid. 
2. Number and weigh the appropriate number of green top cups, number and date 
the appropriate number Petri dishes, get enough long pellets for food holders (i.e. 
at least double the appropriate number, 4 to 4.5 cm long pieces). 
3. Remove water bottle holder, close cage with one of the numbered plates and take 
the bottle out of the holder. Weigh it and refill with fresh tab water or any other 
solution specified in the experimental protocol every second day. Before you 
weigh the bottle to put it back into the holder, tap it  on the palm of your hand to 
make sure that no air bubble is closing the metal nipple and is preventing water 
from coming down. Weigh the bottle with the metal nipple downwards in a 
horizontal position on the scales. Put the bottle back into the holder and do the 
same thing with the second bottle. Make sure that the rubber plate is at the front 
of the two bottles. Now attach rubber strap. 
4. Dismantle lower part of the first metabolic cage and put the round Plexiglas plate 
in, to prevent the loss of feces or urine during collection. Collect any adhering 
urine from the separation and pyramidal conuses. Put adhering feces into feces 
collector. Take out the conus part carefully and remove the ring at the end of the 
conus. Take out the urine collecting tube, put urine into green top cup and weigh 
again. Put feces into Petri dish. Put the ring, and both collecting tubes into a cage 
filled with hot water, to pre-clean them. Clean separation and pyramidal conuses 
with cold water and the small brush. Use a fresh ring and collecting tubes to put 
the metabolic cage together again.  
5. After having done this with all twelve cages start to exchange the food, take care 
of any food inside the cage or fallen into one of the collection tubes. 
6. Weigh the animal. If the mouse looses any urine or stool while being weighed, 
put it into the respective collector. 
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7. As the last step, weigh the drinking bottle and put it back into the holder in an 
upright position, if using the holder in the two bottle mode use a rubber ring to 
strap the bottles tightly into the holder, put into metabolic cage and attach 
collector for lost drinking water. Do not forget to put 200 µl of water saturated 
oil into this collector. 
8. Finally make a visual check that every cage looks the same and that nothing was 
forgotten. 
9. Clean the feces and urine  collector with the big brush and hot water. 
10. Close petridishes with two stripes of tape; put them into a plastic bag and in the 
–20 °C Freezer. 
11. Take one ml of urine (or everything if less), spin it down at 14000 rpm for 5 min. 
in a small Eppendorf centrifuge and put it in a labeled Eppendorf and then into 
the –20 °C as well. 
 
C. Trouble shouting  
 
1. Make sure bottles are labeled correctly. 
2. Put them into the holder in an upright position, attach rubber strap in the same 
position. 
3. If there is urine in the feces collector, measure it and mark the respective result 
in the list.  
4. If there is feces in the urine collector tube mark the respective result. 
5. If a mouse spills drinking water inside the cage, the pair of mice should be 
exchanged against another one. 
 
 
4.3. Blood, fecal and urinary concentrations 
 
To obtain blood specimens, animals were lightly anesthetized with diethyl ether (Roth, 
Karlsruhe, Germany) and approximately 150 μl of blood was withdrawn into heparinized 
capillaries by puncturing the retro-orbital plexus. Plasma and urinary concentrations of Na+, 
K+ and Ca2+ were measured by flame photometry (AFM 5051, Eppendorf, Germany). Plasma 
and urinary creatinine concentrations were measured by using an enzymatic colorimetric 
method (Creatinine PAP, Labortechnik, Berlin, Germany). Plasma intact parathormone levels 
were measured by using an ELISA kit (Immunotopics, San Clemente, California, USA) and 
plasma 1.25(OH)2D3 levels were measured with a RIA kit (IDS, Boldon, UK) according to 
the manufacturer’s instructions. Urinary albumin was measured fluorometrically using an 
albumin determination kit (microfluoral Progen, Heidelberg, Germany) on a multilabel 
counter (Victor 1420, Perkin Elmer, Boston, Massachussets, USA) according to the 
manufacturer’s instructions. Standard curves were generated with mouse albumin (Sigma 
Aldrich, Taufkirchen, Germany) and measurements were performed within the linear range 0–
156 mg/l.  
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 Urine, feces, plasma electrolytes measurement protocol 
 
1. Mix the following standard and zero solutions: 
a. Serum Zero: 1000 µl Li Dilution Solution - 1:100 from stock solution in the 
fridge- and 20µl ddH20 (Ampuwa) make five Eppendorfs (Dilution 1+50) 
b.Serum Standard: 1000 µl Li Dilution Solution and 20µl Serum Standard 
Solution (please take an aliquot, do not take it directly out of the bottle) make 
at least five Eppendorfs (Dilution 1+50) 
c. Urine Zero: 1000 µl Li Dilution Solution and 5 µl ddH20 (Ampuwa) make 
five Eppendorfs (Dilution 1+200) 
d.Urine Standard: 1000 µl Li Dilution Solution and 5µl Urine Standard 
Solution (please take an aliquot, do n0,ot take it directly out of the bottle) make 
at least five Eppendorfs (Dilution 1+200) 
2. Calibrate with zeros and standards  
3. Measure samples  
Measurement range:  Na-60-180 mmol/l; K- 1-9 mmol/l; Ca- 1-5 mmol/l 
Measurement range: Na- 10- 300 mmol/l; K- 5-200 mmol/l 
 
Feces preparation protocol 
 
Dry the feces sample at around 80° C for about 3 hour and take the dry weight. Add 5 
ml of 0.75 M HNO3 (5.2 ml acid in 94.8 ml distilled water) to the feces in a falcon tube of 15 
ml capacity and process for 48 hours to give a homogenous creamy mass (processing involves 
shaking of the sample for 12 hours on an electric shaker and keeping in a water bath at 50 °C 
for another 12 hours alternately and finally vortexing on a minishaker for 2 minutes to hasten 
homogenization). Then centrifuge the sample at 4500 rpm for 10 minutes and collect 1 ml of 
the supernatant. Centrifuge the supernatant again at 14000 rpm in an Eppendorf centrifuge for 
5 min. Take supernatant and store at -20 °C until analysis.  Thaw the sample before analysis 
and take 10 µl of the diluted sample for analysis.  Apply the dilution factor during 
calculations. 
 
 4.4. Blood pressure  
 
The tail cuff method has the advantage to be noninvasive and can provide 
reproducible results of systolic blood pressure if those precautions are taken into account 
(Kurtz et al., (2005) Arterioscler Tromb Vasc Biol). Systolic arterial blood pressure was 
determined by the tail-cuff method (IITC, model 179, Woodland Hills, California, USA) 
before, 7 weeks and 12 weeks following the initiation of DOCA/high-salt treatment. As 
reviewed recently, (Meneton P et al., (2000) J Am Soc Neprhol), the tail cuff approach to 
determine arterial blood pressure requires certain precautions to reduce the stress of the 
animals, including appropriate training of the mice over multiple days and adequate 
prewarming to dilate the tail artery. The animals were placed in a heated chamber at an 
ambient temperature of 28–30°C for 15 minutes and from each animal 10–20 blood pressure 
traces were recorded in one session per day. The readings from 3 days were then averaged to 
obtain a mean blood pressure. All recordings and data analyses were done using a 
computerized data acquisition system and software (PowerLab 400 and Chart 4). All 
measurements were done by one person during a defined time (between 2 and 4 P.M.) 
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4.5. TRPV5 and calbindin D-28K protein abundance  
 
Total protein was isolated from kidneys obtained from untreated sgk1+/+ (n=6) and 
sgk1−/− mice (n=6). Kidneys were removed and immediately frozen in liquid nitrogen. For 
calbindin D-28K the tissue was then homogenized in a lysis buffer containing 50 mM Tris–
HCl (pH 7.4), 100 mM NaCl, 1 mM EDTA, 1 mM EGTA, 50mM sodium fluoride, 5 mM 
sodium pyrophosphate, 1 mM sodium orthovanadate, 1% Triton X-100, 1% sodium 
deoxycholate, 1% sodium dodecyl sulfate, and a protease inhibitor cocktail (1 per 10 ml, 
Complete Mini EDTA-free). The homogenates were centrifuged at approximately 7000×g at 
4°C for 15 minutes and the supernatant was removed and used for Western blotting. 
For TRPV5 the nuclear and mitochondrial debris were cleared by centrifugation at 
7000×g for 15 min at 4°C. The supernatant was subjected to ultracentrifuge spin (100000×g 
for 1 h using Rotor 70.1 Ti, Beckman). The pellet from this spin was considered as a 
membrane fraction and was solubilized by use of lysis buffer containing 50 mM Tris–HCl 
(pH 7.4), 100 mM NaCl, 1 mM EDTA, 1 mM EGTA, 50mM sodium fluoride, 5 mM sodium 
pyrophosphate, 1 mM sodium orthovanadate, 1% Triton X-100, 1% sodium deoxycholate, 1% 
sodium dodecyl sulfate, and protease cocktail inhibitor (1 per 10 ml, Roche). 
 Total protein was determined by BioRad protein assay (BioRad, München, Germany). 
Total proteins (75 μg) were separated by sodium dodecyl sulfate–polyacrylamide gel 
electrophoresis (SDS PAGE) (10% Tris–glycine), transferred to nitrocellulose membranes, 
blocked for 1 h in blocking buffer (5% fat-free milk in PBS containing 0.1% Tween), and 
incubated overnight at 4°C with a  monoclonal anti-calbindin D-28K antibody diluted 1:500 
in a blocking buffer (Swant, Bellizona, Switzerland) and a rabbit polyclonal anti-TRPV5 
antibody (diluted 1:500 in blocking buffer). After incubation with a horseradish peroxidase 
(HRP)-conjugated anti-mouse secondary antibody, the bands were visualized with enhanced 
chemoluminescence (ECL) according to the manufacturer’s instructions. For calbindin D-28K 
homogenates were also probed with a primary glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) antibody (Santa Cruz Biotechnology, Heidelberg, Germany) as a loading control. 
Densitometric analysis of calbindin D-28K and TRPV5 was performed with Quantity One 
software and normalized using GAPDH.  For TRPV5 in addition, a specific blocking peptide, 
with the 20 amino acid sequence near the cytoplasmic C terminus of rat CaT-2/ECaC1, was 
applied in parallel (Alpha Diagnostics). 
 
 
Measurement for total proteins (Bradford assay) protocol 
 
1. Dilute Bradford Reagent in water 1:5 volumes 
2. Use 2µl Sample and 1000µl diluted Bradford reagent 
3. Vortex and add volume in 1 ml cuvette 
4. Measure sample with UV cuvette in Biophotometer  
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Western Blot Protocol 
 
1. Prepare stacking gel and resolving gel in Western blot system 
2. Running  step: 
• prepare samples 
• add samples on the gel according to concentration 
• run gel in running buffer 
3. Transfer step: 
• prepare sandwich for transfer (1 sponge, 1 paper, 1 nitrocellulose membrane, 1 gel, 
1 paper, 1 sponge) 
• add sandwich in transfer system  
• add transfer buffer and run transfer  
4. Determine the transfer of proteins fromm gel on membrane with Ponceau staining  
5. Blocking step: 
• block for non-specific binding in PBST plus non-saturated milk 5 % for 1-2 hours 
6. Add first Antibody: 
• leave overnight at  4° C on rotating system 
7. Wash 4-5 times with PBST buffer 
8. Add second Antibody: 
• leave 1-2 hours at room temperature on rotating system 
9. Wash 4-5 times with PBS Buffer plus 0.15% Tween 
10. Develop with ECL solution on film 
11. Analyse gel with Biorad Quantity One. 
 
 
Preparation of Brush Border Membrane Vesicles (BBMV) protocol 
 
BBMV were prepared from whole mouse kidney, jejunum and ileum using the Mg2+ 
precipitation technique as described previously (Biber B. et al., (1981) Biochem Biophys 
Acta). The small intestines were rinsed with ice-cold saline solution and opened 
longitudinally. Briefly, the mucosa was scraped off with a glass slide in a buffer containing 
(in mM) 250 Sucrose, 20 Tris (pH 7.5), 5 EGTA and a protease inhibitor cocktail (Roche, 
Mannheim, Germany). The suspension was homogenized with an Omnimixer for 1 minute. 
MgCl2 was added to the homogenate to a final concentration of 10 mM. The suspension was 
stirred on ice for 10 minutes and then centrifuged at 1600×g for 15 min. The plasma 
membranes retained in the supernatant were collected by centrifugation at 20000×g for 30 
min. The resultant pellet was suspended in a pH 7.4 buffer consisting of (in mM) 125 
Sucrose, 10 Tris (pH 7.5), 2.5 EGTA, 2.5 MgSO4. This suspension was homogenized with 50 
up-down strokes with a glass homogenizer and centrifuged at 20000×g for 30 minutes. The 
final pellet, containing the purified BBMV, was homogenized by passing the suspension 
through 25- and 28-gauge needles and solubilised. All the steps were carried out at 4°C. After 
the final suspension, samples were frozen at -80°C for later use. Membrane protein was 
assessed as described by Bradford. 
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4.6. TRPV5 and calbindin D-28K mRNA expression 
 
Total RNA of kidneys from sgk1+/+ (n=12 for TRPV5, n=7 for calbindin D-28K) and 
sgk1−/− mice (n=12 for TRPV5, n=7 for calbindin D-28K) was stabilized and extracted by use 
of the PAXgene System (Qiagen, Germany). Subsequently, 1 μg of total RNA was reverse 
transcribed to cDNA by using the reverse transcription system (Promega, Mannheim, 
Germany) with oligo(dT) primers according to the manufacturer’s protocol.  
To determine TRPV5 and calbindin D-28K mRNA levels, quantitative real-time PCR 
with the LightCycler System (Roche) was established. PCR reactions for TRPV5 and 
calbindin D-28K were performed in a final volume of 20 μl containing 2 μl cDNA, 3 mM 
MgCl2, 0.5 μM of both primers, 2 μl cDNA Master SybrGreen I mix (Roche), and 
diethylprocarbonate (DEPC)-treated water. The transcript levels of the housekeeping gene 
GAPDH were also determined for each sample by use of a commercial primer kit (Search-
LC, Heidelberg, Germany). PCR reactions for GAPDH were performed in a final volume of 
20 μl containing 2 μl cDNA, 2 μl primer mix (Search-LC), 2 μl cDNA Master SybrGreen I 
mix (Roche), and 14 μl DEPC-treated water. The target DNA was amplified during 35 cycles 
at 95°C for 10 s, 68°C for 10 s and 72°C for 16 s each with a temperature transition rate of 
20°C/s and a secondary target temperature of 58°C with a step size of 0.5°C. Melting curve 
analysis was performed at 95°C for 0 s, 58°C for 10 s, and 95°C for 0 s to determine melting 
temperatures of primer dimers and the specific PCR products. Melting curve analysis 
confirmed the amplified products, which were then separated on 1.5% agarose gels to confirm 
the expected size. Finally, results were calculated as a ratio of the target versus housekeeping 
gene GAPDH transcripts. The following intron-spanning primers were used for TRPV5 
(GenBank accession no. NM-001007572.1) and calbindin D-28K (GenBank accession no: 
NM-009788) were used TRPV5 - forward f1-5′-CGTTGGTTCTT ACGGGTTGAAC-3′, 
reverse r1-3′-GTTT GGAGAAC CACAGAGCCTCTA-5′; calbindin D-28K - forward f1-5′ 
AACT GACA GAGATGGCCAGGTTA-3′; reverse r1-3′- TGAA CTCTTTC CCACA 
CATTTT GAT-5′. 
 
4.7. SGK2 mRNA expression  
 
Automated disruption and homogenization of frozen renal tissue from sgk1+/+/sgk3+/+ 
(n=5) and sgk1−/−/ sgk3−/− (n=5) mice was performed using the MagNa Lyser (Roche 
Diagnostics, Mannheim, Germany). Cleared cell lysate was transferred for further RNA 
purification (RNeasy Mini Kit, Qiagen, Hilden, Germany). Subsequently, 1 μg of total RNA 
was reverse transcribed to cDNA utilizing the reverse transcription system (Bioscience) with 
oligo(dT) primers according to the manufacturer’s protocol. To determine murine SGK2 
(mSGK2) mRNA levels, quantitative real-time PCR was carried out with the LightCycler 
System (Roche Diagnostics). PCR for mSGK2 were performed in a final volume of 20 μl 
containing 2 μl of cDNA, 2.4 μl of MgCl2 (3 μM), 1 μl of primer mix (0.5 μM both primers), 
2 μl of cDNA Master SybrGreen I mix (Roche Molecular Biochemicals, Mannheim, 
Germany), and 12.6 μl of diethylpyrocarbonate-treated water. The transcript levels of the 
housekeeping gene GAPDH were determined for each sample using a commercial primer kit 
(Search LC, Heidelberg, Germany). PCR for GAPDH were performed in a final volume of 20 
μl containing 2 μl of cDNA, 2 μl of primer mix (Search LC), 2 μl of cDNA Master SybrGreen 
I mix and 14 μl of diethylpyrocarbonate treated water. The target DNA was amplified during 
35 cycles at 95°C for 10 s, 68°C for 10 s and 72°C for 16 s, each with a temperature transition 
rate of 20°C/s and a secondary target temperature of 58°C with a step size of 0.5°C. Melting 
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curve analysis was performed at 95°C at 0 s, 58°C at 10 s and 95°C at 0 s to determine 
melting temperatures of primer dimers and the specific PCR products. Melting curve analysis 
confirmed the amplified products, which were then separated on 1.5% agarose gels to confirm 
the expected size (413 bp). Finally, results were calculated as a ratio of target gene to 
housekeeping gene GAPDH transcripts. The following primers for mSGK2 (GenBank 
accession no. NM - 013731) were used: 5’-CCA CAG ACT TTG ATT TCC TC-3’ (forward) 
and 3’-GGC AGT CCA AGA GAA TGT T-5’ (reverse). The primers showed no overlap with 
murine SGK1 (mSGK1, Gen- Bank accession nr. NM-011361) and murine SGK3 (mSGK3, 
GenBank accession nr. NM-133220). 
 
  4.8. Immunohistochemistry 
 
For immunohistochemistry, kidneys from sgk1+/+ (n=4) and sgk1−/− mice (n=4) were 
fixed with 4% paraformaldehyde/ 0.1 M sodium phosphate buffer (pH 7.2) via retrograde 
perfusion over an indwelling aortic catheter and kept in buffered 4% paraformaldehyde for 
another 4 h. After immersion in 30% sucrose for 48 h, 12-μm cryostat sections were taken. 
After a brief rinse, the sections were incubated for 1 h in normal goat serum with 0.3% Triton 
X- 100. All the following washes and incubations were performed in phosphate-buffered 
saline (PBS) containing 0.3% Triton X-100 and 1% dimethyl sulfoxide. Without rinsing, 
polyclonal (rabbit) antibodies against TRPV5 (Alpha Diagnostics) diluted 1:100 and 
monoclonal (mouse) anti-calbindin D-28K (Swant) diluted 1:1000 were applied together in a 
moist incubation chamber for 12 h at 4°C. After three washes at 10 min each, sections were 
incubated with goat anti-mouse Alexa 488 (for calbindin D-28K detection) and antirabbit 
Alexa 546 (for TRPV5 detection) secondary antibodies (Molecular Probes, diluted 1: 400 for 
1.5 h). Controls were performed by omitting either one or both primary antibodies. After 
coverslipping with Mowiol, the slides were analyzed on a Zeiss LSM 510 Axioplan 2 
confocal microscope equipped with a 40x oil immersion lens (NA 1.3). By use of the 
multitrack function, individual fluorochromes were scanned with laser excitation at 488 and 
543 nm separately with appropriate filter sets to avoid cross talk. Controls were scanned with 
identical laser excitation and filter settings. In addition, transmitted light images were 
recorded. 
 
4.9. Morphology 
 
Fixed kidneys were stored in 4% paraformaldehyde/0.1 M sodium phosphate buffer. 
After the determination of kidney weight and volume, the kidneys were dissected into 1-mm 
thick slices perpendicular to the longitudinal axis. Using area-weighted sampling, 10 small 
pieces of the kidney cortex were selected for embedding in epon araldite. Semithin (1 μm) 
sections were prepared and stained with methylene blue/basic fuchsine. All remaining kidney 
slices were embedded in paraffin yielding one representative section of each slice for 
morphometric and stereological investigations. Four-micrometer sections were cut and stained 
with hematoxylin/eosin (HE), periodic acid-Schiff stain (PAS) and Sirius red as fibrous tissue 
stain. 
 
Semiquantitative, morphometric, and stereological measurements 
 
All semiquantitative, morphometric, and stereological measurements were performed 
in a blinded manner by an observer who was unaware of the study protocol. 
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Indices of renal damage (glomerulosclerosis, tubulointerstitial, and vascular 
damage). 
 
The glomerulosclerosis index as a parameter of progression of renal failure was 
determined on PAS-stained paraffin sections according to a previously described scoring 
system (scores of 0 to 4) for each animal as the arithmetic mean of assessing 100 glomeruli 
(Wolf G. et al., (2005) Kidney Int). The tubulointerstitial damage index, i.e., tubular atrophy, 
dilatation, casts, interstitial inflammation, and fibrosis, was assessed as previously described 
on PAS - stained paraffin sections at a magnification of 100× (Wolf G. et al., (2005) Kidney 
Int). The vascular damage score, i.e., mild/moderate/severe wall thickening, lumen 
obliteration, and fibrinoid necrosis, was determined using a semiquantitative scoring system 
(score 0–4) (Wolf G. et al., (2005) Kidney Int).  
Mesangiolysis, i.e., dissolution of the mesangial matrix with capillary dilation due to 
damage to mesangial or endothelial cells or the mesangial matrix, was determined on PAS - 
stained paraffin sections and graded in 100 systematically subsampled glomeruli per animal 
using a scoring system (0–4). The resulting index in each animal was expressed as the mean 
of all scores obtained.  
 
Glomerular geometry (paraffin sections, light microscopy, various magnifications) 
 
Briefly, glomerular geometry was analyzed as follows: Volume density (VV) of 
glomeruli and area density of glomerular tuft (AAT) were measured by point counting 
according to PP=AA=VV at a magnification of 400x on HE sections (PP, point density; AA, 
area density) (Schwarz U. et al., (1998) Kidney Int). Total area of glomerular tuft (AT) was 
then determined as AT=AAT×ACortex. The number of glomeruli per volume (NV) and the 
volume density (VV) of glomeruli were obtained using the formula NV =k/β x NA1.5 VV0.5, 
with k=1.1 and β=1.382. The total number of glomeruli was derived from the total volume of 
the renal cortex and the number of glomeruli per cortex volume: Nglom=NV×VCortex. The mean 
glomerular tuft volume was determined according to v= β/k x A1.5 T, with β=1.382 and k=1.1. 
 
Glomerular cells and capillaries (semithin sections, magnification 1000x)  
 
Glomerular cell number and volume were analyzed in semithin sections with a 100-
point eyepiece for point-counting at a magnification of 1000× (oil immersion) as previously 
described (Wolf G. et al., (2005) Kidney Int). Glomerular cell numbers (podocytes, mesangial 
cells, and endothelial cells) were calculated in at least 30 glomeruli for each animal, from cell 
density per volume (NcV) and volume density of the respective cell type (VcV) according to 
the formula NcV =k/β x Nc1.5A =Vc0.5 V , with k=1 and β=1.5 for podocytes and β=1.4 for 
mesangial and  endothelial cells. The respective cell volumes were calculated according to the 
equation Vc=VcV ×Vglom. 
 
4.10. Data analysis and statistics 
 
Unpaired t-test, or ANOVA as appropriate, has been employed to analyze for 
significant differences in the respective parameters between wild type and knockout mice. 
Data are provided as means ± SEM (standard error deviation), where n represents the number 
of independent experiments. Only results with p<0.05 were considered statistically 
significant.  
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5. Results 
 
Characterization of sgk1−/− and sgk1+/+ mice under normal and low Ca2+ diet 
 
As evident from immunohistochemistry (Figure nr.14), TRPV5 and calbindin D-28K 
were colocalized in distal convoluted tubules and connecting tubules. The TRPV5 abundance 
in connecting tubules and to a lesser extent in distal convoluted tubules was weaker in 
knockout mice (sgk1−/−) than in their wild-type littermates (sgk1+/+). After the mice were 
given a Ca2+-deficient diet, TRPV5 abundance increased in both sgk1−/− and sgk1+/+ mice, 
clearly pointing to SGK1-independent regulation of TRPV5.  
In Western blot analysis, the membrane protein level of TRPV5 was again lower in 
sgk1−/− than in sgk1+/+ mice (optical density 0.17 ± 0.03 in sgk1−/− vs 0.25 ± 0.03 in sgk1+/+; 
n=8 animals each, p<0.03 at paired comparison; Figure nr. 15). 
 
 
 
 
 
Figure nr. 15 - Western blot analysis of TRPV5 in membranes under control 
conditions in sgk1+/+ and sgk1−/− mice. 
a) Original Western blot showing membrane expression of TRPV5 in kidney of knockout and wild-type animals 
and its absence in liver tissue. 
b) Arithmetic means of the optical density±SEM (n=8 each). *p<0.05, indicates statistically significant difference 
between genotypes. 
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Cytosolic calbindin D-28K expression was significantly smaller in sgk1−/− than in 
sgk1+/+ mice (Figure nr.16). No significant differences were observed between sgk1−/− and 
sgk1+/+ mice under the control diet in the plasma concentrations of intact parathyroid 
hormone (33.1 ± 5.4 pg/ml in sgk1+/+ vs. 31.9  ±  4.9 pg/ml in sgk1−/−; n=12 animals each) 
and 1.25(OH)2D3 (147 ± 19 pmol/l in sgk1+/+ vs. 147 ± 22 pmol/l in sgk1−/−; n=12 animals 
each). Thus, the reduced abundance of membrane TRPV5 and cytosolic calbindin D-28K 
protein in sgk1−/− mice were not attributable to hormonal differences.  
 
 
 
 
Figure nr. 16 - Western blot analysis of cytosolic calbindin D-28K protein 
abundance under control conditions in sgk1+/+ and sgk1−/− mice. 
a. Original Western blots. 
b. Arithmetic means of the GAPDH-normalized relative density ± SEM (n=6 each). *p<0.05, indicates statistically 
significant difference between genotypes. 
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Figure nr. 14 - Immunohistochemistry of TRPV5 (n=4) and calbindin D-28K 
(n=4) abundance in distal tubular segments under control diet and low-Ca2+ diet 
in sgk1+/+ and sgk1−/− mice. 
 a. Overview of TRPV5 staining in sgk1+/+ and sgk1−/− mouse kidneys. 
 b. TRPV5 and calbindin D-28K colocalization in the distal convoluted tubule and connecting tubule. 
 c. High-power confocal images of TRPV5 immunoreactivity in distal tubules reveals its distribution over the entire 
cell cytoplasm in sgk1+/+ and sgk1−/− mice. 
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Quantitative real-time PCR measurements did not reveal statistically significant 
differences between the genotypes in the levels of mRNA encoding TRPV5 (ratio of TRPV5 
mRNA over GAPDH mRNA: 0.63 ± 0.08 in sgk1+/+ vs. 0.59 ± 0.05 in sgk1−/−; n=12 animals 
each) or calbindin D-28K (ratio of calbindin D-28K mRNA over GAPDH mRNA: 20.1 ± 3.0 
in sgk1+/+ vs. 17.8 ± 2.4 in sgk1−/−; n=7 animals each). 
The apparently low TRPV5 protein abundance in the cell membranes of sgk1−/− mice 
is expected to impair tubular Ca2+ reabsorption and thus favor calciuria. However, under the 
control diet the opposite was observed, i.e., absolute and fractional urinary excretion of Ca2+ 
was significantly lower in sgk1−/− than in sgk1+/+ mice (Figure nr. 17, Table nr. 1).  
 
 
 
 
 
Figure nr. 17 - Fractional excretion and renal Ca2+ excretion in sgk1−/− and 
sgk1+/+ mice under control diet and with free access to tap water or 1% saline. 
Arithmetic means ± SEM of fractional Ca2+ excretion (FE, %), and daily urinary excretion of Ca2+ (μmol/24 h/ g 
bw) in sgk1−/− (black bars) and in sgk1+/+ mice (white bars) under control diet and with free access to tap water 
(left, n=30 animals each) or 1% saline after 1 week (middle, n=18 animals each) and after 2 weeks (right, n=6 
animals each). #p<0.05, indicates statistically significant difference between diets; *p<0.05, indicates statistically 
significant difference between genotypes. 
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1% saline Tap water (n=30) 
1 st week (n=18) 2 nd week (n=6) 
 
sgk1+/+ sgk1-/- sgk1+/+ sgk1-/- sgk1+/+ sgk1-/- 
Body Weight  (g) 26.7±0.7 26.5±0.6 27.6±0.7 27.0±0.8 26.8±0.4 25.4±0.5 
Food intake (mg/g BW) 153±4 155±4 154±4 156±5 162±4 166±3 
Fluid Intake (µl/24h/ g BW) 211±11 200±6 229±8 247±15# 227±15 229±8# 
Hematocrit (%) 54.9±0.5 52.1±0.5 n.d. n.d. 53.4±0.7 49.2±0.5#
[Na+]plasma (mM) 153±2 152±2 n.d. n.d. 153±2 154±1 
[K+]plasma (mM) 4.5±0.1 4.6±0.1 n.d. n.d. 4.1±0.1 4.9±0.4 
[Ca2+]plasma (mM) 2.29±0.03 2.27±0.03 n.d. n.d. 2.30±0.07 2.30±0.06
Urinary flow (µl/24h /g BW) 111±9 92±6* 120±5 143±13 126±12 131±9 
Urine Na+ (µmol/24h/ g BW) 15.3±0.8 14.9±0.8 44.0±2.5 44.8±2.9 39.3±2.5 41.7±1.5 
Urine K+ (µmol/24h/ g BW) 33.5±1.1 32.9±1.1 31.3±0.8 32.1±1.1 31.1±0.9 34.4±0.9 
Urine Ca2+ (µmol/24h/g BW) 0.59±0.05 0.41±0.03 0.64±0.04 0.50±0.05 0.48±0.05 0.41±0.04
Creatinine clearance (µl/min /g 
BW) 
6.3±0.4 7.1±0.5 6.1±0.6 5.9±0.3 7.4±1.4 7.8±0.5 
Fractional excretion Na+ (%) 1.04±0.05 0.93±0.04 2.79±0.32 2.50±0.16 2.47±0.23 2.46±0.16
Fractional excretion K+ (%) 77.4±3.7 69.1±4.7 83.8±9.6 81.7±3.2 73.0±9.7 74.1±4.8 
Fractional excretion Ca2+ (%) 2.6±0.2 1.6±0.2 3.2±0.7 2.4±0.2 2.3±0.5 1.8±0.2 
 
Table nr. 1 - Effect of high salt intake on body weight, food and fluid intake, 
plasma concentrations and urinary excretion of electrolytes. 
Body weight, food and fluid intake, hematocrit, Na+, K+ and Ca2+ concentrations in plasma, urinary flow, renal 
excretions of Na+, K+ and Ca2+, creatinine clearance and fractional renal excretions of Na+, K+ and Ca2+ in both  sgk1-/- and 
in sgk1+/+ mice under control diet at free access to tap water (n=30 each) or 1% saline 1st week (n=18 each) or 2nd 
week (n=6 each). Arithmetic means ± SEM (number of animals studied); # (p<0.05) indicates statistically significant 
difference between control and high salt diet; * (p<0.05) indicates statistically significant difference between 
genotypes (n..d. - not determined.). 
 
 
Under the chosen experimental conditions, the differences of renal Ca2+ elimination 
had little influence on the Ca2+ balance, as in both genotypes renal excretion was less than 2% 
of the calculated dietary Ca2+ intake (sgk1+/+: 825 ± 43 μmol/24h/g bw, sgk1−/−: 775 ± 47 
μmol/24h/g bw, n=6 animals) and fecal Ca2+ excretion (sgk1+/+: 773 ± 24 μmol/24 h/g bw, 
sgk1−/−: 709  ±  26 μmol/24h/g bw, n=6 animals).  
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Under a Ca2+-deficient diet, renal elimination of Ca2+ decreased significantly in both 
sgk1−/− and sgk1+/+ mice (Table nr. 2, Figure nr. 19). The ability of the sgk1−/− mice to 
decrease urinary Ca2+ output again points to SGK1- independent regulation of renal tubular 
Ca2+ reabsorption. However, the decrease of absolute and fractional excretion upon exposure 
to the Ca2+-deficient diet was blunted in the sgk1−/− mice.  
Thus, the Ca2+-deficient diet dissipated the differences of absolute and fractional Ca2+ 
excretions between sgk1−/− and sgk1+/+ mice. Replacement of tap water in the drinking bottle 
with 1% saline led to the expected increase in urinary Na+ output (Table nr. 2), which was 
paralleled by a moderate increase in urinary Ca2+ output (Figure nr.18, Table nr. 2). During 
salt loading, the urinary excretion of Ca2+ remained slightly lower in sgk1−/− than in sgk1+/+ 
mice (Figure nr. 17, Table nr. 2). 
 
 
 
 
 
 
Figure nr. 18 - Renal Ca2+ excretion in sgk1−/− and sgk1+/+ mice under control diet 
and low-Ca2+ diet. 
Arithmetic means ± SEM of fractional Ca2+ excretion (FE, %) and daily urinary excretion of Ca2+ (μmol/24h/gbw) 
in sgk1−/− (black bars) and in sgk1+/+ mice (white bars) under control diet (left, n=30 animals each) and under low 
Ca2+ diet (middle and right, n=6 animals each). #p<0.05, indicates statistically significant difference between diets; 
*p<0.05, indicates statistically significant difference between genotypes. 
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Control diet 
tap water (n=30) 
Low Ca2+ diet+ 
tap water (n=6) 
Low Ca2+ diet + 
1%NaCl (n=6) 
 
sgk1+/+ sgk1+/+ sgk1+/+ sgk1-/- sgk1-/- sgk1-/- 
Body Weight (g) 26.7±0.7 25.7±1.4 25.7±1.3 24.9±1.5 24.6±1.7 26.5±0.6 
Food intake 
(mg/g BW) 
153±4 167±7 167±4 171±6 171±7 155±4 
Fluid Intake 
(µl/24h/ g BW) 
210±10 187±14 237±21 205±12 159±16# 199±6 
Hematocrit (%) 54.9±0.4 54.4±0.8 54.2±0.9 51.6±1.1 52.7±0.7 52.1±0.5* 
[Na+]plasma (mM) 153±2 155±1 173±2# 166±1 154±2 152±1 
[Ca2+]plasma (mM) 2.29±0.04 2.07±0.03# 2.41±0.06 2.29±0.08 1.98±0.05# 2.27±0.03
[K+]plasma (mM) 4.45±0.12 4.45±0.21 4.84±0.20 4.33±0.09 4.44±0.14 4.55±0.09
Urinary flow 
(µl/24h /g BW) 
111±9 91±5 114±10 99±8 75±10 92±6 
Urine Na+ 
(µmol/24h//g BW) 
15.3±0.8 13.8±0.5 32.3±1.9 30.1±2.0 14.7±1.1 14.9±0.8 
Urine K+ 
(µmol/24h /g BW) 
33.5±1.1 24.3±0.7 23.0±0.6 23.6±1.0 24.8±1.8 32.9±1.1 
Urine Ca2+ 
(µmol/24h/ g BW) 
0.59±0.05 0.13±0.01 0.14±0.02 0.12±0.01 0.11±0.01 0.41±0.03
Creatinine clearance 
(µl/min/ g BW) 
5.8±0.5 7.5±0.9 6.5±0.9 6.1±0.9 5.5±0.3 6.4±0.5 
Fractional excretion 
Na+ (%) 
1.04±0.05 1.99±0.15# 5.78±0.82# 6.22±1.10# 2.35±0.26# 0.93±0.04
Fractional excretion 
K+ (%) 
77.4±3.8 123.7±7.0# 159.3±24.4# 175.6±29.1# 139.0±16.1# 69.1±4.7* 
Fractional excretion 
Ca2+ (%) 
2.6±0.2 1.4±0.1# 1.7±0.2 1.7±0.3 1.3±0.1 1.6±0.1* 
 
Table nr. 2 - Effect of low-calcium diet on body weight, food and fluid intake, 
plasma concentrations and urinary excretion of electrolytes. 
Body weight, food and fluid intake, hematocrit, Na+, K+ and Ca2+ concentrations in plasma, urinary flow rate, renal 
excretions of Na+, K+ and Ca2+, creatinine clearance and fractional renal excretions of Na+, K+ and Ca2+ in both 
sgk1−/− and in sgk1+/+ mice under control (n=30 animals each) and low-Ca2+ diet (n=6 animals each) with free 
access to tap water or 1% saline. Fecal Ca2+ excretion was measured in n=6 animals each. Values are arithmetic 
means ± SEM. N.d. - Not determined; #p<0.05, statistically significant difference between diets; *p<0.05, 
statistically significant difference between genotypes. 
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To explore the sensitivity of renal Ca2+ excretion to inhibition of Na+ reabsorption, the 
NKCC2 inhibitor furosemide (20 μg/g bw) was applied with or without the carboanhydrase 
inhibitor acetazolamide (50 μg/g bw). Furosemide alone increased renal Ca2+ excretion in 
sgk1−/− and sgk1+/+ mice and abolished the difference of Ca2+ excretion between genotypes 
(Table nr. 3). The additional administration of acetazolamide did not further increase 
natriuresis or calciuria (Table nr. 3). 
 
 
 
Control (n=12) 
 
Furosemide (n=12) 
Furosemide+ 
Acetazolamide (n=12) 
 
sgk1+/+ sgk1-/- sgk1+/+ sgk1-/- sgk1+/+ sgk1-/- 
Urine Na+  
(µmol/mg crea) 
710±54 868±57 3224±857# 4227±710# 3356±307# 2989±246# 
Urine K+  
(µmol/mg crea) 
1905±118 1973±155 1909±180 2519±239 1594±92 1879±84* 
Urine Ca2+ 
(µmol/mg crea) 
30±3 22±2 65±22 64±16# 38±4 40±4# 
 
Table nr. 3 - Effect of furosemide and furosemide plus acetazolamide on urinary 
electrolyte excretion. 
Renal excretions of Na+, K+ and Ca2+ (μmol/mg creatinine) in both sgk1−/− and sgk1+/+ mice (n=12 animals each) 
under control diet with free access to tap water or after intraperitoneal injection with 20 μg furosemide/g bw with or 
without additional 50 μg acetazolamide/g bw. Excretion of electrolytes was expressed as ratio between the urinary 
concentration of the respective electrolyte and urinary creatinine concentration. Values are arithmetic means ± 
SEM #p<0.05, statistically significant difference between diets; *p<0.05, statistically significant difference 
between genotypes. 
 
 
Characterization of sgk1-/- and sgk1+/+ mice under DOCA/high salt 
 
Prior to treatment, fluid intake was similar in gene-targeted mice lacking functional 
SGK1 (sgk1−/−) and in their wildtype littermates (sgk1+/+) (Table nr. 4). Treatment with 
DOCA/high salt led to a marked increase of fluid and Na+ intake in both genotypes. Three 
weeks after the initiation of DOCA/high salt treatment, the fluid intake increased by 3.0 ± 0.2 
- fold (n=9) in sgk1−/− mice, and by 11.1 ± 1.9 - fold (n=9) in sgk1+/+ mice. Fluid intake 
increased further in sgk1+/+ mice during treatment and was significantly larger in sgk1+/+ mice 
than in sgk1−/− mice throughout the DOCA/high salt treatment (Figure nr. 19). 
After 12 weeks of treatment, body weight had increased significantly (p<0.05) more in 
the sgk1+/+ mice (+4.6 ± 0.9 g) than in the sgk1−/− mice (+1.7 ± 1.0 g). The fluid and food 
intake and the respective Na+ content allowed an approximate estimate of Na+ intake (Table 
nr. 4), which was again significantly larger in sgk1+/+ mice than in sgk1−/− mice under 
DOCA/high salt treatment.  
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Water DOCA 1% NaCl (week 12) 
 
sgk1+/+ sgk1-/- sgk1+/+ sgk1-/- 
Body Weight (g) 26.2 ± 1.04 26.6 ± 1.4 31.0 ± 1.1 # 29.3 ± 1.2 # 
Fluid Intake (ml/24h) 5.7 ± 0.4  5.6 ± 0.5 80.8 ± 15.8 # 13.8 ± 3.9 *. # 
Food Intake (g/24h) 3.5 ± 0.2 3.6 ± 0.2 4.9 ± 0.2 # 4.2 ± 0.2 
Daily Na+ Intake  
(µmol/24h) 
280 ± 29 313 ± 21 296441 ± 6737 # 6349 ± 1699* # 
Daily Ca2+ Intake (µmol/24h) 723 ± 75 809 ± 55 1090 ± 43 950 ± 41 
Daily K+ Intake (µmol/24h) 824 ± 85 922 ± 62 1243 ± 49 1082 ± 47 
Hematocrit (%) 54 ± 1 53 ± 1 51 ± 1 51 ± 1 
[Na+]plasma (mM) 151 ± 2 151 ± 2 141 ± 6 137 ± 5 
[K+]plasma (mM) 4.3 ± 0.2 4.4 ± 0.3 3.2 ± 0.3 3.4 ± 0.2 
[Ca2+ ] plasma (mM) 2.4 ± 0.07 2.4 ± 0043 2.3 ± 0.07 2.3 ± 0.05 
 
Table nr. 4 - Effect of DOCA/high salt treatment prior and 12 weeks after 
treatment on urinary electrolyte excretion.  
Body weight, intake of fluid, food, Na+, Ca2+ and K+ , hematocrit, Na+, Ca2+ and K+ concentrations in plasma prior to 
and 12 weeks following DOCA / 1% NaCl treatment. * indicates significant difference between sgk1−/− and sgk1+/+, # 
indicates significant difference to respective baseline (water) value. 
 
 
Figure nr. 19 - Fluid intake, urinary flow, and 24-h-creatinine clearance prior to 
and following DOCA/high salt treatment. 
Arithmetic means ± SEM of fluid intake (left panel), urinary output (middle panel), and 24-hcreatinine clearance 
(right panel) in SGK1 knockout mice (sgk1−/−, closed bars, n=9) and their wild-type littermates (sgk1+/+, open bars, 
n=9) prior to (baseline) and following 3-, 9- and 12-week treatments with DOCA/high salt. * indicate significant 
difference between sgk1−/− and sgk1+/+, # indicate significant difference from respective baseline value. 
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The treatment was followed by hypokalemia in both genotypes (Table nr. 4). Twenty-
four-hour-creatinine clearance and urinary output were similar in both genotypes prior to the 
treatment (Figure nr. 19). DOCA/high salt treatment tended to increase creatinine clearance in 
sgk1+/+ mice and tended to decrease creatinine clearance in sgk1−/− mice, with effects not 
reaching statistical significance. Within 3 weeks of DOCA/high salt treatment, the urinary 
volume increased significantly by 24.8 ± 5.0-fold in sgk1+/+ mice and 3.9 ± 0.4-fold (n=9) in 
sgk1−/− mice. In sgk1+/+ mice, urinary volume increased further within 9 and 12 weeks 
(Figure nr. 19). 
Moreover, the DOCA/high salt treatment significantly increased the fractional 
excretion of Na+ and Ca2+ and tended to increase the fractional excretion of K+ in both 
genotypes (Figure nr. 20). 
 
 
 
Figure nr. 20 - Fractional excretions of Na+, K+ and Ca2+ prior to and following 
DOCA/high salt treatment.  
Arithmetic means ± SEM of fractional excretions of Na+ (FENa, left panel), K+ (FEK, middle panel) and Ca2+ 
(FECa, right panel) in sgk1−/− mice (closed bars, n=9) and sgk1+/+ mice (open bars, n=9) prior to (baseline) and 
following 3-, 9-, and 12-week treatments with DOCA/high salt. * indicate significant difference between sgk1−/− 
and sgk1+/+, # indicate significant difference from respective baseline value. 
 
 The fractional Na+ excretion was similar in both genotypes prior to the treatment 
(Figure nr. 19). Within 3 weeks of DOCA/high salt treatment, the fractional Na+ excretion 
increased 42.7 ± 8.8-fold in sgk1+/+ mice and 14.5 ± 3.6-fold (n=9) in sgk1−/− mice. The 
increase of fractional Na+ excretion was significantly larger in sgk1+/+ mice than in sgk1−/− 
mice. The increase of fractional K+ excretion tended to be larger in sgk1+/+ mice, a difference, 
however, not reaching statistical significance (Figure nr. 20). Under baseline conditions, the 
fractional Ca2+ excretion was similar in sgk1+/+ and sgk1−/− mice. Within 3 weeks of 
DOCA/high salt treatment, the fractional Ca2+ excretion increased 11.5 ± 3.7-fold in sgk1+/+ 
mice and 6.0 ± 1.3-fold (n=9) in sgk1−/− mice. As a consequence, fractional Ca2+ excretion 
was larger in sgk1+/+ mice than in sgk1−/− mice. Because in sgk1+/+ mice fluid intake 
increased further within 9 weeks of DOCA/high salt treatment, the fractional excretion of Na+ 
similarly increased further (Figure nr. 20). The additional natriuresis was paralleled by 
additional calciuria (Figure nr. 20). 
Prior to the treatment of the mice with DOCA/high salt, blood pressure was similar in 
sgk1−/− and sgk1+/+ mice (Figure nr. 21). DOCA/high salt treatment for 7 weeks led to a 
statistically significant increase of systolic blood pressure in both genotypes (Figure nr. 21), 
pointing to SGK1-independent effects of mineralocorticoids on blood pressure.  However, 
within the following weeks of continued DOCA/high salt treatment, systolic blood pressure 
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increased further in sgk1+/+ mice but not in sgk1−/− mice. Thus, 12 weeks after beginning of 
DOCA/high salt treatment, blood pressure was significantly higher in sgk1+/+ mice than in 
sgk1−/− mice. 
 
 
Figure nr. 21 - Blood pressure prior to and following DOCA/high salt treatment. 
Arithmetic means ± SEM of systolic blood pressure (sBP) in sgk1−/− mice (closed bars, n=9) and sgk1+/+ mice 
(open bars, n=9) prior to (baseline) and following 7- and 12-week treatments with DOCA/high salt. * indicates 
significant difference between sgk1−/− and sgk1+/+, # indicate significant difference from respective baseline value. 
 
Urinary albumin excretion as an indicator of glomerular hyperpermeability was 
markedly increased following treatment of sgk1+/+ mice with DOCA/high salt (Figure nr. 22). 
The increase of albuminuria was almost absent in sgk1−/− mice, even though the 
increase of systemic blood pressure was similar up to 7 weeks of treatment of sgk1+/+ and 
sgk1−/− mice. Thus, SGK1 is required for the development of severe albuminuria following 
DOCA/high salt treatment. 
 
 
Figure nr. 22- Urinary albumin excretion prior to and following DOCA/high salt 
treatment.  
Arithmetic means ± SEM of urinary albumin excretion in sgk1−/− mice (closed bars, n=9) and sgk1+/+ mice (open 
bars, n=9) prior to (baseline) and following 3-, 9-, and 12-week treatments with DOCA/high salt. * indicate 
significant difference between sgk1−/− and sgk1+/+, # indicate significant difference from respective baseline value. 
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 Kidney weight significantly increased following DOCA/high salt treatment in sgk1+/+ 
mice only (Figure nr. 23).  
 
 
Figure nr. 23 - Kidney weights following DOCA/high salt treatment.  
Arithmetic means ± SEM of kidney weights from DOCA/high salt treated sgk1+/+ (open bars) and sgk1−/− mice 
(closed bars, n=9 each), as well as from untreated age- and gender-matched sgk1+/+ and sgk1−/− mice (n=8 each). * 
indicates significant difference between sgk1−/− and sgk1+/+ mice, #indicates significant difference from untreated 
mice. 
 
Histological analysis revealed a marked influence of DOCA/high salt treatment on the 
morphology of kidneys from sgk1+/+ mice (Figure nr. 24). The treatment was followed by 
marked glomerular enlargement with segmental glomerulosclerosis and tubulointerstitial 
fibrosis in sgk1+/+ mice, effects clearly blunted in sgk1−/− mice (Tables nr. 5 and 6). 
 
Parameter sgk1+/+ (n=5) sgk1-/- (n=5) P-value
glomerular volume in µm³ 440 ± 23 363 ± 23 P=0.045
glomerular sclerosis index (GSI) 2.21 ± 0.26 1.85 ± 0.16 P=0.27 
mesangial sclerosis index (MSI) 0.62 ± 0.07 0.85 ± 0.14 P=0.18 
tubulointerstitial sclerosis index (TSI) 1.24 ± 0.42 0.15 ± 0.09 P=0.036
vascular sclerosis index (VSI) 0.67 ± 0.03 0.65 ± 0.08 P=0.83 
 
Table nr. 5 - Histomorphological data after 12 weeks of DOCA/high salt 
treatment (paraffin sections). 
Arithmetic means ± SEM of kidney parameteres from DOCA/high salt treated sgk1+/+ (open bars) and sgk1−/− mice 
(closed bars, n=9 each). * indicates significant difference between sgk1−/− and sgk1+/+ mice, #indicates significant 
difference from untreated mice. 
 
 Stereological analysis of semithin sections revealed no difference in glomerular 
capillarization between sgk1+/+ and sgk1−/− mice. The number of podocytes and endothelial 
cells per glomerulus was also not significantly different between the two groups (Table nr. 6). 
Mesangial cell number, however, was significantly higher in sgk1−/− mice compared to 
sgk1+/+ mice. 
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Parameter sgk1+/+ (n=5) sgk1-/- (n=5) p-value
mesangial cell number per glomerulus 283 ± 15 351 ± 20 p<0.05
endothelial cell number per glomerulus 188 ± 19 188 ± 18 n.s. 
podocyte number per glomerulus 127 ± 5 119 ± 5 n.s. 
mesangial cell volume (µm3) 88 ± 8 80 ± 3 n.s. 
endothelial cell volume (µm3) 78.5 ± 3 80 ± 2 n.s. 
podocyte volume (µm3) 281 ± 46.1 325 ± 21 n.s. 
length density of glomerular capillaries 
(mm/mm3) 
10438 ± 2022 11566 ± 2067 n.s. 
 
Table nr. 6 - Glomerular cells and capillaries after 12 weeks of DOCA/high salt 
treatment (semithin sections).  
Arithmetic means ± SEM of kidney parameters from DOCA/high salt treated sgk1+/+ (open bars) and sgk1−/− mice 
(closed bars, n=5 each). * indicates significant difference between sgk1−/− and sgk1+/+ mice, #indicates significant 
difference from untreated mice. 
 
Figure nr. 24 - Morphology of kidneys following DOCA/high salt treatment.  
HE (upper and lower panels) and Sirius red fibrous staining (middle panel) of renal tissue from sgk1−/− (right) and 
sgk1+/+ mice (left) following a 12-week treatment with DOCA/high salt. As indicated by arrows, marked segmental 
glomerulosclerosis and tubulointerstitial inflammation with interstitial fibrosis is seen in sgk1+/+ and not in sgk1−/− 
mice. 
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Characterization of sgk1−/−/ sgk3−/− mice 
 
As shown in Figure nr. 25, hair growth was markedly delayed in sgk1−/−/ sgk3−/− 
mice. The time course of hair growth of the sgk1−/−/ sgk3−/− mice was virtually identical to 
that of the SGK3-knockout mouse (McCornick JA. et al., (2004) Mol Biol Cell). 
 
 
 
 
 
Figure nr. 25 - Hair growths on sgk1+/+/sgk3+/+ and sgk1−/−/sgk3−/−. 
Representative photographs of hair growth on serum- and glucocorticoid-inducible kinase SGK1 and SGK3 
double-knockout (sgk1−/−/ sgk3−/−) (right) mice and their wild-type littermates (sgk1+/+/sgk3+/+) (left) 10 wk after 
birth. 
 
 
After birth, body weight gain was slightly slower in (sgk1−/−/sgk3−/−) than in wildtype 
(Figure nr. 25), but after 12 weeks both groups attained an almost identical body weight. 
Thus, at the time of the experiments, body weight was not significantly different between 
sgk1+/+/sgk3+/+ and sgk1−/−/sgk3−/− mice (Table nr. 7). The low-salt diet did not significantly 
alter body weight (Table nr. 7). Food intake per body weight was slightly, but significantly, 
greater in sgk1−/−/sgk3−/− than in sgk1+/+/sgk3+/+ mice fed the control (p<0.0084) and low-salt 
(p<0.0013) diets (Table nr. 7). Food intake tended to increase after the low-salt diet, but the 
change did not reach statistical significance (p< 0.055 for sgk1+/+/sgk3+/+ and p< 0.057 for 
sgk1−/−/sgk3−/− ).  
Fluid intake in sgk1−/−/sgk3−/− mice similarly tended to increase after a salt-deficient 
diet and tended to be greater in sgk1−/−/sgk3−/− than in sgk1+/+/sgk3+/+ mice; again, the 
differences did not reach statistical significance. In sgk1−/− and sgk1+/+ mice fed the low-salt 
diet, fluid intake was significantly increased (Table nr. 8). 
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Control diet  Low salt diet 
 
sgk1+/+/sgk3+/+ sgk1-/-/ sgk3-/- sgk1+/+/sgk3+/+ sgk1-/-/ sgk3-/- 
Body Weight (g) 27.4 ± 0.8 (27) 26.3 ± 0.6 (24) 27.8 ± 1.7 (9) 25.8 ± 1.3 (9) 
Food intake (mg/g BW) 103.4 ± 5.6 125.1 ± 5.5* 118.7 ± 4.8 (24) 143.8 ± 4.3 (9)* 
Fecal dry weight (mg/g BW) 11.9 ± 1.0 (9) 15.1 ± 0.9 (9)* 11.2 ± 0.6 (9) 12.5 ± 0.6 (9)# 
Fluid Intake (µl/24h g BW) 194 ± 29 (27) 234 ± 29 (22) 122 ± 11 (9) 326 ± 94 (9) 
Urinary flow (µl/24 h g BW) 79.2 ± 16.2 (27) 88.8 ± 16.9 (23) 46.5 ± 5.4 (9) 76.3 ± 13.1 (8) 
Hematocrit (%) 49.9 ± 0.6 (9) 50.7 ± 1.0 (9) 50.1 ± 0.7 (9) 50.0 ± 0.9 (9) 
[Na+]plasma (mM) 141.7 ± 1.1 (9) 143.2 ± 1.6 (9) 141.3 ± 1.2 (9) 143.1 ± 0.5 (9) 
[K+]plasma (mM) 4.1 ± 0.2 (9) 4.2 ± 0.2 (9) 4.3 ± 0.1 (9) 4.5 ± 0.1 (9) 
Creatinine clearance  
(µl/min/g BW)  
5.4 ± 0.4 (9) 5.0 ± 0.5 (9) 4.6 ± 0.5 (9) 5.2 ± 9.5 (8) 
Urine Na+ (µmol/24h g BW) 5.49 ± 0.57 (27) 7.21 ± 0.69 (22)* 0.4  ± 0.1 (9)# 1.18 ± 0.18 (8)*#
Urine K+ (µmol/24h g BW) 14.8 ± 1.7 (27) 17.6 ± 1.6 (22) 11.7  ± 1.3 (9) 17.6 ± 1.3 (7)* 
Fecal Na+ (µmol/24h g BW) 4.0 ± 0.6 (9) 4.6 ± 0.2 (9) 0.9  ± 0.2 (9)# 0.6 ± 0.1 (9)# 
Fecal K+ (µmol/24h g BW) 1.9 ± 0.2 (9) 2.5 ± 0.2 (9) 2.2  ± 0.3 (9) 2.1 ± 0.3 (9) 
Fractional excretion Na+ (%) 
 
0.54 ± 0.07 (9) 0.79 ± 0.09 (9)* 0.04 ± 0.01 (9) 0.12 ± 0.03 (8)* 
Fractional excretion K+ (%) 42.0 ± 6.2 (9) 57.3 ± 5.8 (9) 40.0 ± 5.0 (9) 67.1 ± 9.6 (8) * 
 
 
Table nr. 7 - Physiological parameters for sgk1−/−/sgk3−/− vs. sgk1+/+/sgk3+/+ mice 
fed control and low-salt diets. 
Body weight, food and fluid intake, hematocrit, Na+ and K+ concentrations in plasma, fecal weight, fecal and renal 
excretions of Na+ and K+, creatinine clearance and fractional renal excretions of Na+ and K+, in both sgk1−/−/sgk3−/− 
and in sgk1+/+/sgk3+/+ mice under control and low salt diet. Arithmetic means ± SEM (number of animals studied); # 
p<0.05 control diet vs. low salt diet; * p<0.05 sgk1−/−/sgk3−/− vs. sgk1+/+/sgk3+/+. 
 
 
 
Fecal dry weight was significantly higher in sgk1−/−/sgk3−/− mice fed the control diet; 
this difference disappeared when these animals were fed the low-salt diet (Table nr.7). As 
expected, fecal Na+ excretion significantly decreased in sgk1+/+/sgk3+/+ (p<0.0002) and 
sgk1−/−/sgk3−/− (p<0001) mice fed the low-salt diet. However, no significant differences were 
observed in fecal Na+ excretion between sgk1+/+/sgk3+/+ and sgk1−/−/sgk3−/− mice fed either 
diet. Fecal K+ excretion was similar in sgk1+/+/sgk3+/+ and sgk1−/−/sgk3−/− mice fed either diet 
(Table nr. 7). 
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No significant differences were observed in hematocrit between sgk1+/+/sgk3+/+ and 
sgk1−/−/sgk3−/− mice fed either diet or between the control diet and the low-salt diet in either 
genotype (Table nr.8). Similarly, plasma concentrations of Na+ and K+ were not significantly 
modified by the diet in either genotype  and were virtually identical in sgk1+/+/sgk3+/+ and 
sgk1−/−/sgk3−/− mice fed both diets (Table nr. 7). Plasma K+ concentration tended to increase 
on initiation of the low-salt diet and tended to be higher in sgk1+/+/sgk3+/+ than in 
sgk1−/−/sgk3−/− mice (Table nr. 7). None of these apparent differences reached statistical 
significance.  
 
 
Control diet Low salt diet  
sgk1+/+ Sgk1-/- sgk1+/+ sgk1-/- 
Body Weight (g) 30.1±0.7 32.8±1.6 27.8±0.6# 29.9±1.5# 
Food intake (mg/g BW) 120±8 116±6 111±5 83±5 
Fecal dry weight (mg/g BW) 10.5±0.7 10.4±0.6 11.6±0.9 8.6±0.7 
Fecal Na+ (µmol/24h g BW) 1.5±0.2 1.6±0.1 2.2±0.3 1.5±0.2 
Fecal K+ (µmol/24h g BW) 1.5±0.3 1.9±0.2 2.7±0.4 1.6±0.3 
Fluid Intake (µl/24h g BW) 187±27 162±13 286±29# 302±46# 
Urinary flow (µl/24 h g BW) 79±23 48±5 126±22 122±33# 
Hematocrit (%) 51.5±1.2 51.2±0.5 57.1±1.3# 58.1±1.1# 
[Na+]plasma (mM) 148±0.8 148±0.5 146±1.8 146±0.7 
[K+]plasma (mM) 4.5±0.1 4.6±0.2 5.3±0.2# 5.1±0.3 
24h-Creatinine clearance (µl/min/g BW) 5.0±0.4 5.6±1.2 2.6±0.2# 2.9±0.2# 
Urine Na+ (µmol/24h g BW) 8.0±0.5 6.7±0.4 0.28±0.05# 0.51±0.09#* 
Urine K+ (µmol/24h g BW) 13.1±0.9 11.3±0.7 13.0±0.9 10.3±0.4 
Fractional excretion Na+ (%) 0.79±0.07 0.67±0.08 0.05±0.01# 0.09±0.02 
Fractional excretion K+ (%) 40.5±4.7 36.0±4.3 68.9±6.2# 50.2±1.9# 
 
 
Table nr. 8 - Physiological parameters for sgk1−/− vs. sgk1+/+ mice fed control and 
low-salt diets. 
Body weight, food and fluid intake, hematocrit, Na+ and K+ concentrations in plasma, fecal weight, fecal and renal 
excretions of Na+ and K+, creatinine clearance and fractional renal excretions of Na+ and K+, in both sgk1-/- and in 
sgk1+/+ mice under control and low salt diet. Arithmetic means ± SEM of n=8 animals studied; # p<0.05 control 
diet vs. low salt diet; * p<0.05 sgk1-/- vs. sgk1+/+. 
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Plasma aldosterone concentration was significantly (p<0.01) higher in sgk1−/−/sgk3−/−  
than in sgk1+/+/sgk3+/+ mice fed the standard diet (Figure nr. 26). Over 7 days, plasma 
aldosterone concentration markedly increased in sgk1-/-/sgk3-/- mice fed the low-salt diet 
(p<0.01). The effect of the low-salt diet on plasma aldosterone concentration did not reach 
statistical significance (p<0.17) in sgk1+/+/sgk3+/+ mice. Plasma aldosterone concentration was 
also higher in sgk1−/− than in sgk1+/+ mice fed the control diet (71 ± 35 vs. 42 ± 12 pg/ml; n 
=5 each) and the low-salt diet (4515 ± 949 vs. 3395 ± 350 pg/ml; n =5 each). 
 
 
 
Figure nr. 26 - Plasma aldosterone concentrations in sgk1-/-/sgk3-/-and 
sgk1+/+/sgk3+/+ 
Plasma aldosterone concentrations in sgk1−/−/sgk3−/− (open bars) and sgk1+/+/sgk3+/+ (solid bars) mice fed a control 
or a low-salt diet for 7 days. Values are means ± SE (n=7–8 animals in each group). *significantly different 
(p<0.05) from sgk1+/+/sgk3+/+.  # significantly different (p< 0.05) from control diet. 
 
 
No significant differences were observed in creatinine clearance and urinary flow rate 
between sgk1−/−/sgk3−/− and sgk1+/+/sgk3+/+ mice fed either diet or between the control and the 
low-salt diet in either genotype (Table nr. 6). Urinary sodium excretion decreased 
significantly in sgk1+/+/sgk3+/+ (p<0.0002) and sgk1−/−/sgk3−/− (p<0.0001) mice fed the low-
salt diet. Under control (p<0.05) and low-salt (p<0.005) diet conditions, urinary Na+ excretion 
was significantly higher in sgk1−/−/sgk3−/− than in sgk1+/+/sgk3+/+ mice (Table nr. 7). The 
fractional Na+ excretion was again significantly decreased by the low-salt diet in 
sgk1+/+/sgk3+/+ (p<0.0001) and sgk1-/-/sgk3-/- (p<0.0001) mice. Fractional Na+ excretion was 
significantly higher in sgk1−/−/sgk3−/− than in sgk1+/+/sgk3+/+ mice fed either diet.  
Absolute and fractional urinary K+ excretion tended to be higher in sgk1−/−/sgk3−/− 
than in sgk1+/+/sgk3+/+ mice, a difference reaching statistical significance when the animals 
were fed the low-salt diet (p<0.03). The low-salt diet did not significantly influence absolute 
or fractional K+ excretion in sgk1+/+/sgk3+/+ mice, whereas it tended to increase K+ excretion 
in sgk1−/−/sgk3−/− mice (Table nr.7). 
Blood pressure was significantly (p<0.05) lower in sgk1−/−/sgk3−/− than in 
sgk1+/+/sgk3+/+ mice fed the control diet (103 ± 4 vs. 114 ± 3 mmHg; Figure nr.27). Neither 
the low-salt (2 wk) nor the high-salt diet significantly influenced systemic blood pressure. 
Blood pressure remained significantly lower in sgk1−/−/sgk3−/− than in sgk1+/+/sgk3+/+ mice 
fed low-salt (p<0.05) and high-salt (p<0.05) diets (Figure nr. 27). In sgk1−/− mice fed the 
control diet, blood pressure was similarly lower than in sgk1+/+ mice (106 ± 4 vs.121 ± 4 
mmHg; n =8 each, p<0.05). 
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Figure nr. 27 - Systolic blood pressure in sgk1−/−/sgk3−/− and sgk1+/+/sgk3+/+ under 
different diets. 
 Systolic blood pressure in sgk1-/-/sgk3-/- (open bars) and sgk1+/+/sgk3+/+ (solid bars) mice fed a control diet, a low-
salt diet, or a high-salt diet for 14 days. Values are means SE (n = 8 animals in each group). *Significantly different 
(P <0.05) from sgk1+/+/sgk3+/+. 
 
 
 Quantitative real-time PCR of liver and kidney did not reveal statistically significant 
differences between the genotypes in the levels of mRNA encoding SGK2 (ratio of SGK2 
mRNA to GAPDH mRNA) in liver or kidney (Figure nr.28). 
 
 
 
 
 
 
Figure nr. 28 - SGK2 transcript levels in liver and kidney from sgk1−/−/sgk3−/− 
and sgk1+/+/sgk3+/+. 
SGK2 transcript levels in liver and kidney from sgk1−/−/sgk3−/− (open bars) and sgk1+/+/sgk3+/+ (solid bars) mice 
shown as ratio of SGK2 mRNA to GAPDH mRNA (i.e., mRNA encoding SGK2) in liver and kidney. Values are 
means ± SE (n = 4–5 animals in each group). 
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 6. Discussion  
 
Characterization of sgk1−/− and sgk1+/+ mice under normal and low Ca2+ diet 
 
The present study reveals that under the control diet the abundance of TRPV5 in the 
cell membrane of the distal nephron, particularly in connecting tubules, is lower in  mice 
lacking functional SGK1 (sgk1−/−) than in their wildtype littermates (sgk1+/+). The difference 
was evident only in the membrane fraction but not in the transcript levels.  This observation 
could be taken as evidence of SGK1-dependent regulation of TRPV5 membrane trafficking in 
this nephron segment, confirming the in vitro capacity of SGK1 to enhance TRPV5 protein 
abundance and activity in the cell membrane (Embark HM. et al., (2004) Cell Physiol 
Biochem; Palmada M. et al., (2005) Cell Physiol Biochem). However, the decrease in TRPV5 
activity is expected to cause calciuria. Similarly, the decrease in calbindin D-28K protein 
abundance would be expected to decrease renal tubular Ca2+ reabsorption and thus to enhance 
renal Ca2+ elimination. The opposite is observed, i.e., the absolute and fractional excretion of 
Ca2+ is lower in sgk1−/− than in sgk1+/+ mice despite normal plasma calcitriol and parathyroid 
hormone concentrations in both genotypes. The relative anticalciuria of the sgk1−/− mice may 
be the result of the extracellular volume contraction, which is reflected in those mice by 
enhanced plasma aldosterone concentration even under standard NaCl intake (Wulff P. et al., 
(2002) J Clin Invest). 
 SGK1 mediates part of the stimulating effect of aldosterone on the renal epithelial 
Na+ channel (ENaC) (Pearce D. et al., (2003) Cell Physiol Biochem; Verrey F. et al., (2003) 
Cell Physiol Biochem) and thus the lack of SGK1 leads to impaired Na+ reabsorption in the 
terminal nephron segments (Wulff P. et al., (2002) J Clin Invest). As a result, the Na+ 
reabsorption in the proximal tubule and loop of Henle are enhanced. Micropuncture 
experiments documented the increase in proximal tubular Na+ reabsorption in sgk1−/− mice 
(Wulff P. et al., (2002) J Clin Invest).  
Ca2+ reabsorption in the proximal tubule and loop of Henle parallels the Na+ 
reabsorption (Friedman PA. et al., (1995) Physiol Rev) and is thus expected to be enhanced in 
sgk1−/− as compared to sgk1+/+ mice. Indeed, the difference in Ca2+ excretion between sgk1−/− 
and sgk1+/+ mice is dissipated after treatment with the NKCC2 inhibitor furosemide, which is 
expected to blunt not only Na+ but also Ca2+ reabsorption in the loop of Henle. The 
disappearance of the difference between sgk1+/+ and sgk1−/− mice after furosemide treatment 
thus points to enhanced tubular Ca2+ reabsorption in the furosemide-sensitive thick ascending 
limb of the loop of Henle from sgk1−/− mice. Acetazolamide did not augment natriuresis or 
calciuria and may not have been able to substantially inhibit proximal tubular electrolyte 
reabsorption. It appears that the anticalciuria of sgk1−/− mice is at least partly due to enhanced 
Ca2+ reabsorption in the loop of Henle. It should be kept in mind, however, that the use of 
diuretics provides only circumstantial evidence for the localization of altered renal tubular 
Ca2+ transport.  
The role of SGK1 in renal Ca2+ handling is reminiscent of its role in renal K+ 
elimination (Huang DY. et al., (2004) J Am Soc Nephrol). In contrast to sgk1+/+ mice, sgk1−/− 
mice are unable to rapidly excrete an acute potassium load and their ability to eliminate K+ 
during a K+-rich diet is impaired. Again, it is at least partly due to the impaired increase in 
ENaC activity, which impedes renal K+ elimination. In conclusion, despite decrease in 
TRPV5 abundance in the connecting tubule, SGK1 knockout mice are anticalciuric 
presumably due to a decrease in extracellular volume and enhancement of Na+ and Ca2+ 
reabsorption upstream of the aldosterone-sensitive distal nephron including the loop of Henle.  
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Characterization of sgk1−/− and sgk1 +/+ mice under Doca/high salt 
 
The present observations reveal similarities and differences in the renal effects of 
mineralocorticoids on gene-targeted mice lacking functional SGK1 (sgk1−/−) and their wild-
type littermates (sgk1+/+). These observations allow some conclusions as to the functional role 
of SGK1 in the mineralocorticoid-dependent regulation of renal function and the development 
of renal damage during mineralocorticoid and high salt excess. As observed earlier (Vallon V. 
et al., (2005) Am J Physiol Regul Integr Comp Physiol), mineralocorticoid excess leads to 
excessive salt intake and, hence, renal salt excretion in sgk1+/+ mice, an effect blunted in 
sgk1−/− mice. The enhanced salt intake and subsequent renal Na+ excretion in sgk1+/+ mice 
results from SGK1-dependent stimulation of salt appetite (Vallon V. et al., (2005) Am J 
Physiol Regul Integr Comp Physiol). The differences of salt intake by sgk1−/− and sgk1+/+ 
mice lead to the respective alterations of renal salt excretion concealing subtle differences of 
renal tubular Na+ transport regulation (Wulff P. et al., (2002) J Clin Invest). In a previous 
study focusing on the role of SGK1 in the regulation of salt appetite (Vallon V. et al., (2005) 
Am J Physiol Regul Integr Comp Physiol), the mineralocorticoid excess had been maintained 
only for 3 weeks, and no attempts had been made to assess the effect of chronic 
mineralocorticoid excess on the integrity of the kidney, the focus of the present study. 
Fractional urinary K+ excretion tended to be lower in sgk1−/− mice, which may relate 
to the stimulating effect of SGK1 on the renal outer medullary K+ channel ROMK1 (Yoo D. 
et al., (2003) J Biol Chem; Yun CC. et al., (2002) J Am Soc Nephrol) or other renal K+ 
channels leading to the impaired renal potassium elimination by the sgk1−/− mice (Huang DY. 
et al., (2004) J Am Soc Nephrol). Moreover, the calciuria appears to be blunted in sgk1−/− 
mice, again reflecting the tendency of the sgk1−/− mice to retain calcium (Sandulache D. et al., 
(2005) Pflügers Arch). Most importantly, the present observations disclose a crucial role of 
SGK1 in the development of albuminuria and renal tubulointerstitial fibrosis during 
mineralocorticoid and salt excess. SGK1 may be effective, in part indirectly, due to the 
stimulation of salt appetite (Vallon V. et al., (2005) Am J Physiol Regul Integr Comp 
Physiol), which leads to excessive salt intake in sgk1+/+ mice and subsequent excessive 
increase of blood pressure. 
  Hypertension is known to induce albuminuria and renal fibrosis (Fiebeler A. et al., 
(2005) Circulation; Kang N. et al.,  (2002) J Mol Med; Markmann A. et al., (2005) Cell 
Physiol Biochem; Shindo T. et al., (2002) J Mol Med). However, in the early stages of 
mineralocorticoid excess, blood pressure was similar in both genotypes but severe 
albuminuria occurred only in the wild-type mice. The effect of mineralocorticoid excess on 
albuminuria could thus have been, at least in part, more direct. Albuminuria in turn favors the 
development of renal fibrosis in part by upregulation of transforming growth factor beta 
(TGFβ) receptors (Wolf G. et al., (2004) Kidney Int). SGK1 is a transcriptional target of 
TGFβ (Lang F. et al., (2000) Proc Natl Acad Sci USA; Waldegger S. et al., (1999) 
Gastroenterology) and was suspected to participate in the machinery eventually leading to the 
stimulation of matrix protein deposition during fibrosing disease (Lang F. et al., (2000) Proc 
Natl Acad Sci USA; Friedrich B. et al., (2002) Kidney Blood Press Res; Waldegger S. et al., 
(1999) Gastroenterology; Wärntges S. et al., (2002) Cell Physiol Biochem; Fillon S. et al., 
(2002) Cell Physiol Biochem; Klingel K. et al., (2000) Am J Physiol Gastrointest Liver 
Physiol). 
It was, however, only recently that the functional significance of SGK1 in fibrosis 
became apparent (Vallon V. et al., (2006). J Mol Medicine; Feng Y. et al., (2005) Cell Physiol 
Biochem). SGK1 stimulates the transcription factor NFκB (Zhang L. et al., (2005) Cancer 
Res), which in turn stimulates the expression of connective tissue growth factor (CTGF) 
(Blom IE. et al., (2002) Matrix Biol). Mineralocorticoids increase the release of CTGF 
(Moussad EE. et al., (2000) Mol Genet Metab), which stimulates matrix protein formation 
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(Brigstock DR. et al., (2003) J Endocrinol; Ihn H. et al., (2002) Curr Opin Rheumatol). Most 
recently, it was shown that the upregulation of CTGF in cardiac tissue required the presence 
of SGK1 (Vallon V. et al., (2006) J Mol Medicine).  
Gene array further suggested the SGK1-dependent upregulation of plasminogen 
activator inhibitor-1 (Vallon V. et al., (2006) J Mol Medicine), a further signaling molecule 
participating in the regulation of fibrosis (Coffman TM. et al., (1998) Am J Physiol; Edgtton 
KL. et al., (2004) Kidney Int; Kanasaki K. et al., (2003) J Am Soc Nephrol; Okada H. et al., 
(2004) J Am Soc Nephrol). SGK1 transcription is similarly increased in diabetic nephropathy 
(Feng Y. et al., (2005) Cell Physiol Biochem; Lang F. et al., (2000) Proc Natl Acad Sci USA; 
Lang F. and Cohen P. (2001) Sci STKE 2001: RE17; Kumar JM. et al., (1999) J Am Soc 
Nephrol) and glomerulonephritis (Friedrich B. et al., (2002) Kidney Blood Press Res) and the 
present observations could indicate that SGK1 plays an active role in the pathophysiology of 
those diseases as well. 
SGK1 has been shown to be upregulated by excessive glucose concentrations and to 
participate in the stimulation of fibronectin formation by glucose (Feng Y. et al., (2005) Cell 
Physiol Biochem; Lang F. et al., (2000) Proc Natl Acad Sci USA). Interestingly, the 
overexpression of SGK1 did not significantly increase the formation of the matrix protein 
fibronectin at normal extracellular glucose concentrations but markedly increased the 
fibronectin formation at excessive extracellular glucose concentrations (Feng Y. Et al., (2005) 
Cell Physiol Biochem). Apparently, matrix protein formation is not triggered by increased 
expression of SGK1 alone, but requires the concerted action with further glucose- or 
mineralocorticoid-dependent mechanisms. 
Irrespective of the mechanisms involved, the present observations disclose the 
enhanced susceptibility to the fibrosing effects of mineralocorticoids plus high salt in the 
presence of SGK1. The observations could indicate that individuals with increased SGK1 
activity could be at an enhanced risk of developing fibrosing disease. Some 3–5% of 
Caucasians carry a gene variant of SGK1, which is associated with increased blood pressure 
(Busjahn A. et al., (2002) Hypertension; von Wowern F. et al., (2005) Kidney Int), increased 
body weight (Dieter M. et al., (2004) Obes Res), and a decreased QT interval (Busjahn A. et 
al., (2004) Cell Physiol Biochem), effects correlating with effects of SGK1 on the renal 
epithelial Na+ channel ENaC (Chen SY. et al., (1999) Proc Natl Acad Sci USA; Naray-Fejes-
Toth A. et al., (1999) J Biol Chem; Diakov A. and Korbmacher C., (2004) J Biol Chem), the 
renal and intestinal glucose transporter SGLT1 (Busjahn A. et al., (2004) Cell Physiol 
Biochem), and the cardiac K+ channel KCNE1/KCNQ1 (Busjahn A. et al. (2004) Cell Physiol 
Biochem).  
It is tempting to speculate that those individuals would be more prone to develop 
fibrosis following exposure to mineralocorticoid and salt excess.  
 
Characterization of sgk1−/−/sgk3−/− mice 
 
The present observations show that sgk1−/−/sgk3−/− mice are viable and display a 
phenotype reflecting properties of sgk1−/−and sgk3−/− mice. On the one hand, the mice display 
the same delay of hair growth described previously for sgk3−/− mice (McCormick JA. et al., 
(2004) Mol Biol Cell). Moreover, similar to sgk3-/- mice (McCormick JA. et al., (2004) Mol 
Biol Cell) they tend to be smaller, despite significantly greater food intake. The discrepancy 
may be due to moderately impaired intestinal nutrient absorption in the intestine, similar to 
that shown in sgk3−/− mice (Sandu C. et al., (2005) Pflügers Arch). 
On the other hand, the sgk1−/−/sgk3−/− mice display a moderate impairment of renal 
Na+ retention previously described in sgk1-/- mice (Wulff P. et al., (2002) J Clin Invest). 
This impairment is evident because of enhanced renal excretion of Na+, particularly in 
animals fed a low-salt diet, the enhanced plasma aldosterone concentration, and the decreased 
blood pressure under anesthesia (Wulff P. et al., (2002) J Clin Invest). The enhanced plasma 
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aldosterone concentration partially overrides the lack of SGK1 and apparently prevents 
hypotension in non-anesthetized animals. The moderate salt wasting of the sgk1−/−/sgk3−/− 
mice is similar to that of sgk1−/− mice, but by far less severe than that of mice lacking 
functional mineralocorticoid receptors (Berger S. et al., (1998) Proc Natl Acad Sci USA) or 
mice lacking a functional ENaC (Hummler E. et al., (1996) Nat Genet). Mice without 
mineralocorticoid receptors suffer from severe renal salt wasting (Berger S. et al., (1998) Proc 
Natl Acad Sci USA), and ENaC knockout mice are not viable (Hummler E. et al., (1996) Nat 
Genet). 
The mild salt wasting of sgk1−/− mice is consistent with SGK1-independent regulation 
of renal Na+ reabsorption (Wulff P. et al., (2002) J Clin Invest). In theory, the lack of severe 
salt wasting could have been due to the partial functional compensation by SGK3 in sgk1−/− 
mice. The present observations clearly demonstrate that this is not the case. Instead, the salt 
wasting in the sgk1−/−/sgk3−/− mice is not substantially more severe than that in sgk1−/− mice. 
Thus it appears safe to conclude that SGK3 does not play a major role in renal Na+ 
reabsorption and that it does not account for the SGK1-independent regulation of the ENaC.  
The third isoform, SGK2, similarly stimulated the ENaC in vitro (Friedrich B. et al., 
(2003) Pflügers Arch) and thus, is a further candidate for the SGK1-independent stimulation 
of the ENaC. However, SGK2 transcript levels are not upregulated in sgk1−/−/sgk3−/−  mice. 
Even though the influence of SGK1 on renal salt retention is only moderate, it may well play 
a significant role in deranged blood pressure regulation. 
 Enhanced SGK1 expression has been observed in the salt-sensitive Dahl rat (Farjah 
M. et al., (2003) Hypertension), and moderately enhanced blood pressure is observed in 
individuals carrying a variant of the SGK1 gene, affecting as many as 5% of unselected 
Caucasians (Busjahn A. et al., (2002) Hypertension). In the same individuals, increased body 
mass index (Dieter M. et al., (2004) Obes Res) and a shortening of the Q-T interval (Busjahn 
A. et al., (2002) Hypertension; Busjahn A and Luft FC., (2003) Cell Physiol Biochem) have 
been observed. The increased body mass index may be partially due to enhanced stimulation 
of the intestinal glucose transporter SGLT1 (Dieter M. et al., (2004) Obes Res), the 
accelerated cardiac repolarization due to enhanced activation of the cardiac K+ channel 
KCNE1 (Busjahn A. et al., (2004) Cell Physiol Biochem; Embark HM. et al., (2004) Cell 
Physiol Biochem). Thus excessive stimulation of carriers and channels by SGK1 could 
account for obesity, hypertension, and shortened cardiac action potential. SGK1 has 
previously been shown to regulate the ROMK1 channel (Yun CC et al., (2002) J Biol Chem). 
Moreover, SGK1-dependent ENaC activity is expected to depolarize the apical cell membrane 
of principal cells, thus favoring K+ secretion. Presumably, both effects lead to slightly 
impaired renal K+ elimination by the sgk1−/− mice (Huang DY. et al., (2004) J Am Soc 
Nephrol). Despite enhanced plasma aldosterone concentration, plasma K+ concentration is not 
lower in the sgk1−/−/sgk3−/−  mice. However, neither plasma concentration nor renal excretion 
of K+ is significantly different between sgk1−/−/sgk3−/− mice and sgk1+/+/sgk3+/+  mice. The 
phenotype of a gene-targeted mouse is influenced by the genetic background.  
We have been unable to breed sgk1−/− mice on a pure C57BL/6 background 
(unpublished observations). To minimize the bias of variable genetic background, 
comparisons were always made between littermates. The observations that hair phenotype is 
not as pronounced in sgk1−/−/sgk3−/− as in sgk3−/− mice and that salt wasting is not as severe 
in sgk1−/−/sgk3−/− as in sgk1−/− mice indicate that there is little overlap of SGK1 and SGK3 in 
these functions. Thus, even though there is considerable overlap of targets (Lang F. et al., 
(2003) Cell Physiol Biochem; Pearce D., (2003) Cell Physiol Biochem) and regulation (Lang 
F and Cohen P., (2001) Sci STKE), the kinases are apparently not serving identical functions. 
Additional experiments are needed to elucidate whether the lack of SGK1 and SGK3 has 
additive effects on other functions. If so, those functions are not required for viability, or they 
are sufficiently maintained in the absence of SGK1 and SGK3 that the mice do not show 
gross functional deficits. 
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